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vABSTRACT
The immune system generates discrete lineages of cells that are designed to 
respond optimally to environmental cues and infectious agents. Two distinct lineages of 
T cells, distinguished by expression of either an αβ or γδ T cell receptor (TCR), arise 
from a common progenitor in the thymus. The type of pathogen and the cytokine milieu 
directs effector differentiation of αβ T cells in the periphery through the induction of 
specific transcriptional networks. γδ T cell development is distinct from that of αβ T cells 
in its ordered rearrangement of TCR genes and the pairing of Vγ and Vδ chains to 
generate γδ T cell subsets that home to specific tissues. Unlike conventional αβ T cells, 
γδ T cells express a preactivated or memory phenotype prior to pathogen encounter, and 
recent evidence indicates that effector functions may be programmed during thymic 
development. To better understand the development and function of γδ T cells, we 
analyzed the gene expression profiles of subsets of γδ T cells segregated by TCR 
repertoire and maturation state in the thymus. We also determined the impact of TCR 
signaling and trans-conditioning on γδ T cell subset-specific gene signatures by analysis 
of Itk-/- and Tcrb-/- γδ T cell subsets. Our analysis has defined three stages of γδ T cell 
subset-specific differentiation, and indicates that γδ T cells may consist of at least two 
separate lineages, distinguished by the expression of a Vγ2 or Vγ1.1 TCR, that arise from 
different precursors during thymic development. Key transcriptional networks are 
established in immature γδ T cells during the first phase of development, independent of 
TCR signaling and trans-conditioning, with Vγ2+ cells expressing modulators of WNT 
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signaling, and Vγ1.1+ cells expressing high levels of inhibitor of DNA binding 3 (ID3), 
which regulates E2A/HEB proteins. The second stage involves the further specification 
of the Vγ2+ subset specific gene signature, which is dependent upon ITK-mediated 
signals. In the third stage, terminal maturation of γδ T cell subsets occurs, dependent on 
both TCR and trans-conditioning signals. The expression patterns of Vγ1.1+ subsets that 
differ in Vδ usage diverge, and all subsets further elaborate and reinforce their effector 
programming by the distinct expression of chemokine and cytokine receptors. Alteration 
of WNT signaling or E2A/HEB activity results in subset specific defects in effector 
programming, indicating that the transcriptional networks established at the immature 
stage are crucial for the functional maturation of γδ T cells. These data provide a new 
picture of γδ T cell development, regulated by multiple checkpoints that shape the 
acquisition of subset-specific molecular signatures and effector functions.
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CHAPTER I:
INTRODUCTION
1. Innate versus adaptive immunity
Throughout evolution, organisms and the pathogens that infect them have been 
engaged in a constant struggle for survival. The immune system that evolved to defend 
against challenges by viral and bacterial pathogens can be divided into two arms: innate 
and adaptive immunity (Figure 1.1). The innate immune system consists of cells with 
germline-encoded receptors, such as macrophages and NK cells, which recognize 
common features of pathogen infections. These cells are poised to react very quickly to 
detect antigen and respond without the need for cell division and expansion. In contrast, 
cells of the adaptive immune system, such as conventional αβ T cells and B2 B cells, 
undergo gene rearrangement to generate a diverse set of antigen receptors capable of 
recognizing an almost infinite array of pathogens. As only small numbers of these cells 
will be specific to any given pathogen, the adaptive immune response takes longer to 
develop to allow for the clonal expansion of antigen specific cells. After the pathogen is 
cleared, the innate cell population remains roughly unchanged, and would respond with 
similar kinetics to a secondary challenge with the same pathogen. However, adaptive 
cells generate long-lived memory cells that that can respond much more quickly and 
robustly to a secondary challenge with the same pathogen.  
There are several types of cells that do not fit strictly into the innate or adaptive 
category, such as NKT cells, γδ T cells, intestinal intraepithelial lymphocytes (IELs), and 
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Figure 1.1 Different characteristics of innate and adaptive immune cells.
The immune system is divided into two arms: innate and adaptive immunity. Innate 
immune cells have invariant antigen receptors, respond quickly to pathogen challenge, 
and respond with similar kinetics to a secondary infection with the same pathogen. In 
contrast, adaptive immune cells undergo gene rearrangement to generate a diverse set of 
antigen receptors. As only small numbers of these cells will be specific to any given 
pathogen, the adaptive immune response takes longer to develop to allow for the clonal 
expansion of antigen specific cells. Adaptive cells generate long-lived memory cells that 
that can respond much more quickly and robustly to a secondary challenge with the same 
pathogen.
3
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B1a B cells. These cells have characteristics of both adaptive and innate immune cells 
(Figure 1.2)(1). For example, similar to adaptive cells, they do rearrange their antigen 
receptors, although in some cases their repertoires are more restricted. These cells also 
usually have an activated or memory-like phenotype and are able to respond rapidly to 
antigen challenge, similar to innate cells. Again, similar to innate cells, most of these 
subsets either do not have any significant memory response, or the status of memory is 
not yet known.  This category of cells is collectively known as innate-like lymphocytes, 
and these cells play an important role in immunity, providing an early, antigen specific 
response to infection and priming the adaptive immune response for action. 
2. Ordered generation of γδ T cells
γδ T cells are a unique subset of innate-like T cells that are generated beginning 
early in fetal development. Like other innate-like cells, they undergo RAG-dependent 
VDJ recombination to generate their antigen receptors. Rearrangement of the different Vγ
gene segments is temporally regulated, and as a result γδ T cells are produced in waves of 
cells with specific Vγ genes (Figure 1.3)(2). The earliest γδ T cells that arise in the fetal 
thymus beginning at days 12-14 of development are Vγ3+ and they migrate to the 
epithelial layer of the skin. The next wave of γδ T cells to develop are the Vγ4+ cells, 
which predominantly migrate to the uterovaginal epithelium as well as the lung and 
tongue but can also be found in the peripheral lymphoid organs. Vγ5+ cells specifically 
home to the gut epithelium, where they make up ~50% of the T cells in that tissue. Vγ2+
and Vγ1.1+ cells are the major circulating populations of γδ T cells, and they are found in 
5
Figure 1.2 Innate-like cells share characteristics with both innate and adaptive 
immune cells.
Some cells do not fit strictly into the innate or adaptive categories, and have 
characteristics of both cell types. These cells include γδ T cells, NKT cells, B1a B cells, 
and others (listed in red box). These cells undergo gene rearrangement to generate their 
antigen receptors, can respond very quickly to pathogens, but do not necessarily generate 
long-lived memory responses. 
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Figure 1.3 γδ T cells are generated in waves that home to specific tissues.
Schematic of the ordered development of γδ T cells showing the approximate days during 
embryonic development when a given γδ subset is generated and the primary anatomical 
locations that the γδ T cell subset homes to after thymic egress.  
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the blood, spleen, and lymph nodes. In addition, Vγ2+ cells are also found in the lung, 
while some subsets of Vγ1.1+ cells are found at a high frequency in the liver (3-5). These 
different subsets of γδ T cells play diverse roles in the immune system, and have roles in 
wound healing, tumor surveillance, and responses to numerous viruses and bacteria (6, 
7).
3. Common origin of γδ and αβ T cells
αβ and γδ T cells are derived from common precursors in the thymus. The earliest 
double-negative (DN) T cell precursors lack expression of CD4 and CD8 and can be 
further subdivided into four successive stages based on differential cell surface 
expression of c-kit, CD25, and CD44. DN1 (CD25-CD44+) cells are a heterogeneous 
population that retain myeloid and NK potential. DN1 precursors that are ckit+ are 
thought to be more restricted to the T cell lineage, and are therefore designated as early T 
lineage progenitors (ETPs) (8, 9). At the DN2 (CD25+CD44+ckit+) stage, precursors are 
committed to the T cell lineage and begin to rearrange their γ, δ, and β genes (10, 11).
Gene rearrangement is completed during the DN3 (CD25+CD44-) stage, and precursors 
that productively rearrange their β chain and pair with the invariant α chain (preTα)
transition to the DN4 (CD25-CD44-) stage where TCRα gene rearrangement begins. 
Further differentiation into immature CD4+CD8+ double positive (DP) cells is indicative 
of irreversible commitment to the αβ T cell lineage. Precursors that productively 
rearrange Tcrg and Tcrd genes differentiate into γδ T cells, which can arise from DN2-
DN4 subsets, albeit with different efficiencies (12, 13). While many of the intermediates 
10
in T cell development are well established, the molecular mechanisms that direct αβ
versus γδ T cell lineage commitment from a common precursor remain controversial and 
unresolved.
4. Models of γδ/αβ T cell commitment
Over the years, two evolving models have been the focus of the field of γδ/αβ T 
cell lineage commitment, differing mainly in the role assigned to the T cell receptor 
(TCR) in determining cell fate. The TCR instructive model proposes that the strength of 
the signal through the TCR determines the lineage of bipotential precursors, where strong 
signals are thought to generate γδ T cells and weaker signals are thought to generate αβ T 
cells (14, 15). The stochastic model proposes that that a functional TCR simply permits 
the survival and maturation of precursor cells that are already lineage-biased (13, 16).
One of the predictions of the stochastic model is that T cell precursors are a 
heterogeneous population with distinct variations in gene expression that, once reinforced 
and fixed, become lineage-restricted. Thus, precursors that express TCRs that match their 
bias goes on to mature, while precursors that express TCRs that contradict their bias will 
not survive (Figure 1.4). 
5. The instructive model of T cell lineage commitment
The recent conceptual framework of the instructive model consists of documented 
differences in signaling by the preTCR and γδTCR (17), and the precedent that other T 
cell lineage and subset differentiation are thought to be controlled by TCR signal strength 
11
Figure 1.4 Two models of lineage commitment.
Schematic representation of the two major models of γδ/αβ T cell lineage commitment in 
the thymus. In the stochastic model (top), DN precursors are a molecularly heterogeneous 
population that are pre-committed to the αβ or γδ T cell fate prior to TCR expression. 
Subsequent expression of a TCR that matches the pre-determined fate serves to reinforce 
the fate decision and leads to cell survival and maturation. In the signal strength model 
(bottom), cell fate is determined by the strength of the TCR signal, with those receiving a 
strong signal (usually through the γδTCR) choosing the γδ T cell fate, and those receiving 
a weak signal (usually through the preTCR) choosing the αβ T cells fate.
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or duration (18, 19). Convincing experimental support for the quantitative instructive 
model of γδ/αβ T cell lineage commitment was provided by the laboratories of Love and 
Wiest using γδTCR transgenic (Tg) mice with altered signaling capacity (14, 15).
Hayes et al. showed that increasing the TCR signal strength in γδTCR Tg mice by 
overexpression of CD3ζ or the loss of an inhibitory signal via CD5 led to the generation 
of more Tg γδ T cells (14). Conversely, manipulations that led to decreased TCR 
signaling through loss of CD3ζ favored the development of DP thymocytes (14). These 
studies indicated that γδTCR-dependent αβ T cell development was favored when cells 
received “weak” signals through the TCR. In another system, using KN6 γδTCR Tg 
mice, which recognize the β2m-dependent non-classical MHC class Ib molecule T22, it 
was shown that decreasing the signal strength through restriction of ligand availability 
resulted in the generation of αβ lineage DP cells (15). However, in an alternate transgenic 
model of γδTCR interaction with T22 (G8 TCR Tg) the ligand was not essential for the 
production of mature (CD24lo) Tg+ thymocytes; rather it reduces the number of Tg+
thymocytes by negative selection (20).  Further, more recent analysis in non-transgenic 
mice has shown that γδ T cells reactive to T22 and T10 (which is highly homologous to 
T22) do arise in β2m-/- mice, which lack the ligands, and they remain CD4-CD8- with no 
down-regulation of the TCR, and show no skewing toward the αβ lineage (21). These 
issues will be discussed further in section 1.8. These conflicting results indicated that the 
requirements for γδTCR signaling in TCR transgenic mice may not be universally 
applicable to all γδ T cells developing in WT environments. Further, these studies still 
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cannot distinguish between altering the initial lineage choice and confirming a lineage 
choice made previously through a stochastic mechanism. 
The importance of the TCR in T cell lineage commitment was assessed in a non-
TCR Tg model by differentiating precursors on OP9 stromal cells expressing the Notch 
ligand Delta-like-1 (OP9-DL1) and manipulating TCR signaling. This system has been 
used extensively to study T cell development in vitro and is capable of supporting the 
development of αβ and γδ T cells (22). In this system, single αβ lineage pre-TCR 
expressing DN3 cells (DN3b) that would normally become αβ lineage DP cells could be 
altered toward a γδ-like fate (CD4-CD8-) by artificial manipulation of TCR signaling 
(23). Similar DN αβTCR+ thymocytes are especially prevalent in TCRαβ transgenic mice 
and have been shown to belong to the γδ T cell lineage (24, 25). Hence, these in vitro
studies suggested that TCR signaling impacts lineage maturation and that single preTCR+
DN3b cells that have been presumably weakly signaled by the preTCR (in some cases for 
as long as 8 days) are not lineage fixed. However, the transit time from the DN3 to DP 
stage in vivo is usually much shorter, about three days or less (26). The reasons for such 
an extended DN3b maturation in this system are unknown, as are the extent of any related 
gene expression changes in the precursors that arise from such prolonged signaling. 
Additionally, in reciprocal experiments where γδ T cells are generated in OP9-DL1 
cultures by strong signaling (TCRδ crosslinking), the cells that develop are not 
“conventional” γδ T cells, but instead resemble NKT cells (γδNKT cells discussed in 
section 1.8). Also troubling, cell surface levels of CD5, which normally correlate with 
signal strength, were diminished rather than enhanced on cells that received TCRδ
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crosslinking. Finally, when transferred into mice, all of the OP9-DL1 culture-derived γδ
T cells homed to the gut epithelium and few, if any, were found in the spleen and lymph 
nodes (23). From these results it is not clear whether the cells generated by TCR 
crosslinking in this system are representative of normal T cell development in vivo.
6. The stochastic model of lineage commitment
The stochastic model maintains that precursors are pre-committed to the γδ or αβ
lineage prior to TCR expression, which occurs at the DN3 stage. Thus, one issue that has 
long been in question is the precise developmental stage at which γδ/αβ lineage 
commitment occurs. Ciofani et. al provided the first evidence at the single cell level that 
the major point of lineage commitment occurs at the DN2/DN3 stage (27). They sorted 
single DN1, DN2, and DN3 cells and tested their developmental potential using the OP9-
DL1 culture system. The results showed that DN1 cells were not committed to either the 
αβ or γδ lineage, as almost all single cells were capable of giving rise to both αβ and γδ T 
cells. In contrast, over half of DN2 cells were already committed to one T cell lineage: 
~60% of DN2 cells were capable of generating only αβ T cells, while ~3% generated 
only γδ T cells. By the DN3 stage, virtually all cells had committed to either the αβ or γδ
lineage, with most of them committing to the αβ lineage (27). These results established 
the DN2-DN3 transition as the time when lineage commitment occurs and provided 
support for the existence of lineage-committed cells prior to TCR gene rearrangement, 
favoring the stochastic model. 
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Some have argued that the commitment seen at the DN3 stage in the OP9-DL1 
assays may not be accurate (23). It has been shown that the DN3 population can be 
further subdivided in two subsets: DN3a cells which have not committed to either T cell 
lineage, and DN3b cells which have functionally rearranged either the γδ TCR or passed 
the β-selection checkpoint (28). These subsets can be distinguished by expression of 
CD27 on the surface of DN3b cells, which make up the minority of the DN3 population 
(28). As the studies determining lineage potential from DN3 cells had a very low cloning 
efficiency, it is possible that the wells that did produce cells arose from largely lineage 
committed DN3b cells, biasing the results. However, even if this is indeed the case, the 
cloning efficiency for DN2 cells was relatively high, and these cells clearly gave rise to 
αβ and γδ lineage-committed cells (27). Thus, while the DN3 results may need to be 
reevaluated or repeated by sorting with additional markers, the DN2 results establish that 
lineage commitment can occur partly at the DN2 stage, prior to TCR expression. 
One condition of the stochastic model, that TCR-DN2 precursors are a 
molecularly heterogeneous population, has been proven to exist. Differential expression 
of IL-7R has been shown on single DN2 cells, as about half of DN2 cells express 
relatively high levels of IL-7R on their cell surface (13). Intrathymic injection of IL-7Rhi
DN2 cells favored γδ T cell development, while injection of IL-7Rlo DN2 cells favored 
αβ T cell lineage development, showing that lineage biased precursors do exist prior to 
TCR expression. Given the known influence of IL-7R signaling on TCRγ gene 
rearrangement and expression, it was possible that differences in the germline 
rearrangement status of cells could be responsible for the biased development of 
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precursors distinguished by IL-7R expression. However, even when functional Tcrg gene 
transcription was enforced equally in both DN2 subsets, the lineage bias was observed 
(13). Although IL-7R is not an absolute marker of γδ lineage precursors, these results 
showed that lineage-biased precursors do exist at the DN2 stage, and prompted studies to 
identify other genes of developmental relevance that are differentially expressed among 
DN2 cells. 
We have identified additional factors that are differentially expressed in DN2 
cells, including Trim13 (which will be discussed in Chapter II), and Sox13, the first γδ
lineage gene identified (29). Sox13 was expressed in precursor subsets and γδ T cells, but 
it was absent from αβ lineage cells, including DPs and non-conventional αβ lineage 
subsets such as αβ IELs. Sox13 was heterogeneously expressed in about half of DN2 
precursors as determined by single-cell (sc) RT-PCR. In addition, Sox13 was expressed in 
all immature γδ T cells in the thymus. These results implicated Sox13 as a candidate 
molecule of lineage fate determination. Consistent with this possibility, Sox13 expression 
was higher in IL-7R+ DN2 cells, which are biased toward γδ T cell generation, compared 
to IL-7Rlo cells (29).  
SOX13 is transcription factor that is a member of the SRY related high mobility 
group (HMG)-box protein family, members of which have been shown to bind and bend 
DNA. Other family members include LEF1 and TCF1 (Tcf7), both of which are essential 
for αβ T cell development (30, 31). Transgenic expression of Sox13 inhibits αβ T cell 
development, and imposes a γδ-like molecular program on αβ lineage cells. 
Correspondingly, Sox13-/- mice have defects in γδ T cell development, indicating that 
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Sox13 promotes γδ lineage development and opposes αβ lineage development. SOX13 
acts in part by binding to and antagonizing the activity of TCF1, which is activated 
downstream of WNT signaling (29) (discussed in more detail in Chapter 6). 
We are currently generating Sox13 reporter mice to directly test whether Sox13+
DN2 cells are the committed precursors of γδ T cells. We have already begun similar 
studies using Axin2 reporter mice. Axin2 is a component of the WNT signaling pathway 
(32), and it is also expressed heterogeneously in DN2 cells (unpublished data). As 
SOX13 antagonizes the WNT pathway, we are investigating the use of Axin2 as a marker 
of αβ lineage committed precursors. Preliminary analysis of precursor development using 
the OP9-DL1 system indicate that Axin2+ cells are less efficient at generating γδ T cells 
than Axin2- cells (unpublished data). These studies have provided promising results and 
we are moving toward the final goal of identifying and tracking lineage-restricted 
precursors in vivo, which would provide the most definitive proof of the stochastic 
model. 
7. The role of trans-conditioning in γδ T cell development
Apart from the TCR, other factors have also been proposed to play a role in the 
development and function of γδ T cells. Hayday’s group used representational difference 
analysis to compare DP and total immature γδ T cells to identify genes specifically 
expressed in γδ T cells (33). Using this technique, they identified Rgs1, Rgs2, Nr4a1
(Nur77), Nr4a2 (Nurr1), Nr4a3 (Nor1), and Icer (derived from the Crem locus) as γδ
lineage-biased genes. Many of these genes were also expressed in innate-like αβ lineages, 
19
including αβIELs and CD8αα splenocytes, indicating that they were not truly γδ
specific, but may be more characteristic of innate-like cells. Interestingly, they found that 
γδ T cells from Tcrb-/- mice did not express this cluster of genes and, when stimulated, 
proliferated less and made less interferon γ (IFNγ) than WT splenic γδ T cells (33). They 
subsequently showed that the defect in Tcrb-/- γδ T cells arose from the lack of 
lymphotoxin production, which is made by normal αβ DP cells but absent in Tcrb-/- mice. 
In addition to affecting γδ T cells, lack of lymphotoxin expression also resulted in the 
absence of expression of the cluster of genes from DN precursors, and it was proposed 
that DP-derived lymphotoxin conditions the development of both DN precursors and γδ T 
cells (34). The possibility that the presence of αβ lineage cells could influence the 
development and functional competence of γδ T cells (trans-conditioning) was intriguing. 
Some subsets of γδ T cells develop early during fetal development, prior to the presence 
of αβ DP cells, which would indicate that some cells may not depend on DP derived 
lymphotoxin. It has been suggested that the expansion of DP cells that occurs later in 
development may disrupt γδ-stromal cell interactions, robbing developing γδ T cells of 
necessary signals. The lymphotoxin production by DP cells may compensate for the loss 
of the stromal cell interactions. As different subsets of γδ T cells were not tested in these 
studies, it is unclear whether all γδ T cells depend on lymphotoxin signals, even in the 
adult thymus. However, it is clear that precursor and γδ T cell development may not be 
normal in Tcrb-/- mice, and other mouse models lacking normal DP cells. Due to the low 
numbers of γδ T cells in WT mice, Tcrb-/- mice have been used extensively to study γδ T 
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cells, and these results strongly caution against the assumption that these γδ T cells are 
representative of WT cells.  
8. Selection of γδ T cells and functional development in the thymus
αβ T cell development involves ligand-driven positive and negative selection in 
the thymus. Positive and negative selection determines the antigen specificity of the αβ T 
cell pool and also directs the lineage differentiation of αβ T cells into CD4+ or CD8+ T 
cells. In contrast to αβ T cells, which recognize peptide bound to MHC molecules, γδ T 
cells are thought to recognize soluble antigens that do not need to undergo antigen 
processing or presentation on MHC molecules (35, 36). The role of thymic selection in γδ
T cell development has remained elusive, in part due to the lack of knowledge regarding 
the identity of γδ T cell ligands. Studies over the past several years have begun to add 
some clarity to the issue. A positive selection step has been identified for the skin homing 
γδ dendritic epidermal T cell (DETC) lineage involving interaction with a thymic stromal 
ligand (37, 38). DETCs express Vγ3Vδ1 T cell receptors that are relatively canonical as 
they are essentially devoid of junctional diversity. Generation of DETCs was dependent 
upon TCRγ genes within the Cγ1 cluster and on specific combinations of γ and δ chains, 
indicating selection for specific rearrangements. Cells bearing these specific TCRs were 
activated (as determined by expression of CD122, the IL-2Rβ chain) in the fetal thymus, 
indicating interaction with a thymic ligand (37). Selection of DETCs was found to 
depend upon expression of a thymic stromal ligand, as determined by analysis of a 
mutant mouse strain deficient in this ligand that leads to the selective absence of 
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canonical γδ DETCs (38). By genetic mapping and complementation studies, the ligand 
was identified as selection and upkeep of intraepithelial T cells 1 (SKINT1), a protein 
expressed on thymic epithelial cells and in the skin (39). In the absence of SKINT1, 
Vγ3Vδ1 T cells are present in the fetal thymus, but they cannot mature and they remain 
predominantly CD122-CD62LhiCD24+. Instead, a population of DETCs made up of 
noncanonical γδ T cells expressing a diverse array of Vγ genes populates the skin. This 
altered repertoire of γδ T cells in the skin was incapable of completely substituting for 
canonical DETCs, however, as mice developed spontaneous ear inflammation and had 
enhanced irritant contact dertmatitis responses (39). These data formally confirm that 
Vγ3+ DETCs require a positive selection step prior to maturation, similar to αβ T cells, 
although it remains uncertain whether this selection is TCR-mediated.
In contrast to DETC cells, the development of other subsets of γδ T cells appears 
to be unaffected by ligand availability. While it was originally shown that γδ T cells in 
TCR transgenic mice specific for the β2-microglobulin-associated nonclassical MHC 
class I molecules T10 and T22 (KN6 and G8) were dependent on these ligands for 
positive and/or negative selection (15), other studies indicated otherwise (20, 21). This 
was most definitively determined by analysis of endogenous T10/T22 specific γδ T cell 
populations in unmanipulated mice, which consist of about 0.1-1% of total γδ T cells 
(21). Tetramer staining for endogenous T10/T22 γδ T cells indicated that there was no 
defect in the generation of these cells in mice that lacked the ligands (β2m-/-), expressed 
only T10 (Balb/C) or expressed both ligands (C57BL/6), indicating that ligand interaction 
was not required for the generation of these γδ T cells. While absolute numbers of 
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tetramer positive cells were unaffected in β2m-/- mice, there were differences in the 
phenotype of tetramer positive cells compared to those from mice that expressed the 
ligands. Analysis of cell surface markers showed that tetramer positive cells from β2m-/-
mice had lower expression of CD122 and higher levels of TCR expression, indicative of 
cells that may be antigen-naïve. Further analysis suggested ligand engagement versus 
antigen-naivety in the thymus resulted in distinct functional outcomes such that CD122+
(antigen-experienced) cells produced IFNγ upon stimulation while CD122- (antigen-
naïve) cells produced IL-17 (21). Subsequent analysis of IL-17 producing γδ T cells in 
the peritoneal cavity by another group showed that IL-17+ cells were CD25+CD122-
while IFNγ+ cells were CD25-CD122+, and the ability to produce IL-17 was greatest from 
cells of the fetal thymus (40). The scavenger receptors SCART1 and SCART2 were also 
shown to mark IL-17 producing cells (41). These data indicated that while ligand 
interaction is dispensable for the development of normal numbers of γδ T cells, the 
interaction has consequences for the subsequent function of the cells. These studies set 
the stage for the analysis of different subsets of γδ T cells and the programming of 
function during thymic development. 
Identification of an additional marker differentially expressed on γδ T cells, 
CD27, proved to be the best marker for distinguishing IL-17 versus IFNγ producing γδ T 
cells (42). CD27 is a member of the tumor necrosis factor (TNF) receptor superfamily, 
and its ligand is CD70, is a TNF related transmembrane glycoprotein found on 
lymphocytes and dendritic cells. Thymic and peripheral γδ T cell populations were 
mostly CD27+ but contained a substantial fraction of CD27- cells (10-30%) that varied 
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based on the organ analyzed. Significantly, cytokine production strongly correlated with 
CD27 expression. CD27+ γδ T cells exclusively produced IFNγ upon stimulation in vitro 
or infection with pathogens, while CD27- γδ T cells exclusively produced IL-17 under 
similar conditions, and these functions appeared to be imprinted in the thymus. CD27 
deficiency resulted in a decrease in the frequency of IFNγ and TNFα producing cells in 
the spleen and lymph nodes (LNs). In contrast, the number of IL-17 producing cells was 
unaffected (42). This indicated that in addition to marking IFNγ producing cells, CD27 
was also involved in the functional differentiation of these cells. A similar decrease in 
IFNγ production has been seen in γδ T cells from Tcrb-/- mice, as discussed in the 
previous section, and has been attributed to differences in gene expression due to the lack 
of trans-conditioning signals from DP cells (33, 34). Gene expression analysis of Cd27-/-
γδ T cells by microarray indicated that many of the genes that were decreased in Cd27-/-
γδ T cells were the same genes identified as being controlled by trans-conditioning 
signals (42). Most notably, expression of the lymphotoxin β receptor (Ltbr) was 
significantly decreased in Cd27-/- cells, as well as the γδ lineage-biased genes Crem,
Nr4a2, Rgs1, and Rgs2. Interestingly, these genes were also differentially regulated in 
WT cells. Sorted CD27+ γδ T cells expressed high levels of Ltbr, Rgs2, Rgs2, and Nr4a2,
but these genes were absent from CD27- γδ T cells (42). These data linked CD27 
expression with trans-conditioning and indicated that all γδ T cell subsets may not depend 
on trans-conditioning signals from DP cells. It is possible that CD27+ γδ T cells do 
receive these signals, which causes them to upregulate lymphotoxin-regulated genes, but 
CD27- γδ T cells may develop independently of these signals. 
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IL-17 and IFNγ producing cells can be further distinguished by differential 
expression of CCR6 and NK1.1 (43). It was shown that most mature γδ T cells in the 
thymus were either NK1.1+CCR6-, which correlated with IFNγ production, or NK1.1-
CCR6+, which correlated with IL-17 production. Consistent with previously described 
markers of IFNγ production, NK1.1+ cells were CD27+CD122+ and had an activated 
CD44+CD62Llo phenotype. The CCR6+ population was found at the highest frequency in 
the LNs and they were also CD27-CD122- with a more naïve phenotype, as evidenced by 
the higher expression of CCR9 (43), which is thought to be downregulated on developing 
γδ T cells that encounter ligands (44). These studies point to the importance of 
chemokine receptor expression in the functional characterization of γδ T cell subsets.
A population of γδIELs are also specific for T10/T22, and again, these cells were 
able to develop and migrate to the gut in the absence of ligand expression in β2m-/- mice 
(44). In contrast to αβIELs, which are thought to derive from thymic precursors that 
undergo positive selection on self-agonist peptides (45), these results indicate that 
positive selection may not be required for the development of γδIELs. In the absence of 
ligand, T10/T22 specific thymocytes expressed and maintained high levels of CCR9, a 
chemokine receptor that is thought to be required for homing to the gut (44). In contrast, 
CCR9 expression was low on T10/T22 specific thymocytes in C57BL/6 mice, which 
express the ligands. Further, thymocytes that were CCR9hi were also CD122lo, indicating 
that high CCR9 expression is indicative of antigen-naïve cells. The opposite was also 
true, as CCR9lo cells were CD122hi, indicating they had interacted with antigen. γδIELs 
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were all CD122lo in C57BL/6 mice, suggesting that antigen-naïve cells are preferentially 
exported to the gut epithelium to detect and react to foreign antigens (44).
The requirement for ligand interaction has been clearly shown for Vγ3+ DETC 
cells, and a ligand may be required for IFNγ production by T10/T22 specific γδ T cells. 
While there are hints that other γδ T cell subsets have seen ligands or are antigen naïve, 
in the absence of identified ligands for these subsets, it has been difficult to definitively 
confirm these requirements.
9. γδ T cell subset generation
The identification of the ligand for positive selection of Vγ3+ DETC cells has 
made it even more clear that different subsets of γδ T cells may have very distinct 
developmental requirements and can no longer be studied as a single lineage. The 
mechanisms leading to the generation and functional specification of γδ T cell subsets are 
not well understood. The studies outlined in the previous section have made it clear that 
the function of γδ T cells can be imprinted early during thymic development. Whether 
these differences are established when TCRs are first expressed on DN cells is unknown, 
as are the mechanisms that control the functional imprinting. 
As mentioned previously, γδ T cell subsets produce distinct combinations of 
cytokines that correlate with their unique functional roles. Vγ1.1+ cells predominately 
make IFNγ, while Vγ2+ are capable of making IL-17 and IFNγ. Another unique subset of 
γδ T cells that expresses the Vγ1.1+Vδ6.3+ TCR can make IL-4 and resembles αβNKT
cells (46, 47). These cells, commonly called γδNKT cells, can express NK1.1 on their 
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cell surface along with other NK cell markers and can produce IL-4 and IFNγ
simultaneously, similar to αβNKT cells. Like αβNKT cells, γδNKT cells are found in the 
thymus and peripheral lymphoid organs, but they are most abundant in the liver. γδNKT 
cells also express PLZF (promyelocytic leukemia zinc finger, Zbtb16), which is 
expressed exclusively αβNKT and mucosal associate invariant T (MAIT) cells, innate-
like cells that are found in the gut lamina propria (48-51).
PLZF is a BTB-POZ domain protein that is necessary for the development of 
functional αβNKT cells (48, 49). Small numbers of αβNKT cells were present in the 
absence of PLZF, indicating that PLZF is not absolutely required for the generation of 
αβNKT cells, although in its absence αβNKT cells accumulated in the LNs rather than 
the liver. However, PLZF was necessary for the acquisition of the innate-like 
effector/memory phenotype of αβNKT cells. Plzf-/- αβNKT cells were unable to make 
cytokines in short term cultures and had lost their characteristic dual IL-4 and IFNγ
producing abilities. PLZF deficiency affected the development of γδNKT cells in a 
similar manner (50, 51). The frequency, number and localization of γδNKT cells were 
unaffected in Plzf-/- mice. However, like Plzf-/- αβNKT cells, they were incapable of dual 
IL-4 and IFNγ production after stimulation, indicating that PLZF expression is necessary 
for the innate-like phenotype of these cells. The similarity in the function of αβ and 
γδNKT cells, and their mutual dependence on PLZF for their innate-like phenotype, 
indicates that these two cell types may be closely related despite the fact that they belong 
to different T cell lineages.
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Evidence exists that NKT cells and other unconventional T cell subsets are 
selected by high avidity interactions with self-ligands that results in the acquisition of an 
activated/memory phenotype in these cells (52). Based on this model, it was proposed 
that PLZF expression in γδNKT cells was induced by strong TCR signals. TCR 
stimulation of immature γδ T cells in vitro in the OP9-DL1 system for 5 days resulted in 
the upregulation of PLZF in γδ T cells, indicating that prolonged strong TCR signaling 
can lead to PLZF induction (50). However the analysis of several mouse models with 
reduced signal strength (Itk-/-, SLP76 mutants, Id3-/-) appear to contradict this mechanism 
(51, 53-55).
IL-2 inducible T cell kinase (ITK) is a critical mediator of signaling downstream 
of the TCR.  It is expressed in αβ and γδ T cells, as well as αβNKT cells.  Mice deficient 
in Itk have defects in TCR signaling, including decreased PLCγ activation, diminished 
calcium flux and reduced MAPK activation, which leads to impaired NFAT and AP-1
activation in αβ T cells (56). Interestingly, there is an expanded population of γδ T cells 
in Itk-/-mice, contrary to what one would expect based on the signal strength model, as 
lower levels of TCR signaling would be expected to lead to decreased generation of γδ T 
cells (53, 54). The increase in γδ T cells came mainly from an increase in the γδNKT cell 
population. In Itk-/- mice, the γδNKT cells expressed CD4 and NK1.1 and secreted high 
levels of IL-4 that caused a hyper IgE phenotype in these mice (53, 54). Similar results 
were obtained in another mouse model in which a mutation was made in SLP-76 that 
prevents its interaction with ITK, again resulting in decreased TCR signaling (51).
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Clearly, in this case, decreased signaling through the TCR resulted in an increase in the 
development of γδ T cells, in contrast to the predictions of the signal strength model. 
Strong signals through the TCR result in increased phosphorylation of ERK 
leading to higher levels of EGR, which then induces higher levels of the EGR target gene 
Id3, a helix-loop-helix protein that antagonizes the function of E proteins such as E2A 
and HEB (57). Id3-/- mice also have a significant increase in γδ T cell proportions and 
numbers and a decrease in αβ T cell proportions and numbers (51).  It does not appear 
that this decrease in αβ T cells numbers is due to altered αβ/γδ lineage commitment, as 
Id3-/- mice were shown to have equal numbers of DP cells but showed defects in positive 
and negative selection of αβ T cells leading to decreased generation of mature αβ T cells 
(58). The main subset of γδ T cells that are expanded in Id3-/- mice, similar to Itk-/- mice, 
are the γδNKT cells (51). These cells were not present in Id3-/- mice crossed to mice with 
a T cell specific loss of E2A, indicating that the increase in γδ T cells seen in the Id3-/-
mice is the result of an inability to dampen E2A activity (59). These data clearly indicate 
that reduced TCR signaling, through Id3 or Itk deficiency, results in an increased 
generation of γδNKT cells. 
The explanation proposed for this phenomenon is that in the presence of ID3 and 
ITK, a very strong signal is delivered to γδNKT cells that would normally lead to the
deletion of most of these cells. Attenuating that signal rescues these cells from deletion 
and results in their increase in Itk-/- and Id3-/- mice. However, there has been no evidence 
to date showing that γδNKT cells are indeed deleted when TCR signal strength is 
increased. In addition, while approximately 70% of WT γδNKT cells express PLZF, 
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virtually all γδNKT cells from Id3-/- and SLP-76 mutant mice express PLZF, even though 
both models result in reduced TCR signaling (51). Furthermore, when Vγ1.1/Vδ6.4 
(Vδ6.3 allele of DBA/J mice) TCR transgenic mice were made, only about half the γδ T 
cells were PLZF+, despite the fact that all the cells had an identical TCR and should have 
received the same strength of signal (50). In fact, it may be possible that the 
activated/memory phenotype shared by these PLZF expressing cells is not due to the 
strength of signal they receive, but instead due to the properties that PLZF expression 
imprints on the cells.  One way to study this is to separate γδNKT cells based on PLZF 
expression, as roughly 20% do not express PLZF. Interestingly, it is only PLZF+ γδNKT 
cells that can simultaneously produce IL-4 and IFNγ upon activation, indicating that 
PLZF, not TCR signal strength, determines the functional properties of these cells (51).
Another transcription factor that plays a role in γδNKT cell development is 
ThPOK (Zbtb7b). ThPOK was previously identified as the master regulator of CD4/CD8 
T cell fate, as ThPOK overexpression leads to the exclusive generation of CD4+T cells 
whereas ThPOK deletion leads to the development of CD8+T cells (60, 61). Analysis of 
ThPOK GFP knock-in reporter mice indicated that ThPOK was expressed in αβNKT 
cells and γδNKT cells (51). Interestingly, all PLZF+ γδNKT cells also expressed ThPOK. 
While most of these cells were not CD4+, mice without a functional copy of ThPOK 
completely lost all CD4+ γδNKT cells and instead, a portion of γδNKT cells expressed 
CD8. ThPOK deficient mice had decreased levels of PLZF expression on γδNKT cells, 
and these cells were incapable of dual production of IL-4 and IFNγ, although IFNγ
production alone was increased (51). TCR signaling has also been proposed as an inducer 
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of ThPOK expression in γδNKT cells (62), however, convincing evidence for this 
mechanism has yet to be generated. It is clear, however, that ThPOK may also play a role 
in the development and function of γδNKT cells, perhaps in cooperation with PLZF. 
10. Transcription factors in effector T cell generation
The factors leading to the generation of distinct effector lineages has been well 
studied in the CD4+ αβ T cell lineage. The cytokine environment and the nature of the 
pathogen initiates the differentiation of CD4+ T cells into T helper (Th) effector lineages 
by the induction of key transcription factors that act as master regulators of effector fate 
(63). Differentiation of Th1 cells is induced by the presence of IL-12 and IFNγ and 
induces the transcription of T-bet, which in turn leads to the generation of IFNγ
producing Th1 cells (64). Similarly, Th2 differentiation is regulated by GATA3 (65),
Th17 by RORγt (66), and T follicular helper (Tfh) cells by Bcl6 (67, 68). Each of these 
subsets produces distinct combinations of cytokines and performs specific functions 
during immune responses. As discussed previously, it is clear that different γδ T cell 
subsets are also equipped with the ability to produce specific cytokines and perform 
distinct effector functions, but the mechanism by which these effector subsets are 
generated remains unknown (Figure S1). 
In contrast to αβ T cells, γδ T cells are exported from the thymus with an 
activated/memory phenotype, capable of rapid cytokine production in the absence of 
environmental cues. It has also become evident that these effector functions may be 
programmed during thymic development of γδ T cells, based on the expression of 
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markers in γδ thymocytes that correlate with cytokine production. However, as γδ T cells 
have often been studied as a bulk population, many questions remain. For example, it is 
not clear when these different subsets of γδ T cells diverge and acquire the distinct 
transcription factor networks that specify effector function. Further, the signals that are 
responsible for the generation of these different effector subsets are also unknown. TCR 
signals and trans-conditioning have both been implicated in the development γδ T cells 
and in the acquisition of their functional properties, but they have largely been studied in 
total γδ T cells, and their importance in the function of distinct subsets of γδ T cells is 
unclear. 
The experiments that follow in this thesis attempt to answer some of these
questions through the analysis of gene expression profiles and functions of γδ T cell 
subsets. The next chapter of this thesis investigates the role of TRIM13, a γδ lineage-
biased gene, in γδ T cell development. Subsequent chapters detail our work in dissecting 
the molecular signatures of γδ T cell subsets by microarray analysis of immature and 
mature γδ T cells from WT mice, mice with decreased TCR signaling, and mice deficient 
in trans-conditioning. The results of these studies provide a more detailed view of γδ T 
cell development and the role of TCR signaling and trans-conditioning at different stages 
of their development. 
32
Chapter II Attributions and Copyright Information
Some of the material in this chapter has been submitted for publication in a modified 
format. All sections were written by me, and all experiments in this chapter were 
performed by me. 
Narayan, K, Waggoner, L, Waggoner, SN, Conlon, J, Fitzgerald KA, Kang, J. TRIM13 is 
a negative regulator of MDA5-mediated type I IFN production.
33
CHAPTER II:
SUBSET-SPECIFIC DEFECTS IN PERIPHERAL γδ T CELLS IN TRIM13-/-
MICE 
Introduction:
One major hindrance to the study of early γδ T cell development and αβ/γδ
lineage commitment is the lack of markers to identify γδ T cells prior to TCR expression. 
We previously compared immature αβ lineage DP cells with immature γδ T cells by 
microarray to identify γδ lineage-specific genes. Of the genes whose expression was 
increased more than two-fold in γδ T cells versus DP cells, we selected several for further 
analysis and validation, including Sox13 (discussed in Chapter I) and Tripartite Motif 13 
(Trim13), which will be discussed in this thesis.
TRIM13 belongs to the larger TRIM family, which contains over 60 proteins. The 
family is defined by the presence of N-terminal domains that are conserved in their
spacing, consisting of a RING domain, one or two B-Box domains, and a coiled-coil 
domain. The RING domain is a zinc-binding domain that mediates E3 ubiquitin ligase 
activity. The B-Box domains also bind zinc but their function remains largely unknown, 
and coiled-coil domains are involved in protein-protein interactions and homo- and/or 
heterodimerization of TRIM proteins. The more varied C-termini of the TRIM proteins 
can be used to cluster the family into 11 sub-groups based on domain structure and 
homology. TRIM13 belongs to a unique subgroup of TRIM proteins containing a 
transmembrane domain in their C-terminal regions (Figure 2.1) that contains only one 
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Figure 2.1 Schematic of TRIM13 protein domains.
TRIM13 is a 407 amino acid (AA) protein that contains a tripartite motif consisting of a 
RING, B-Box, and Coiled-coil domain. In addition, TRIM13 belongs to a unique 
subgroup of TRIM proteins that contain a transmembrane (TM) domain in their C 
terminal region. This region has been shown to localize TRIM13 to the ER and nuclear 
membranes. The function of each domain is listed.
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other protein, TRIM59 (69). TRIM proteins are involved in a wide array of cellular 
processes such as transcription, microRNA activation, cell cycle regulation, apoptosis, 
and oncogenesis (70, 71).
TRIM13 is highly conserved across species, with over 90% amino acid 
conservation between human and mouse (Figure 2.2). TRIM13 was originally identified 
as a candidate tumor suppressor for B cell chronic lymphocytic leukemia (B-CLL), the 
most prevalent cancer in adults in the Western world (72, 73). Genetic abnormalities 
focused in several chromosomal areas have been found in patients with B-CLL, and 
Trim13 is located in the minimally deleted region. Recent attention has also been focused 
on microRNAs in the region that may play a role in the disease pathogenesis. However, 
no firm conclusions have been reached on the genetic basis of B-CLL, and further work 
is necessary to validate the candidate genes (74).
A role for TRIM13 has been established in ER-associated degradation (ERAD), 
the process by which unfolded or misfolded proteins in the ER are transported to the 
cytoplasm for degradation by the proteasome. In addition to degrading misfolded 
proteins, ERAD also plays a role in the turnover of membrane and secretory proteins, as 
well as degrading proteins that are part of multi-subunit complexes when their stabilizing 
partners are not expressed. Mutations in ERAD lead to serious diseases, such as Cystic 
Fibrosis and Parkinsons’ disease, which result from enhanced and reduced degradation of 
proteins, respectively (75). TRIM13 was shown to localize to the ER and nuclear 
membrane, and to act as an E3 ubiquitin ligase. TRIM13 was capable of mediating 
turnover of CD3δ, a substrate degraded by ERAD when expressed in the absence of other 
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Figure 2.2 Schematic of TRIM13 protein conservation across species.
The amino acid sequence of TRIM13 from various species was aligned using ClustalW. 
Residues are marked as identical (*), conserved (one dot) or semi-conserved (two dots) in 
all species. Areas of identical conservation are highlighted in yellow. The RING, B-box, 
and coiled-coil domain residues are highlighted in red, green, and pink, respectively. The 
percent homology between human and other species is shown in the bottom right. 
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TCR proteins, in a RING dependent process, and TRIM13 also interacted with several 
other ER resident proteins (76). Further evidence of the involvement of TRIM13 in 
ERAD came recently from a group studying high-voltage-gated calcium channels 
(Cav1.2), which are membrane proteins that translate electrical impulses into calcium 
fluxes that regulate the function of many cell types including neuronal cells, cardiac cells, 
and muscle cells (77). Pore-forming Cavα subunits associate with Cavβ subunits, most of
which are cytoplasmic proteins that regulate the location and function of the Cavα pore 
complex. It was shown that the Cavβ subunit stabilizes Cav1.2 channels by preventing 
their ubiquitination and proteasomal degradation through the ERAD pathway. TRIM13 
was shown to be the E3 ligase responsible for the ubiquitination of Cav1.2 channels in 
the absence of Cavβ (77). These results indicated that TRIM13 plays a crucial role in 
regulating the ubiquitination and expression of Cav1.2 channels in neuronal systems, and 
represents one of the few examples where a specific E3 ligase has been linked to 
regulation of channels in the ER. 
 Although very little information was available about the function TRIM13 in the 
immune system, the strong evolutionary conservation of TRIM13 combined with the 
important roles TRIM family members play in regulating immune processes indicated 
that TRIM13 may also be an important regulator of immune cell development. Based on 
our microarray data that indicated Trim13 was expressed in γδ but not αβ lineage cells, 
we began by investigating the role of TRIM13 in γδ T cell development and function. 
Results:
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Trim13 is expressed in T cell precursors and innate and innate-like lymphocytes
Our original microarray data indicated that Trim13 was expressed in γδ T cells but 
not in αβ lineage DP cells. To confirm and extend these results, we determined the 
expression of Trim13 in various sorted subsets of immune cells and precursors from the 
thymus and spleen by quantitative RT-PCR (qPCR). In confirmation of our microarray 
data, we found that Trim13 expression was low on DP cells in the thymus but was highly 
expressed on thymic γδ T cells (Figure 2.3). In addition, similar to Sox13, Trim13 was 
expressed at high levels in DN precursor cells. Trim13 was expressed in thymic CD8+
and NKT cells, indicating a broader expression pattern than Sox13. In the periphery, 
Trim13 expression was low in naïve CD4+ and CD8+ cells, but was expressed in innate 
and innate-like lymphocytes including γδ T cells, NK cells, and IELs (Figure 2.3). These 
results indicated that Trim13 was expressed in γδ T cells and other innate and innate-like 
lymphocytes, and may play a role in the development or function of these cells. 
Trim13 is heterogeneously expressed in T cell precursors
As Trim13 was expressed very highly in T cell precursors, we sought to determine 
whether it was expressed heterogeneously in DN2 cells. To do this, we sorted single DN2 
precursor cells and detected Trim13 expression by scRT-PCR. We found that Trim13 was 
expressed in about 50% of DN2 precursors (Figure 2.4A). This indicated that Trim13,
like Sox13, could potentially be a marker of γδ T cell committed precursors. It is expected 
that any gene that marks γδ T cell precursors would also mark all γδ T cells. To test this, 
we looked at the expression of Trim13 in single sorted γδ T cells by scRT-PCR. 
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2.3 Trim13 is expressed in T cell precursors and innate-like lymphocytes.
IELs and purified subsets of lymphocytes from the thymus and spleen were analyzed for 
Trim13 mRNA expression by qPCR and normalized to β-actin expression. For the 
thymus: DN, CD4-CD8-TCRδ- double-negative; DP, CD4+CD8+ double-positive; CD4, 
CD4+CD8-CD25-; CD8, CD4-CD8+; γδ, TCRδ+CD3+; NKT, NK1.1+TCRβ+CD3+. For 
spleen: CD4, CD4+CD8-CD25-CD44-CD62L+; CD8, CD4-CD8+CD44-CD62L+; γδ,
TCRδ+CD3+; NK, NK1.1+TCRβ-CD3-. IELs, total intraepithelial lymphocytes. Data 
shown are expressed as the mean ±SD of duplicate qPCR analysis and are representative 
of two independent experiments. ND, not detected.
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2.4 Heterogeneous expression of Trim13 in DN2 precursors and γδ T cells.
Representative scRT-PCR assay on single sorted DN2 (CD4-CD8-CD3-
CD25+CD44+ckit+) (A) or γδ (CD4-CD8-γδ+CD3+) thymocytes (B) from WT mice (n=3). 
Numbers above wells indicate individual cells. Single cells were assayed for expression 
of β-actin and Trim13. The frequency of β-actin+ clones that were Trim13+ across all 
experiments is listed on the right of the gels.
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Interestingly, Trim13 was expressed in only about half of γδ T cells (Figure 2.4B). This 
indicated that while Sox13 was a marker of γδ T cells (29), Trim13 expression may 
correlate with other phenotypic or functional aspects of γδ T cells. For example, it was 
possible that Trim13 expression marked certain subsets of γδ T cells, or was a marker of 
some type of effector function that distinguished γδ T cell subsets. Additional differences 
in the expression pattern of Sox13 and Trim13 were also evident. While Sox13 expression 
was restricted to the γδ lineage, Trim13 was expressed in both αβ and γδ IELs (data not 
shown), indicating that Trim13 expression is not γδ lineage-restricted, but γδ lineage-
biased. Trim13 expression was similar to that of the γδ lineage-biased genes identified by 
Hayday’s lab, which were also expressed in γδ T cells and innate-like αβ lineage cells. 
These γδ lineage-biased genes were shown to be dependent on lymphotoxin signaling and 
loss of their expression in Tcrb-/- mice led to defective cytokine production after 
activation. Therefore, the expression of γδ lineage-biased genes may have a significant 
impact on γδ T cell development and/or function, and may affect other innate and innate-
like subsets as well.  
Trim13-/- mice have subset-specific defects in γδ T cells
As Trim13 appeared to be a γδ lineage-biased gene, we performed a series of in 
vitro and in vivo overexpression assays to determine the impact of TRIM13 on γδ T cell 
development. While these studies will not be discussed in detail in this thesis, in 
summary, they indicated that similar to SOX13, TRIM13 overexpression had a negative 
impact on αβ T cell development and enhanced γδ T cell development. Based on these 
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data, we decided to generate Trim13-/- mice to determine the impact of TRIM13 on γδ T 
cell development. As Trim13 was not expressed in every γδ T cell, we did not expect to 
see a global defect in γδ T cell development. However, we were interested in studying the 
role of Trim13 as an example of a lineage-biased gene, as its expression may identify 
certain subsets of γδ T cells or perhaps regulate subset specific effector functions.
In mice, Trim13 consists of 5 exons that can be alternatively spliced to generate at 
least three different isoforms that differ only in their 3’ untranslated regions. All isoforms 
contain exons 2 and 3, but they differ in their usage of one of three different 5’ exons 
(1A, 1B, and 1C) (Figure 2.5). The entire coding sequence of TRIM13 is contained 
within exon 3, and the relevance of the different isoforms is unclear. The Trim13
targeting vector was generated by PCR cloning from genomic DNA extracted from 
embryonic stem (ES) cell lines (AB2.2). Approximately 1.6kb of sequence, including the 
entire coding region of Trim13 contained in exon 3, was flanked by loxP sites in the 
targeting vector downstream of a neomycin (neo) resistance gene (Figure 2.6A). The 
targeting vector was electroporated into ES cells and clones that had deleted Trim13 on 
one allele after homologous recombination and subsequent in vitro transient Cre 
expression were identified by Southern blotting (Figure 2.6B). PCR on tail DNA was 
used to type subsequent WT and KO mice (Figure 2.6C). To confirm the deletion of 
Trim13, we analyzed Trim13-/- fetal thymocytes and as expected, we did not detect any 
mRNA expression for Trim13 (Figure 2.6D).  
Trim13-/- mice were born at the expected Mendelian ratios, indicating deletion of 
Trim13 did not grossly affect the development of these mice. However, Trim13-/- male 
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2.5 Schematic of Trim13 mRNA isoforms.
Trim13 consists of 5 exons that are differentially spliced to generate three different 
Trim13 mRNA isoforms. All isoforms contain exon 2 and exon 3, but they each begin 
with a different first exon (1A, 1B, or 1C). The entire protein-coding region is located in 
exon 3, and all isoforms generate an identical protein sequence. Exons are indicated by 
rectangles, with intervening lines representing intronic sequences. Transcriptional start 
sites are marked with arrows, and the polyadenylation site (pA) is indicated. 
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Figure 2.6 Generation of Trim13-/- mice. 
(A) Schematic of the Trim13 endogenous locus, targeting construct, and KO allele (not to 
scale). The protein-coding region of Trim13 (exon 3) is shown in black and non-protein 
coding exons are in white. The Trim13 targeting construct was generated by PCR cloning 
from genomic DNA extracted from ES cell lines (AB2.2). Approximately 1.6kb of 
sequence, including the entire coding region of Trim13 contained in exon 3, was flanked 
by loxP sites (black triangles) in the targeting vector downstream of a neomycin (neo)
resistance gene. The targeting vector contained the herpes simplex virus thymidine kinase 
gene (TK) in the 3’homology region to negatively select against random integrations. The 
location of probes used for Southern blot is indicated along with the position of relevant 
restriction sites. (B) Representative Southern blot and PCR to identify Trim13+/+,
Trim13+/-, and Trim13-/- mice. Tail DNA was digested with BamHI and subjected to 
Southern blotting using a probe located in the 5’ homology region (WT allele ~16.1kb, 
KO allele ~2.6kb). (C) Representative PCR on genomic tail DNA from Trim13+/+,
Trim13+/-, and Trim13-/- mice (WT allele 650bp, KO allele 250bp). (D) Semi-quantitative 
RT-PCR to detect expression of Trim13 in 4-fold serial dilutions of cDNA from 
embryonic day 18 fetal thymus from WT and Trim13-/- mice. Expression of β-actin is 
shown as a loading control.
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mice were significantly underweight compared to WT counterparts (Figure 2.7, top). This 
weight difference was most evident after ~6-8 weeks of age. Female mice were also 
slightly underweight, but the difference was much smaller and inconsistent (Figure 2.7, 
bottom). The reason for this weight difference is currently under investigation. 
As Trim13 was expressed at high levels in DN precursors, it was possible that 
Trim13 deficiency could affect αβ lineage cells. Trim13-/- mice had normal numbers of 
total thymocytes and splenocytes, and analysis of T cell development in Trim13-/- mice 
revealed normal development of precursors (data not shown) and αβ T cells (Figure 2.8). 
Normal frequencies of DN, DP, and single positive cells were found in the thymus of 
Trim13-/- mice, and frequencies of CD4+ and CD8+ T cells were also normal in the spleen 
(Figure 2.8A). There was no defect in the activation status of CD4+ and CD8+ T cells, or 
in the generation of FoxP3+ T regulatory cells (Figure 2.8B and 2.8C). We stimulated 
CD4+ and CD8+ splenic T cells with multiple doses of anti-CD3 and anti-CD28 and saw 
no defects in cytokine production (data not shown). As TRIM13 was originally identified 
as a candidate tumor suppressor for B-CLL (72), we also analyzed B cells in Trim13-/-
mice. However, we found no gross defects in B cell development or activation (data not 
shown), and we did not observe any spontaneous tumor development in mice up to one 
year of age. 
 We then analyzed γδ T cell development in Trim13-/- mice. γδ T cell development 
in the thymus of Trim13-/- mice was relatively normal. Trim13-/- mice had normal 
frequencies and numbers of γδ T cells, and subset distribution of Vγ1.1, Vγ2, and Vδ6.3 
cells was similar to WT mice (Figure 2.9A and 2.9C and data not shown). However, γδ T 
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Figure 2.7 Trim13-/- males are significantly underweight compared to WT males.
WT and Trim13-/- mice were weighed weekly beginning at 5-7 weeks of age (week 1) and 
the percent of starting weight ±SD is shown for male (top) and female (bottom) mice. 
WT males n=7, females n=10; Trim13-/- males n=17, females n=15. Asterisk, p < 0.05 
(Student’s t test). Data are representative of two independent experiments. 
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Figure 2.8 Trim13-/-αβ T cells develop normally. 
(A) Representative FACS plots showing CD4 and CD8 expression in the thymus and 
spleen of WT and Trim13-/- mice. (B) Representative FACS plots showing CD44 and 
CD62L expression on CD4+ and CD8+ single-positive cells in the spleen of WT and 
Trim13-/- mice. (C) Representative histograms of intranuclear FoxP3 expression gated on 
CD4+ single-positive cells from the spleen of WT and Trim13-/- mice. All data are 
representative of 3 independent experiments. 
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Figure 2.9 Distribution of γδ T cell subsets in the periphery of Trim13-/- mice is 
aberrant.
Cells from the thymus (A) and spleen (B) of WT and Trim13-/- mice were stained with 
cell surface markers to identify Vγ1.1+, Vδ6.3+, and Vγ2+ γδ T cells. Middle and bottom 
FACS plots are gated on γδ+ cells. (C, D) Graphs showing the frequency of subsets of γδ
T cells in the thymus (C) and spleen (D) of WT and Trim13-/- mice. Mean and standard 
deviation are indicated. A p-value <0.05 was considered significant (Student’s t test). ns, 
not significant. Results were combined from 2-3 independent experiments. 
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cells in the spleen of Trim13-/- mice were aberrant. There was no change in the frequency 
of total γδ T cells in the spleen of Trim13-/- mice, however there was a small, but 
significant decrease in the frequency of Vγ1.1+ cells, which resulted primarily from a 
decrease in Vγ1.1+Vδ6.3- cells, and a corresponding increase in the frequency of Vγ1.1-
and Vγ2+ cells (Figure 2.9B and 2.9D). We then assessed the activation status γδ T cells 
from the thymus and spleen of these mice. We found that activation markers on both the 
Vγ1.1+ and Vγ1.1- subsets was normal in the thymus of Trim13-/- mice (Figure 2.10). 
However, splenic Trim13-/- Vγ1.1- cells showed a significant increase in the proportion of 
CD44+CD62L- activated cells (Figure 2.10A and 2.10B). In contrast, Vγ1.1+ cells were 
unaffected and maintained a normal activation profile (Figure 2.10A and 2.10B). As the 
Vγ1.1- population contains a mixture of Vγ2+ and Vγ4+ cells, we attempted to identify 
which population is being affected in these mice. As there is no commercially available 
antibody against Vγ4, we stained cells for Vγ2 and Vγ1 to look at Vγ2+ cells and Vγ1.1-
Vγ2- cells, which presumably consist mainly of Vγ4+ cells. We found that both the Vγ2+
and Vγ1.1-Vγ2- populations contained an increase in activated cells in Trim13-/- mice 
(Figure 2.10C). These data indicate that, as we expected, Trim13 deficiency does not 
have a global effect on γδ T cells. Instead, TRIM13 appears to affect the activation of 
Vγ2+ and Vγ1.1-Vγ2- (presumably Vγ4+) cells in the periphery. This does not appear to be 
a developmental effect, as thymic γδ T cell development appears normal in these mice, 
although we cannot rule out the possibility that a thymic defect exists that is only 
manifested upon thymic egress. Further studies to examine the impact of these 
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Figure 2.10 Increase in the frequency of activated splenic Vγ1.1- γδ T cells in Trim13-
/-mice.
(A) Cells from the thymus (left) and spleen (right) of WT and Trim13-/- mice were stained 
with cell surface markers against γδ, Vγ1.1, CD62L, and CD44. FACS plots were gated 
on Vγ1.1+ γδ+ (top) or Vγ1.1- γδ+ (bottom). The Vγ2-CD62L-CD44+ quadrants in the 
spleen of WT and Trim13-/- mice are highlighted with a red box. (B) The frequency of 
Vγ1.1+ or Vγ1.1- cells that had an activated phenotype (CD62L-CD44+) in the spleen of 
WT and Trim13-/- was plotted. Mean and standard deviation are shown. A p-value <0.05 
was considered significant (Student’s t test). ns, not significant. Results were combined 
from 2-3 independent experiments. (C) FACS plots of CD62L and CD44 expression on 
Vγ2+γδ+ or Vγ2-Vγ1-γδ+ cells from WT and Trim13-/- mice. 
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differences are underway, including determining whether the cytokine profile of these 
cells is also aberrant.    
Possible compensation for loss of Trim13 by Trim59
As mentioned previously, TRIM13 is most closely related to another protein, 
TRIM59, which shares its unique domain structure. Given the similarity in the sequence 
and structure of TRIM13 and TRIM59, it was important to examine the expression 
pattern of Trim59 to determine whether it could be in part compensating for the loss of 
TRIM13. We investigated the expression of Trim59 in sorted immune cell subsets by
qPCR. While the expression patterns of Trim13 and Trim59 were distinct, especially in 
the secondary lymphoid tissues, Trim59 was expressed highly in γδ T cells from the 
thymus and spleen, similar to Trim13. Trim59 expression was negligible in all other 
peripheral lymphocyte subsets tested, in contrast to Trim13, which was expressed in γδ T 
cells and other peripheral innate and innate-like subsets including NK cells and total IELs 
(Figure 2.3 and 2.11). While we did not see any upregulation of Trim59 expression in 
Trim13-/- mice (data not shown), its high expression in γδ T cells indicates it may be 
partially compensating for the loss of TRIM13 in vivo. 
Summary and future directions:
The study of Sox13 and Trim13 as representative γδ lineage-restricted and γδ
lineage-biased genes has provided us with unique insights into γδ T cell development. 
Sox13 is expressed heterogeneously in DN2 cells and is expressed in all thymic γδ T cells 
62
2.11 Trim59 may compensate for the loss of Trim13 expression in γδ T cells.
IELs and purified subsets of lymphocytes from the thymus and spleen were analyzed for 
Trim59 mRNA expression by qPCR and normalized to β-actin expression. For thymus: 
DN, CD4-CD8-TCRδ- double-negative; DP, CD4+CD8+ double-positive; CD4, 
CD4+CD8-CD25-; CD8, CD4-CD8+; γδ, TCRδ+CD3+; NKT, NK1.1+TCRβ+CD3+. For 
spleen: CD4, CD4+CD8-CD25-CD44-CD62L+; CD8, CD4-CD8+CD44-CD62L+; γδ,
TCRδ+CD3+; NK, NK1.1+TCRβ-CD3-. IELs, total intraepithelial lymphocytes. Data 
shown are expressed as the mean ±SD of duplicate qPCR analysis and are representative 
of two independent experiments. 
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(29), allowing us to study its role in the γδ T cell lineage commitment process. We are 
currently generating Sox13 reporter mice, which will allow us to track the developmental 
potential of Sox13-expressing DN2 precursors and determine if they are indeed γδ-
lineage-committed precursors. 
We studied Trim13 as an example of a γδ lineage-biased gene that may be subset 
specific in expression. Despite the expression of related family member Trim59 in γδ T 
cells, analysis of Trim13-/- mice indicated a role for TRIM13 in regulation of γδ T cell 
activation. TRIM13 was not required for thymic γδ T cell development, but interestingly, 
it plays a subset specific role in regulating γδ T cell activation in the periphery, as Vγ2+
and Vγ1.1-Vγ2- (presumable Vγ4+) cells were specifically more activated in Trim13-/-
mice. These subset-specific differences may indicate that TRIM13 expression is 
restricted to a specific subset of γδ T cells. Therefore, we are planning a more detailed 
analysis of the expression pattern of Trim13 in γδ T cell subsets to help us understand its 
role in γδ T cells. In addition, we are investigating the role of TRIM13 in cytokine 
production and effector function of γδ T cells to determine whether these cells are hyper-
responsive upon stimulation. As Trim13 was also expressed in other subsets of innate and 
innate-like lymphocytes, we are also planning to determine whether Trim13 deficiency 
has any impact on the development or function of other cell types.
The most closely related family member to TRIM13, TRIM59, is also expressed 
highly in thymic and splenic γδ T cells. Trim59 and IFT80 encode a joint transcript 
termed IFT80L, mutation of which may be associated with some cases of Jeune 
syndrome, a developmental disease in humans (78). Recent data indicate that 
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overexpression of c-Myc in small lung cancer cell lines leads to the repression of Trim59
by promoter hypermethylation, indicating that Trim59 may play a role in oncogenesis 
(79). As we saw high expression of Trim59 in γδ T cells, it is possible that Trim59 can 
compensate for the loss of Trim13. Further elucidation of the role of Trim13 in γδ T cells 
may require the generation of Trim13/Trim59 double-deficient mice. Trim59 gene 
trapped mice are commercially available and could be used for this purpose. 
Members of the TRIM family have recently gained prominence for their 
involvement in anti-viral and innate immunity (69). As a result, we began studying 
TRIM13 function in the context of the innate immune system. We identified TRIM13 as 
a negative regulator of MDA5 and showed that it is a non-redundant regulator of MDA5-
mediated type I interferon production during in vivo infection. This work is detailed in 
the Appendix at the end of this thesis. 
Materials and Methods:
Mice 
The Trim13 targeting construct was generated by PCR cloning from genomic DNA 
extracted from ES cell lines (AB2.2). High fidelity Taq polymerase was used for PCR 
amplification, and all PCR cloned segments were sequenced to ensure no mutations were 
introduced. Approximately 1.6kb of sequence, including the entire coding region of 
Trim13 contained in exon 3, was flanked by loxP sites in the targeting vector downstream 
of a neomycin (neo) resistance gene. The targeting vector contained the herpes simplex 
virus thymidine kinase gene (TK) in the 3’homology region to negatively select against 
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random integrations. The targeting vector was electroporated into ES cells and clones
were selected for neomycin (G418) and TK resistance and correctly targeted clones were 
identified by Southern blotting. Targeted clones were subjected to transient Cre 
expression, and a second round of screening by Southern blot and PCR was performed to 
identify clones that had deleted neo and either contained Trim13 exon 3 flanked by loxP 
sites (conditional) or had deleted Trim13 exon 3 (KO) on one allele. One ES cell clone of 
each type was injected into mouse blastocyts and implanted into psuedopregnant mice. 
The resulting chimeras born from the injected blastocyts were bred to C57BL/6 mice to 
look for germline transmission of the conditional and KO allele.  Germline transmission 
of the conditional allele was confirmed, but the KO chimeras did not transmit the KO 
allele. Conditional F1 mice were bred to protamine Cre transgenic mice (provided by 
Steve Jones) to achieve germline deletion of Trim13 and generate KO mice. Mice were 
genotyped by PCR performed on tail DNA using the following primers: Trim13-for-
5706, 3’-TCC TCT AGT CAA GGT TGA CCT ACA-3’; Trim13-for-7561, 5’-CTT GAT 
GGG ATT GTT GGA GAA C-3’; Trim13-rev-104, 5’-CAG CTC ATG TGT CGT AGT 
TGG T-3’. Mice used for analysis were backcrossed to C57BL/6 for 8 to 10 generations 
and were 8-12 weeks old. All mice used in these experiments were housed in a specific 
pathogen free rodent barrier facility. All animal experiments were approved by the 
University of Massachusetts Medical School Institutional Animal Care and Use 
Committee (Worcester, MA). 
Flow cytometry and cell sorting 
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Standard culture medium (RPMI 1640 with 10% FCS, 50 µM 2-ME, 2 mM L-glutamine, 
20 mM HEPES, and antibiotics) was used for all experiments unless otherwise indicated.  
The following monoclonal fluorochrome conjugated antibodies used for flow cytometry 
were purchased from eBiosciences or BD Biosciences: CD3, CD4, CD8α, TCRγ, TCRβ,
NK1.1, CD25, CD44, CD62L, Vγ2, FoxP3, Vδ6.3. Vγ1.1 antibody was purified from 
antibody producing cell lines by Bio-XCell and biotinylated using the FluoReporter 
Mini-Biotin-XX Protein Labeling Kit (Invitrogen). Intranuclear FoxP3 staining was 
performed with the FoxP3 staining kit (eBioscience). All data were acquired on a BD 
LSRII and analysis was performed using FlowJo (Treestar). Cells were sorted from 
pooled thymus and spleen from 5-10 C57BL/6 mice  (Jackson Labs). For sorting of γδ
and NKT cells from the thymus, thymocytes were first depleted with CD4 magnetic 
beads (Dynal). For sorting of γδ, NKT, and NK cells from the spleen, splenocytes were 
first depleted with CD8, and B220 magnetic beads (Dynal). For sorting of all other 
splenic subsets, splenocytes were first depleted with B220 magnetic beads (Dynal). After 
depletion, cells were stained for surface markers and sorted with a FACSAria (Becton 
Dickinson) or MoFlo (Dako Cytomation) cytometer. IELs were prepared using standard 
protocols with some modifications. Peyer’s patches and fecal matter was removed from 
the intestines, and the intestines were cut into small segments and put into a conical flask 
with 25mls of RPMI 1640 containing 2% FBS (GIBCO). The flask was incubated for 30 
minutes at 37°C with gentle shaking. Tissues were transferred to a 50ml tube, shaken, 
and filtered twice. To isolate lymphocytes, cells were resuspended in 40% Percoll 
(Sigma) and layered on top of 70% Percoll and centrifuged. 
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scRT-PCR
Thymocytes were isolated from 2 C57BL/6 mice, depleted with CD4 magnetic beads 
(Dynal), and stained for cell surface markers. DN2 (CD4-CD8-CD3-CD25+CD44+ckit+)
or γδ T cells (CD4-CD8-TCRγ+) were sorted into 96-well plates containing 5ul of lysis 
buffer (0.4% NP40, 25uM DTT, 0.5U RNasin, and 65uM dNTPs) at one single cell per 
well. To perform the RT reaction, 5ul of 2x Sensiscript RT (Quiagen) was added to each 
well, and plates were incubated for 1 hour at 37°C. Two rounds of amplification by PCR 
were performed to detect β-actin and Trim13 expression. In the first round, 1ul of cDNA 
from each individual cell was used to amplify β-actin, and 5ul was used to amplify
Trim13. Amplification was performed for 35 cycles in 25ul total volume. For the second 
round of amplification, nested PCR primers were used to amplify β-actin and Trim13
from 1ul of PCR product from the first round PCR reaction for an additional 35 cycles in 
25ul total volume. To optimize single cell PCR conditions, Trim13 was first tested on 
cells sorted from a Trim13 over-expressing T cell line in which every cell expressed 
Trim13. In these samples, all cells tested were positive for Trim13 expression. Primers for 
the first round of PCR were: β-actin-for 5’-CTA GGC ACC GTG TGA TGG-3’; β-actin-
rev 5’-TCT CTT TGA TGT CAC GCA CGA-3’;; Trim13-1599-for 5’-GGA AAA CGA 
ACT GC TCT CTC; Trim13-594-rev 5’-CGG CGC CAA GTC TCG AAA C-3’. Primers 
for the second round of PCR were: β-actin-for 5’-CGA GGC CCA GAG CAA GAG AG-
3’ and β-actin-rev 5’-CGG TTG GCC TTA GGG TTC AG-3’; Trim13-e8-for 5’-GCA 
TAT ACT TGC CTG GAA CA-3’; Trim13-6532-rev 5’-GGA GTA ATT GAC CTG 
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CAG ACT G-3’.
RT-PCR and qPCR
RNA was prepared from cell subsets using the Trizol reagent (Invitrogen) and cDNA was 
prepared using Sensiscript RT (Quiagen). RT-PCR was performed using the following 
primers: Trim13-e8-for, 5’-GCA TAT ACT TGC CTG GAA CA-3’; Trim13-594-rev, 5’-
CGG CGC CAA GTC TCG AAA C-3’. qPCR was performed using SYBR Green 
(Applied Biosystems) on a BioRad iCycler using the following primers: Trim13-51-for 
5’-AAC GAA CTG GCT CTC TCC AC-3’ Trim13-143-rev 5’-CTT CTT CAA GCA 
GCT CCA TTA C-3’; Trim59-179-for 5’-GTC CAG ATC AGG AGA TTG ACA GAC-
3’ Trim59-292-rev 5’-TGT ATG AGA GCA TGG TAG TAC ACG G-3’ β-actin-for 5’-
CTA GGC ACC AGG GTG TGA TGG-3’ and β-actin-rev 5’-TCT CTT TGA TGT CAC 
GCA CGA-3’.  
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CHAPTER III:
 THE TRANSCRIPTIONAL NETWORKS THAT SPECIFY γδ T CELL SUBSET-
SPECIFIC EFFECTOR FUNCTIONS ARE EVIDENT AT THE IMMATURE 
STAGE
Introduction:
The immune system generates distinct lineages of cells that are designed to 
respond optimally to environmental cues and infectious agents. Among αβ T cells, for 
example, in the CD4 lineage, these effectors are well defined and established as separate 
lineages, including Th1, Th2, Th17, and Tfh. These different lineages are controlled by 
distinct transcription factor networks that are programmed upon pathogen encounter. The 
cytokine milieu and the nature of the pathogen triggers the initiation of effector 
differentiation pathways by turning on the expression of transcription factors such as T-
bet, GATA3, and RORγt, which act as key main regulators of Th1, Th2, and Th17 cell 
differentiation, respectively (63).
γδ T cell development is distinct from that of αβ T cells in its ordered 
rearrangement of TCR genes and the pairing of Vγ and Vδ chains to generate γδ subsets 
that home to specific tissues (2). In spite of this knowledge, γδ T cells have been studied 
primarily as if they were a homogenous population of cells that interpret extrinsic signals 
in an identical fashion. Unlike conventional αβ T cells, γδ T cells express a preactivated 
or memory phenotype prior to pathogen encounter, and recent evidence indicates that 
their effector functions may be programmed during thymic development. As discussed 
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previously, proteins have been identified that mark IL-17-producing and IFNγ-producing 
γδ T cells in the thymus (21, 40-43). In addition, a number of studies have linked 
cytokine production and effector function with γδ T cells expressing TCRs based on Vγ
and Vδ gene usage. Therefore, it is possible that the earliest identifiable γδ T cells in the 
thymus (CD24hiγδ+) are composed of molecularly heterogeneous γδ T cell lineages 
distinguished by TCR expression. 
To test this possibility, we embarked on the most detailed study of γδ T cell 
molecular patterns to date. In collaboration with the members of the Immunological 
Genome Project (Immgen.org), we determined the gene expression signatures of γδ T 
cells subsets sorted based on Vγ and Vδ gene usage and the maturation marker CD24 
(HSA). Adult thymic γδ T cells consist of Vγ2+, Vγ1.1+, Vγ4+, and Vγ5+ cells. Subsets 
sorted were Vγ2+ (designated as V2 in the remaining sections of this thesis), 
Vγ1.1+Vδ6.3- (V1), and Vγ1.1+Vδ6.3+ (V6) with additional discrimination of CD24+
(immature) and CD24lo/- (mature) subsets sorted for each population. The V2 cells sorted 
consisted of cells that had paired the Vγ2 chain with Vδ4 (~50%) or Vδ5 (~40%) as well 
as other minor pairings. The V1 cells sorted consisted of the Vγ1.1 chain paired with 
multiple Vδs, including ~25% Vδ4, ~15% Vδ5 but not Vδ6.3. The V6 cells sorted 
consisted only of the Vγ1.1 chain paired with the Vδ6.3 chain (Figure S2). We did not 
analyze Vγ5+ or Vγ4+ cells as their frequency in the thymus was too low to provide 
adequate cell numbers for microarray analysis or the necessary reagents for accurate cell 
sorting were not available.
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These data allowed us to study the stage-specific development of γδ T cell subsets 
with a precision that has not been possible previously. Upon analysis of the gene 
expression patterns of these cells, we’ve identified three stages in the molecular 
programming of γδ T cells in the thymus (Figure S3). During the first stage of immature 
γδ T cell development, upon differentiation from precursors, the transcription factor 
profile of γδ T cell subsets is established independent of TCR signaling. The second stage 
of immature development involves the acquisition of the full V2 molecular program, 
which depends on TCR signaling. Maturation occurs in the third stage, and at this point, 
the γδ T cell lineages diverge further, and induction of specific homing and growth 
receptors occurs as cells prepare to leave the thymus for the periphery.
The subsequent chapters of this thesis will focus on identifying the molecular 
signatures of γδ T cell subsets at the immature and mature stage, the impact of TCR 
signaling and trans-conditioning on the molecular profiles of γδ T cell subsets, and how 
and when the functional characteristics of γδ T cell subsets are established. The final 
chapter identifies the consequences of alterations in key regulatory pathways and their 
effect on γδ T cell function.  
Results:
Molecular signatures of immature γδ T cell subsets are distinct
γδ T cells have long been regarded as a homogenous population, but our results 
clearly demonstrate that there are significant differences among γδ T cell subsets 
beginning as early as the immature stage of development. In pairwise comparisons, the 
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number of genes differentially expressed between immature (imm)V2 cells and immV6 
cells (1000 genes) is even greater than the difference between immV2 and αβ lineage 
semi-mature CD8+ cells (690 genes) (Figure 3.1). Interestingly, while both immV1 and 
immV6 differ greatly from immV2 cells, they are strikingly similar to each other, with 
only 39 genes distinguishing them. The classic comparisons of gene expression between 
total γδ T cells and immature αβ DPs results in differences of ~1700 genes (for CD69-
DPs) and ~1000 (for CD69+ MHC selected DPs). Comparisons within the αβ T cell 
lineage, such as FoxP3+CD4 T regulatory cells versus FoxP3-CD4+ conventional T cells 
shows a difference of ~500 genes (Figure 3.1). These data indicate that γδ T cells, even at 
the immature stage, cannot be treated as one homogenous lineage. Further, the striking 
similarity of immV1 and immV6 cells and their dissimilarity to immV2 cells indicates 
that at the immature stage, γδ T cells may consist of at least two distinct lineages: those 
expressing the Vγ2 chain, and those expression the Vγ1 chain. To confirm the results 
obtained from our gene expression analysis, we stained γδ T cell subsets to determine the 
protein expression of differentially expressed genes (Figure 3.2 and 3.3). The incredible 
heterogeneity of immature γδ T cell subsets is evident in these studies, with distinct 
expression of transcriptional regulators, proteins regulating migration, growth factor 
receptors, NK receptors, and cell surface receptors, many of which will be discussed in 
more detail in subsequent sections. Protein expression is also shown for mature γδ T cell 
subsets for comparison and completeness, the results of which will be discussed in more 
detail in Chapter 5.  
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Figure 3.1 Distinct global gene expression profiles of γδ cell subsets defined by TCR 
repertoire.
The mean expression of sample replicates for consolidated probe sets was plotted to 
compare populations of cells from WT mice using Multiplot. Each dot represents one 
gene (mean of all probe sets), and dots highlighted in red represent genes whose 
expression is changed by greater than 2 fold, p<0.05, coefficient of variation (cv)<1. The 
total number of highlighted genes is listed in parenthesis at the top of each plot. MatCD8, 
CD8+CD24lo/-TCRhi; Semi-mature CD8, CD8+CD24intTCRhi; ISP, immature single-
positive CD4-CD8+CD24hiTCR-/lo; MatCD4, CD4+CD24lo/-TCRhi.
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Figure 3.2 Confirmation of microarray data illustrates the heterogeneity of 
immature and mature γδ T cell subsets in expression of transcriptional regulators 
and migration-related proteins.
Histograms of the expression of various cell surface, intracellular, and intranuclear 
proteins in immature (CD24hi) and mature (CD24lo) V2, V1, and V6 γδ T cells. Samples 
located in between V1 and V6 represent histograms gated on total Vγ1.1+ cells. For FDG 
reporter mice, staining on WT cells is shown in grey. Some histrograms, including all 
mature V2 samples, were generated by concatenating data from several samples in 
FlowJo.
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Figure 3.3 Confirmation of microarray data illustrates the heterogeneity of 
immature and mature γδ T cell subsets in expression of growth factors, NK cell 
receptors, and cell surface receptors.
Histograms of the expression of various cell surface, intracellular, and intranuclear 
proteins in immature (CD24hi) and mature (CD24lo) V2, V1, and V6 γδ T cells. Samples 
located in between V1 and V6 represent histograms gated on total Vγ1.1+ cells. For FDG 
reporter mice, staining on WT cells is shown in grey. Some histrograms, including all 
mature V2 samples, were generated by concatenating data from several samples in 
FlowJo.
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ImmV2 and ImmV1/V6 subsets are closely related to different developmental precursor 
subsets
To better understand the nature of the genes that differ between immV2 and 
immV1/V6 cells, we used principal component analysis, a mathematical technique that 
uses an orthogonal linear transformation to uncover the main variance in 
multidimensional data and displays the relative similarity among sample populations 
(80). When this analysis was performed on the genes differentially expressed among 
immV2 and immV1/V6 cells, immV2 cells segregated with the early precursors, ETPs 
and DN1s, while immV1 and immV6 cells were more closely related to later precursors, 
DN2 and DN3. We quantified the relatedness of precursors and immature γδ subsets 
using hierarchical clustering based on the discriminatory gene signatures of the immature 
γδ populations. The genes distinguishing immV2 cells are most closely related to that of 
early DN1 precursors, while the shared signature of immV1 and V6 cells is most similar 
to late DN3 precursors. These results suggest that γδ T cell subsets are very different
from each other, and that these differences in part correspond with the germline location 
of the rearranged Vγ genes. γδ T cells that express TCRs derived from the Vγ2-Cγ1 
cluster are very distinct from those derived from the Vγ1-Cγ4 cluster, despite their usage 
of different Vδ genes and the attendant variations in junctional sequences, and may 
represent unique subpopulations. The traces of the gene signatures of early and late 
precursors present in immV2 and immV1/V6 cells respectively also indicate that these 
subsets may diverge from different stages of precursor development, inheriting part of 
their unique signatures from the precursors from which they originate. Most importantly, 
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Figure 3.4 ImmV2 and ImmV1/V6 T cell subsets retain traces of the gene expression 
programs of different DN precursors.
(A) and (B) The discriminating gene signature of immV2 versus immV1/V6 cells was 
established by identifying genes that were differentially expressed (>2 fold, cv<0.5) 
among immV2 cells vs. immV1 cells or immV2 cells vs. immV6 cells. This comparison 
identified 1148 unique genes. (A) Principal component analysis was performed on the 
1148 identified genes. The first and second principal components are shown and immune 
subsets were plotted relative to the distribution of the components. (B) Subsets were 
hierarchically clustered based on the expression pattern of the 1148 V2 versus V1/V6 
discriminatory genes and the Pearson correlation between subsets was used to calculate 
the degree of dissimilarity of the subsets in the dendrogram. 
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the vast difference in gene expression between immV2 and immV1/V6 cells, combined 
with the relatedness to precursors of different stages, indicate that the V2 and V1/V6 
subsets of γδ T cells may in fact be distinct lineages of γδ T cells segregated by Vγ gene 
expression. 
Distinct gene regulatory circuits in immature γδ subsets
We used pathway analysis to identify networks of genes that were distinctly 
expressed in immV2 and immV1/V6 cells. Analysis of the genes that are increased in 
immV1/V6 cells versus immV2 cells (the V1/V6 signature, 927 genes, Table 3.1) showed 
a significant representation of genes involved in oxidative phosphorylation and other 
metabolic pathways (Table 3.2). Over one-third of V1/V6 signature genes are involved in 
DNA synthesis, RNA biogenesis, protein translation, and metabolism. Interestingly, 
genes involved in metabolism are also highly upregulated in precursor DN2 and DN3 
cells (Figure 3.5A, Table 3.3). In contrast, expression of metabolic genes is low in 
immV2 cells and in early ETP and DN1 precursors (Figure 3.5A, Table 3.3). It was 
possible that this difference in metabolic gene expression was the result of differences in 
the proliferative state of these γδ T cell subsets. To determine if that was the case, we 
stained immature subsets of γδ T cells with intranuclear Ki-67, a dye that marks cells that 
are in non-G0 phases of the cell cycle. All three populations of immature γδ T cells had 
equivalent amounts of Ki-67 expression, indicating that differences in cell cycle are not 
responsible for the upregulation of metabolic genes in V1/V6 cells (Figure 3.5B).
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Table 3.1 List of V1/V6 signature genes.
List of genes upregulated in immV1/V6 versus immV2 cells (the immV1/V6 signature). 
Genes were identified as being increased by 2-fold or more in either immV1 or immV6 
versus immV2 cells with a cv<0.5.
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Table 3.1
0610007P14Rik
0610009D07Rik
0610011F06Rik
0610040B10Rik
1110002B05Rik
1110059E24Rik
1110059G10Rik
1500012F01Rik
1500032L24Rik
1700029F09Rik
1700034H14Rik
1810020D17Rik
1810027O10Rik
1810035L17Rik
1810037I17Rik
2010107E04Rik
2210016F16Rik
2310003F16Rik
2310061C15Rik
2410015M20Rik
2410127L17Rik
2610001J05Rik
2610029I01Rik
2810008D09Rik
2810008M24Rik
2810417H13Rik
2810422O20Rik
2900010J23Rik
2900064A13Rik
3110001D03Rik
3110003A17Rik
4930401B11Rik
4930420K17Rik
5033414D02Rik
9130401M01Rik
A430093F15Rik
A530021J07Rik
A630033H20Rik
Acot10
Acot13
Acot9
Actl6a
Adamts6
Adamtsl3
Adh1
Adk
Ahcy
Ahr
AI462493
Ak2
Akr1c18
Alcam
Alg5
Amn1
Anapc13
Anxa2
Anxa4
Ap1s2
Ap2s1
Apex1
Apool
Apoo-ps
Appl2
Arhgap20
Arl6ip1
Arpc3
Arpp19
Arsb
Art2b
As3mt
Asah1
Asf1b
Atox1
Atp5d
Atp5e
Atp5g1
Atp5g3
Atp5j
Atp5j2
Atp5k
Atp5l
Atp5o
Atp6v0e
Atpif1
AW112010
B230307C23Rik
B930036N10Rik
Bcap29
Bcap31
Bet1
Bin1
Bloc1s1
Blvra
Bnip3
Bola3
Brcc3
Brix1
Btla
C030034I22Rik
C1d
C1ql3
Cap2
Capg
Casp1
Casp4
Casp6
Cbr4
Cbwd1
Ccdc53
Ccdc56
Ccl5
Ccnc
Ccr10
Cct8
Cd160
Cd200
Cd200r1
Cd274
Cd28
Cd3d
Cd4
Cd40lg
Cd48
Cd52
Cd59a
Cd69
Cd7
Cd72
Cd9
Cd97
Cdc45
Cdc6
Cdkn2c
Cenpa
Cenph
Cenpk
Cenpm
Cenpp
Cep55
Cetn2
Cetn3
Chchd1
Chchd2
Chek1
Chn2
Chst2
Churc1
Cib1
Cinp
Cisd1
Cks1b
Cks2
Cldn10a
Cldnd1
Clec2d
Clns1a
Clpp
Cnbp
Cndp2
Cnih4
Cntnap1
Commd6
Comt1
Cox17
Cox18
Cox4i1
Cox5b
Cox6b1
Cox6c
Cox7a2
Cox7b
Cox7c
Cox8a
Crcp
Crtam
Cst3
Cstb
Ctsc
Ctss
Ctsw
Cxcr6
Cyba
Cycs
Cyp20a1
Cysltr2
Cyth3
Cytip
D030056L22Rik
D14Ertd449e
D17Wsu104e
D8Ertd738e
D930014E17Rik
Dad1
Dapl1
Dbi
Dcps
Dctn3
Dctpp1
Ddt
Ddx39
Decr1
Dera
Dguok
Dhfr
Dimt1
Dnajc15
Dnajc19
Dph5
Dpm1
Dpm2
Dpy30
Dse
Dstn
Dtl
Dusp2
Dut
Dynll1
Dynlrb1
Dynlt3
E030037K03Rik
Ebna1bp2
Ebp
Echdc1
Ecm1
Eef1e1
Egr2
Ehd4
Eif1
Eif1ax
Eif1b
Eif2b3
Eif3k
Eif3m
Eif4h
Elof1
Emp3
Endod1
Eno3
Enpp1
Eomes
Ephx1
Ept1
Erh
Esd
Etfb
Etohi1
Exo1
Exosc2
Exosc5
Exosc7
Exosc8
Fabp5
Faim
Fam124b
Fam18b
Fam3c
Fam54a
Fam60a
Fam96a
Fancd2
Fbxo5
Fcer1g
Fcf1
Fcrl1
Fgl2
Fhl2
Fignl1
Fis1
Fkbp2
Frrs1
Fuca2
Fundc1
Fundc2
Gadd45b
Gas5
Gbe1
Gcet2
Gemin6
Gimap3
Gins1
Gla
Glipr1
Glod4
Glrx2
Glrx3
Gm10012
Gm10072
Gm10237
Gm10752
Gm10784
Gm11275
Gm11277
Gm11401
Gm11472
Gm11971
Gm12058
Gm12191
Gm12238
Gm12755
Gm12760
Gm13015
Gm13352
Gm13892
Gm13895
Gm13926
Gm16372
Gm16399
Gm16494
Gm2701
Gm3258
Gm3338
Gm3771
Gm4483
Gm4945
Gm5471
Gm5502
Gm5617
Gm6134
Gm6181
Gm6273
Gm6344
Gm6394
Gm6581
Gm7079
Gm71
Gm7123
Gm7172
Gm7246
Gm7312
Gm7567
Gm7780
Gm8290
Gm8580
Gm9028
Gm9238
Gm9457
Gng5
Gnpnat1
Golm1
Gpn3
Gpr155
Gpr174
Gpx1
Gramd1b
Gsta4
Gstk1
Gstm1
Gsto1
Gtf2a2
Gtf2e2
Gtf2h5
H19
H2afz
H2-Ke2
Hat1
Haus7
Hbxip
Hddc2
Higd2a
Hint1
Hist1h1a
Hist1h2ab
Hist1h2ac
Hist1h2bb
Hist1h2bc
Hist1h2be
Hist1h2bg
Hist1h2bh
Hist1h2bm
Hist1h4b
Hist1h4c
Hist1h4d
Hist1h4f
Hist1h4i
Hist1h4m
Hist2h2bb
Hist3h2a
Hist3h2bb
Hist4h4
Hmga2
Hmgn3
Hprt
Hrsp12
Hsd17b10
Hsd17b12
Hspa13
Hspe1
Hvcn1
Id2
Id3
Idh1
Idi1
Ier2
Ier3ip1
Ifi27l1
Ifi27l2a
Ifi30
Ifi35
Ifit1
Ifrd1
Ift27
Igbp1
kzf3
l18r1
l2rb
l7r
Impa1
Ino80
Ipcef1
Irak3
tgb8
tih5
tm2a
tpa
Klf10
Klhdc2
Klrb1a
Klrc1
Klrc2
Klrd1
Klri1
Kpna2
l7Rn6
Lactb
Lag3
Lage3
Lass4
Lat2
Ldhb
Lgals1
Litaf
LOC100044526
Lrmp
Lsm3
Lsm4
Lsm5
Lsm6
Lsm7
Lta4h
Ly6c1
Ly96
Lypla1
Mad2l1
Magoh
Magohb
Mapk11
Mapksp1
Mcee
Mcm5
Med21
Med31
Med6
Mgst2
Mid1ip1
Mif
Mitd1
Mmd
Mmp7
Mnd1
Mphosph6
Mrpl13
Mrpl14
Mrpl16
Mrpl2
Mrpl20
Mrpl22
Mrpl23
Mrpl24
Mrpl30
Mrpl32
Mrpl35
Mrpl36
Mrpl42
Mrpl45
Mrpl50
Mrpl51
Mrpl52
Mrps18b
Mrps18c
Mrps21
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Table 3.1 continued
Mrps26
Mrps27
Mrps28
Mrps33
Mrps6
Ms4a4b
Ms4a4c
Mtch2
Mtcp1
Mterf
Mthfd1l
Mthfd2
Mtx2
Myg1
Myl6
Myo1e
N6amt2
Naa10
Naa38
Naa50
Nae1
Napb
ND3
Ndufa1
Ndufa13
Ndufa2
Ndufa3
Ndufa4
Ndufa6
Ndufa9
Ndufab1
Ndufb3
Ndufb4
Ndufb6
Ndufb7
Ndufb9
Ndufc1
Ndufc2
Ndufs3
Ndufs4
Ndufs6
Ndufs7
Ndufs8
Ndufv1
Ndufv2
Nedd8
Neil3
Neto2
Neurl3
Nfu1
Nhp2
Nhp2l1
Nkg7
Nmd3
Nme1
Nme2
Nmi
Nop10
Nop16
Nop56
Nop58
Npm3-ps1
Nr4a2
Nr4a3
Nrgn
Nsg2
Nsmce2
Nt5c
Nt5e
Nubp2
Nudcd2
Nudt21
Nudt5
Nuf2
Nup133
Oip5
Orc6l
Ostf1
Otud1
Paics
Paip2
Park7
Pbk
Pcna
Pdcd1lg2
Pde2a
Pfdn1
Pfdn5
Pfkp
Pgcp
Pglyrp1
Pgm3
Pgrmc1
Phf11
Phf5a
Phospho2
Pin4
Pion
Pla2g16
Plac8
Plcg2
Plp2
Plrg1
Plscr1
Pnp
Pnp2
Pold2
Pold4
Pole2
Polr1b
Polr2d
Polr2f
Polr2g
Polr2h
Polr2i
Polr2j
Polr2k
Polr2l
Pomp
Pop4
Ppa1
Ppie
Ppih
Ppil1
Ppil3
Ppp6c
Pqlc3
Prdx1
Prdx2
Prdx4
Prdx6
Prdxdd1
Prelid2
Prim1
Prmt1
Prpf31
Prps1
Prr13
Prr5l
Psat1
Psen2
Psma1
Psma2
Psma3
Psma4
Psma5
Psmb1
Psmb10
Psmb2
Psmb3
Psmb5
Psmb6
Psmb7
Psmb8
Psmb9
Psmc4
Psmd10
Psmd14
Psmd6
Psme1
Psme2
Psmg1
Psmg2
Pter
Ptplb
Pttg1
Pycrl
Qpct
Rab11a
Rab28
Rab3ip
Rabggtb
Rabif
Rad1
Rad51
Rad51l1
Rad54l
Ran
Raph1
Rbm3
Rbm7
Rbx1
Rdm1
Rfc3
Rfc4
Rgs2
Rilpl2
Ripk3
Rmrp
Rnu12
Rnu1b1
Rnu2
Rnu3a
Rnu3b1
Rnu73a
Rnu73b
Rny1
Rny3
Romo1
Rpa2
Rpa3
Rpl10
Rpl11
Rpl12
Rpl15
Rpl22l1
Rpl23a
Rpl27
Rpl29
Rpl30
Rpl31
Rpl34
Rpl35
Rpl35a
Rpl36
Rpl36al
Rpl37
Rpl38
Rpl39
Rpl41
Rpl9
Rplp1
Rpp30
Rps11
Rps12
Rps13
Rps15
Rps15a
Rps16
Rps17
Rps18
Rps21
Rps27
Rps27a
Rps27l
Rps28
Rps29
Rps3
Rps5
Rrm1
Rrm2
Rrp15
Rsu1
Samd9l
Sap18
Sar1b
Sat1
Sccpdh
Scn4b
Sdf2
Sdhb
Sdhd
Sec11a
Sec11c
Sec13
Selk
Sepx1
Serpinb6b
Sf3b5
Sh2d1a
Shfm1
Shq1
Siae
Siva1
Skp1a
Slamf6
Slamf7
Slc25a17
Slc25a24
Slc25a5
Slc27a2
Slc29a1
Slc35b1
Slc36a4
Slc7a1
Slfn1
Slfn3
Smyd5
Snapc5
Snhg1
Snora21
Snora23
Snora28
Snora3
Snora34
Snora44
Snora52
Snora61
Snora62
Snora65
Snora69
Snora70
Snora74a
Snora75
Snora7a
Snord118
Snord14a
Snord15a
Snord16a
Snord1c
Snord22
Snord32a
Snord33
Snord35a
Snord35b
Snord38a
Snord49a
Snord49b
Snord61
Snord68
Snord8
Snord82
Snord85
Snord87
Snrnp25
Snrpa1
Snrpb
Snrpd2
Snrpd3
Snrpe
Snrpf
Snrpg
Spc24
Spcs1
Spock2
Spry2
Srm
Srp14
Ssna1
Ssr2
Ssr4
Ssu72
Steap3
Stmn1
Stx8
Sumo1
Sumo2
Supt4h1
Susd2
Syce2
Syt11
Taf1d
Taf9b
Tagap
Tbca
Tceb1
Tceb2
Tcrb-J
Tgm3
Thg1l
Thoc3
Tigit
Timm10
Timm17a
Timm23
Timm8a1
Timm8b
Tipin
Tjp2
Tk1
Tmco1
Tmed3
Tmem126a
Tmem128
Tmem14c
Tmem160
Tmem167
Tmem177
Tmem194
Tmem199
Tmem203
Tmem208
Tmem38b
Tmem60
Tmem97
Tmem9b
Tmsb4x
Tmx2
Tnfrsf18
Tnfrsf9
Tnfsf10
Tnfsf8
Tnni1
Toe1
Tomm20
Tomm7
Tpi1
Tprkb
Tpt1
Traf5
Trappc1
Trappc2
Trappc2l
Trappc4
Trf
Triap1
Trmt61a
Tsga10ip
Tsn
Tspan32
Tspan5
Tspan6
Tspo
Ttc27
Ttc35
Ttc39b
Ttc39c
Tubg1
Tusc3
Txn1
Txndc9
U2af1
Ubash3b
Ube2a
Ube2v2
Ublcp1
Ufc1
Uhrf1
Umps
Uqcr10
Uqcrb
Uqcrh
Usmg5
Uxt
Vamp8
Vps25
Vps29
Wdhd1
Wdr55
Wdr61
Wdr73
Xcl1
Xdh
Xkrx
Xpnpep3
Yaf2
Yif1b
Yipf5
Zadh2
Zbtb16
Zbtb8os
Zcchc12
Zfp52
Zfp536
Zfp800
Znhit6
Znrd1
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Table 3.2 Pathways associated with V1/V6 signature genes.
Genes upregulated in immV1/V6 versus immV2 cells (the immV1/V6 signature) were 
classified into functional pathways using Ingenuity pathway analysis. The relevant 
pathway, p-value, and genes associated with that pathway are shown. Pathways with a p-
value of less than 0.5 that contained 4 or more genes are shown.
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 Oxidative Phosphorylation
 Mitochondrial Dysfunction
 Ubiquinone Biosynthesis
 Purine Metabolism
 Pyrimidine Metabolism
 Nucleotide Excision Repair Pathway
 Protein Ubiquitination Pathway
 Assembly of RNA Polymerase II Complex
 Cell Cycle Control of Chromosomal Replication
 Estrogen Receptor Signaling
 Glutathione Metabolism
 Mismatch Repair in Eukaryotes
 Androgen Signaling
 One Carbon Pool by Folate
 CCR5 Signaling in Macrophages
 Citrate Cycle
 Role of CHK Proteins in Cell Cycle Checkpoint Control
 Phenylalanine Metabolism
 ATM Signaling
 Glucocorticoid Receptor Signaling
 Pentose Phosphate Pathway
????? ?????????
 N-Glycan Biosynthesis
 Role of BRCA1 in DNA Damage Response
 Antigen Presentation Pathway
 Aryl Hydrocarbon Receptor Signaling
 Cell Cycle: G2/M DNA Damage Checkpoint Regulation
 NRF2-mediated Oxidative Stress Response
 Glycolysis/Gluconeogenesis
 Tyrosine Metabolism
 Crosstalk between Dendritic Cells and Natural Killer Cells
 CREB Signaling in Neurons
 CTLA4 Signaling in Cytotoxic T Lymphocytes
 Nur77 Signaling in T Lymphocytes
 Butanoate Metabolism
 Natural Killer Cell Signaling
 iCOS-iCOSL Signaling in T Helper Cells
 Androgen and Estrogen Metabolism
 T Helper Cell Differentiation
 Communication between Innate and Adaptive Immune Cells
 Starch and Sucrose Metabolism
 Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells
 LPS/IL-1 Mediated Inhibition of RXR Function
 Sphingolipid Metabolism
 Regulation of eIF4 and p70S6K Signaling
 Sphingosine-1-phosphate Signaling
 OX40 Signaling Pathway
6.31E-28
1.00E-23
1.26E-14
3.16E-14
6.31E-12
8.71E-08
3.63E-07
6.03E-07
6.61E-04
7.94E-04
1.29E-03
3.47E-03
6.76E-03
1.35E-02
2.45E-02
3.31E-02
4.47E-02
5.89E-02
6.17E-02
6.17E-02
6.92E-02
7.41E-02
7.41E-02
7.94E-02
8.13E-02
1.04E-01
1.06E-01
1.23E-01
1.32E-01
1.32E-01
1.77E-01
1.89E-01
1.96E-01
1.98E-01
2.51E-01
2.92E-01
2.92E-01
3.11E-01
3.16E-01
3.19E-01
3.52E-01
4.38E-01
4.51E-01
4.56E-01
4.58E-01
4.74E-01
4.83E-01
 NDUFA4, COX7B, SDHB, NDUFA9 (includes EG:4704), ATP5D, COX8A, COX5B, ATP5L, UQCRB, NDUFA1, 
 NDUFA2, UQCRH, NDUFB9, NDUFC2, ATP5G1, NDUFAB1, NDUFS6, ATP5J2, NDUFB6, ATP5G3, COX7C, 
 COX4I1, NDUFS4, ATP5J, NDUFV1, NDUFC1, COX7A2, COX6B1, NDUFB3, COX17, ATP5O, NDUFS7, COX6C, 
 NDUFS3, NDUFA13, NDUFB4, PPA1, 
 UQCR10, NDUFV2, NDUFS8, NDUFA6, ATP5E, NDUFB7, SDHD, NDUFA3, ATP6V0E1, HSD17B10, NDUFA4, 
 COX7B, SDHB, NDUFA9 (includes EG:4704), XDH, COX8A, COX5B, PSEN2, UQCRB, NDUFA2, UQCRH, NDUFB9, 
 PARK7, NDUFAB1, NDUFS6, NDUFB6, COX7C, COX4I1, NDUFS4, ATP5J, NDUFV1, COX7A2, COX17, NDUFB3,
 COX6B1, NDUFS7, GLRX2, COX6C,NDUFS3, NDUFA13, NDUFB4, NDUFV2, NDUFS8, NDUFA6, NDUFB7, CYCS, 
 SDHD, NDUFA3, 
 NDUFA4, NDUFC1, NDUFV1, NDUFB3, NDUFA9, NDUFS7, AS3MT, NDUFS3, NDUFA1, NDUFA2, NDUFB4, 
 NDUFA13, NDUFB9, NDUFV2, NDUFS8, NDUFC2, NDUFAB1, NDUFA6, NDUFB7, NDUFS6, NDUFB6, NDUFA3,
 NDUFS4
 CRCP, PRIM1, POLR2F, NME1, POLR2D, DDX39, ATP5D, XDH, POLR2J, NME2, ATP5L, POLD4, RAD51, POLR2L,
 PRPS1, ATP5G1, ADK, ATP5J2, POLR2H, ATP5G3, ATP5J, PDE2A, TJP2, ENPP1, POLR1B, POLE2, RRM2, 
 PSMC4, PAICS, PSMD6, DGUOK, RRM1, NT5C, POLR2G, NUDT5, INO80, ITPA, NT5E, PNP, HPRT1, AK2, 
 POLR2I, ATP6V0E1, POLD2, RFC3, POLR2K
 CRCP, POLR2F, PRIM1, NME1, POLR2D, NME2, POLR2J, POLD4, POLR2L, POLR2H, DUT, ENPP1, POLR1B, 
 POLE2, RRM2, UMPS, RRM1, POLR2G, NT5C, NUDT5, ITPA, NT5E, EHD4, PNP, POLR2I, POLD2, TK1, POLR2K, 
 RFC3
 POLR2G, POLR2F, POLR2L, RPA3, POLR2D, POLR2J, GTF2H5, POLR2H, POLR2I, RPA2, POLR2K
 PSMB3, PSMA3, UBE2A, PSMB10, UBE2V2, DNAJC15, PSMB8, PSMB6, TCEB2, HSPE1, PSMD10, PSMD14, 
 PSMA2, PSMB9, PSMB5, DNAJC19, PSME2, PSMC4, PSMD6, PSMA1, SKP1, PSMB7, PSME1, PSMB2, RBX1, 
 PSMA5, PSMA4, PSMB1, HSPA13, TCEB1
 POLR2G, GTF2A2, POLR2F, POLR2L, POLR2D, POLR2J, GTF2H5, POLR2H, GTF2E2, POLR2I, TAF9B, POLR2K
 MCM5, CDC45, RPA3, CDC6, ORC6L, RPA2
 POLR2F, POLR2D, CCNC, POLR2J, MED21, MED6, TAF9B, POLR2G, POLR2L, MED31, GTF2H5, POLR2H, 
 POLR2I, POLR2K
 GSTM1, MGST2, GSTA4, GPX1, ATP5G3, GSTO1, PRDX6, GSTK1, IDH1
 PCNA, RFC4, EXO1, RFC3
 POLR2G, POLR2F, POLR2L, POLR2D, POLR2J, GTF2H5, POLR2H, GTF2E2, GNG5, POLR2I, POLR2K
 EHD4, MTHFD2, DHFR, MTHFD1L
 PLCG2, CD4, FCER1G, CCL5, GNG5, MAPK11, CD3D
 SDHB, SDHD, ATP5G3, IDH1
 PCNA, RFC4, CHEK1, RFC3
 MIF, PRDX1, PRDX6, PRDX2
 RAD51, GADD45B, FANCD2, MAPK11, CHEK1
 POLR2F, POLR2D, POLR2J, GTF2E2, CCL5, MAPK11, CD3D, TAF9B, POLR2G, GTF2A2, POLR2L, 
 GTF2H5, POLR2H, SUMO1, POLR2I, POLR2K
 DERA, PRPS1, PGM3, PFKP
 MMP7, TCEB2, RBX1, NAA10, MAPK11, APEX1, LDHB, TCEB1
 DAD1, ALG5, DPM1, TUSC3, DPM2
 RAD51, FANCD2, RFC4, CHEK1, RFC3
 PSMB9, PSMB5, PSMB8, PSMB6
 GSTM1, MGST2, GSTA4, NEDD8, DHFR, AHR, GSTO1, GSTK1, CHEK1
 CKS2, CKS1B, SKP1, CHEK1
 GSTM1, MGST2, GSTA4, PRDX1, RBX1, DNAJC19, DNAJC15, CLPP, GSTO1, GSTK1, EPHX1
 HSD17B10, ADH1A, PGM3, ENO3, PFKP, TPI1, LDHB
 HSD17B10, ADH1A, MIF, DDT, AS3MT, FRRS1
 CD28, CD40LG, KLRD1, CD69, TNFSF10, IL2RB
 POLR2G, POLR2F, POLR2L, POLR2D, PLCG2, POLR2J, POLR2H, GNG5, POLR2I, POLR2K
 CD28, CD4, AP1S2, FCER1G, CD3D, AP2S1
 CD28, FCER1G, CYCS, CD3D
 HSD17B10, SDHB, SDHD, PRDX6
 KLRC2, SH2D1A, KLRD1, PLCG2, FCER1G, KLRC1
 CD28, CD40LG, CD4, FCER1G, CD3D, IL2RB
 HSD17B10, EBP, AS3MT, HSD17B12, ARSB
 CD28, CD40LG, FCER1G, IL18R1
 CD28, CD40LG, CD4, FCER1G, CCL5
 NUDT5, ENPP1, PGM3, PNP, GBE1
 CASP6, FCER1G, CYCS, CD3D
 CHST2, GSTM1, LY96, MGST2, SLC27A2, GSTA4, FABP5, GSTO1, GSTK1
 GLA, ARSB, ASAH1, LASS4
 EIF1AX, EIF1, EIF2B3, PAIP2, MAPK11
 CASP6, PLCG2, CASP1, CASP4, ASAH1
 CD4, FCER1G, TRAF5, CD3D
Pathways associated with immV1/V6 signature genes
Pathway p-value Genes
Table 3.2
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Figure 3.5 Increase in expression of metabolic genes in ImmV1/V6 cells is not due to 
differences in cell cycle.
(A) Heat map of relative expression of metabolic genes in immune cell subsets. Data 
were gene row normalized and hierarchically clustered by gene and subset. Genes are 
color coded (see legend) to display relative gene expression. (B) Thymocytes were 
stained for cell surface markers and intranuclear Ki-67 to identify cycling cells.  Samples 
were first gated on total γδ cells and then gated on V2, V1, or V6. Histograms of Ki-67 
expression on immature (CD24hi, Imm) and mature (CD24lo, Mat) γδ T cell subsets are 
shown. 
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Table 3.3 List of metabolic genes.
List of genes related to metabolism. Genes were categorized based on functional 
annotation (AmiGO), Ingenuity, and/or visual inspection. 
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Atp2b4
Atp5d
Atp5e
Atp5g1
Atp5g3
Atp5j
Atp5j2
Atp5k
Atp5l
Atp5o
ATP6
Atp6v0e
Atpif1
Chchd2
Cox17
Cox4i1
Cox5b
Cox6b1
Cox6c
Cox7a2
Cox7b
Cox7c
Cox8a
Cyba
Cybrd1
Cycs
Cyp20a1
Etfb
Lass4
Ndufa1
Ndufa13
Ndufa2
Ndufa3
Ndufa4
Ndufa9
Ndufab1
Ndufb3
Ndufb4
Ndufb5
Ndufb6
Ndufb7
Ndufb9
Ndufc1
Ndufc2
Ndufs3
Ndufs4
Ndufs6
Ndufs7
Ndufs8
Ndufv1
Ndufv2
Ppie
Ppih
Ppil1
Ppil3
Prdx1
Prdx2
Prdx4
Prdx6
Sdhb
Sdhd
Timm10
Timm23
Timm8a1
Timm8b
Txn1
Txndc9
Uqcrb
Uqcrh
Genes involved in Metabolism
Table 3.3
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Pathway analysis of the genes upregulated in immV2 cells compared to 
immV1/V6 cells (the V2 signature, 221 genes, Table 3.4) showed a significant 
enrichment for genes regulating WNT signaling, GPCR signaling, and genes involved in 
T effector generation (Table 3.5). Transcription factors are known to play a crucial role in 
the divergence of common precursors into distinct cell lineages and have been shown to  
act as master regulators to determine B/T lineage fate (Notch1) (81, 82) and CD4 lineage 
fate (ThPOK) (60, 61). Further, as discussed previously, transcription factors also specify 
the functional differentiation of αβ T cell effector lineages (63). Analysis of the 
transcription factors differentially regulated in immV2 versus immV1/V6 cells showed a 
striking enrichment for transcription factor genes in immV2 cells (Figure 3.6). Most 
prominent among the transcription factors upregulated in immV2 cells, as mentioned 
previously, are those of the WNT signaling pathway, including those that are part of the 
SOX13/TCF1 HMG box family. Additionally, ETS family members Etv5 and Etv6 are 
also upregulated in immV2 cells. Transcription factors upregulated in V1/V6 cells over 
V2 include those that inhibit E protein signaling, including Id2 and Id3, in addition to 
their upstream regulator Egr2. Of these differentially regulated transcription factors, 65% 
are expressed more highly in γδ T cells compared to conventional αβ T cells (Figure 3.7). 
Analysis of Sox13-/- and Id3-/- mice in Chapter 6 indicates that expression of these 
transcription factors is essential for subset-specific development and function of γδ T 
cells. 
Transcriptional networks specifying effector function 
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Table 3.4 List of V2 signature genes.
List of genes upregulated in immV2 versus immV1/V6 cells (the immV2 signature). 
Genes were identified as being increased by 2-fold or more in either immV2 cells versus 
either immV1 or immV6 cells and with a cv<1.
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Table 3.4
1110028C15Rik
1190002N15Rik
4930427A07Rik
5830411N06Rik
Abhd15
Abi3
Acss1
Acvr2a
Adrb2
Aff4
AI504432
Angptl2
Ankrd12
Ankrd6
Ano6
Arhgap26
Arhgef6
Arid1a
Arl8a
Arpp21
Atp2b4
Atp8b4
Atxn2l
Axin2
AY036118
Bat2
Baz2a
Bcl11b
Bcl9
Bcl9l
Blk
Bmf
C030019I05Rik
C630004H02Rik
Camk2d
Ccr8
Ccr9
Cd163l1
Cd93
Cdk16
Chd3
Chd7
Cic
Clec12a
Clip1
Coro2b
Cpa3
Crtc3
Csnk1e
Cybrd1
Dgkz
Dntt
Dyrk1b
E2f4
Endou
Etv5
Etv6
Fam102a
Fam117a
Fam125b
Fam167a
Fam169b
Fbrs
Fbxl20
Foxj2
Foxp1
Furin
Fyb
G530012D18Rik
Gabbr1
Galm
Galnt10
Galnt3
Gata3
Gatsl2
Gcnt7
Gem
Gfra1
Glcci1
Gltscr1
Gm10008
Gm10101
Gm10397
Gm10688
Gm10785
Gm10786
Gm12000
Gm6033
Gm6683
Gm8613
Gm8899
Gm9990
Gngt2
Gpr132
Gpr25
Grap2
Gria3
Gsk3a
Gzma
H2-Q2
Hdac7
Heatr7b1
Heg1
Herc3
Ifngr1
Igf1r
Il12rb2
Il1r1
Itgae
Itpr1
Itpr2
Kbtbd11
Kcna3
Kdm5b
Kdm6b
Kif21b
Klf3
Lig4
Lingo4
Lpar6
Lphn1
Lztfl1
Maf
Man1a
Mark2
Mbd5
Mbd6
Med13l
Mef2d
Mex3b
Midn
Mllt6
Mn1
Mospd3
Mrgpra9
N4bp2
Nat6
Nav2
Nck2
Notch3
Nucb2
Olfr524
Olfr525
Pdgfrb
Pdk2
Pgpep1l
Phf1
Phf2
Phf21a
Phospho1
Plcl1
Plxnd1
Pmepa1
Podnl1
Ppm1e
Ppm1h
Ppm1l
Ppp1r9b
Prr12
Ptger1
Ptgir
Ptprs
Rap1gap2
Rapgef3
Rasgrp1
Rbl2
Rcbtb2
Rcor2
Rin3
Rnf125
Rorc
Runx3
Scaf1
Sell
Setd1b
Sh3kbp1
Slc12a6
Slc15a1
Slc16a5
Slc25a23
Slc27a6
Slc43a2
Slc7a8
Slc9a3r1
Slc9a9
Smo
Sox13
Sp140
Spats2
Spsb1
Sstr2
St6galnac5
St8sia1
Stat4
Stom
Syvn1
Tcf12
Tcf7
Tdrkh
Tgfb3
Thy1
Tiam1
Tmc8
Tmem121
Tox2
Tox3
Trav13-3
Trav13n-1
Trio
Tuba8
Ulk1
Vasn
Vezf1
Wfs1
Xylt1
Zfp358
Zfp362
Zfp652
Zfp704
Zmiz1
Znrf1
V2 signature genes
97
Table 3.5 Pathways associated with V2 signature genes.
Genes upregulated in immV2 versus immV1/V6 cells (the immV2 signature) were 
classified into functional pathways using Ingenuity pathway analysis. The relevant 
pathway, p-value, and genes associated with that pathway are shown. Pathways with a p-
value of less than 0.05 that contained 4 or more genes are shown. Genes marked with an 
asterisk were categorized by hand and were not used to calculate the p values.
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Figure 3.6 Expression of transcription factor networks that specify effector function 
are evident in immature γδ T cell subsets.
Heat map of relative expression of transcription factors in immune cell subsets. Data 
were gene row normalized and hierarchically clustered by gene and subset. Genes are 
color coded (see legend) to display relative gene expression. Genes mentioned in text are 
marked with arrows, and blue arrows refer to genes implicated in IL-17 production.
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Figure 3.7 Most transcription factors that are differentially regulated among 
immature γδ T cell subsets are preferentially expressed in γδ T cells.
Heat map of relative expression of transcription factors in total γδ T cells and total DP 
cells (CD4+CD8+CD69-). Data were gene row normalized and hierarchically clustered by 
gene and subset. Genes are color coded (see legend) to display relative gene expression.
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In CD4+ αβ T cells, effector differentiation occurs after pathogen interaction and 
involves the induction of distinct transcriptional networks. As mentioned previously, T-
bet, GATA3, and RORγt are the main regulators of Th1, Th2, and Th17 differentiation, 
respectively (63). In contrast, γδ T cells are thought to be exported from the thymus as 
pre-made memory/effector cells, and their functions might be programmed in the thymus. 
Supporting this notion, the key transcriptional networks that specify effector function are 
already evident in immature γδ T cell subsets. The transcription factors RORγt (encoded 
by Rorc), Eomesodermin (Eomes), and PLZF (Zbtb16, will be referred to as Plzf for the 
remainder of this thesis, although it will appear as Zbtb16 in gene expression figures)
have been shown to regulate production of IL-17, IFNγ, and IL-4, respectively (49, 66, 
83). Immature γδ T cell subsets already differentially expressed these transcription 
factors based on their future peripheral effector bias (Figure 3.7). Rorc is upregulated in 
immV2 cells compared to immV1/V6 cells. BLK (B lymphoid kinase) and SCART1/2 
(Cd163l1 and 5830411N06Rik) have also been identified as markers of IL-17 producing 
γδ T cells (41, 84), and both of these genes were upregulated in immV2 cells (Table 3.4), 
further supporting the thymic programming of γδ T cell subset function. Other factors 
involved in regulation of IL-17 production in αβ T cells are similarly enriched in immV2 
cells, such as Rora (66), Maf (85), and Irf1 (86) (Figure 3.6). Genes involved in αβ Th 
cell differentiation such as Gata3 (65) and Runx3 (87) are also upregulated in immV2 
cells. The transcription factor networks specific to V1/V6 cells are also evident at the 
immature stage. Immature V1/V6 cells express higher levels of Eomes, Id2, Id3, and Plzf.
PLZF, as discussed previously, is the signature transcription factor of NKT cells and is 
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not found in any other T cell lineage except the innate-like MAIT cells that populate the 
gut (48, 49, 51).  These transcriptional networks are established at the early stages of γδ T 
cell development, prior to maturation and ligand interaction, and indicate that the 
developmental program of γδ T cells is set at the immature stage. 
Summary and future directions:
Our analysis of the molecular signatures of immature V2, V1, and V6 cells has 
made it evident that γδ T cell subsets are a heterogeneous population. While γδ T cells 
are often treated as a single cell lineage, some subsets of γδ T cells are as molecularly 
distinct from each other as they are from αβ T cells. ImmV2 cells are very different from 
immV1 and V6 cells, but interestingly, immV1 and immV6 cells are nearly identical in 
their gene expression patterns. Further, the gene expression signatures of different γδ T 
cell subsets contain the remnants of different DN precursors. ImmV1/V6 cells are more 
metabolically active, similar to DN2 and DN3 precursors, while immV2 cells share the 
lower metabolic activity of ETP and DN1 cells. The traces of the gene expression 
patterns of different thymic precursor populations found in γδ T cell subsets indicates 
they may originate from different precursors during development. 
Transcription factors are an essential component of the lineage differentiation
process and play important roles in the acquisition of effector functions. Previous studies 
have dissected the transcription factor expression patterns of early precursors and T cells 
in great detail (88). However, in these studies, γδ T cells were bulk sorted, which could 
greatly mask any γδ T cell subset specific transcription factor expression, especially since 
105
some populations, such as V6, make up such a small frequency of total γδ T cells (~5-
8%). We found that immV2 cells were strikingly enriched for the expression of 
transcription factors, including those of the WNT family that are crucial for many cell 
differentiation processes, including T cell development (31, 89, 90). ImmV1/V6 cells had 
higher expression of Eomes and Plzf, transcription factors that have been shown to 
regulate IFNγ (83) and dual IFNγ/IL-4 (48, 49) production, respectively, and also 
expressed higher levels of Id3 (Figure S4). Additionally, immV2 cells had also 
upregulated a number of factors known to be associated with IL-17 production. Thus, 
effector lineage programming of γδ T cell subsets at the molecular level is established at 
the immature stage, prior to maturation, and independent of ligand engagement. As some 
of the transcription factors identified as higher in immV2 cells are also expressed at lower 
levels in V1/V6 cells, and vice versa, these factors are technically V2-biased and V1/V6-
biased. However, for simplicity, we will refer to these genes in as V2 or V1/V6 specific 
throughout this thesis, with the understanding that these designations are not absolute in 
their nature.
Our cell sorting strategy based on Vγ/Vδ gene usage and the maturation marker 
CD24 clearly identify the V1 and V6 populations as relatively homogeneous at the 
immature stage. However, it is possible that the V2 population is more heterogeneous, 
and that further cell sorting based on additional markers could split the V2 population 
into additional more homogeneous subsets. Due to the low number of γδ T cells found in 
they thymus, further dissection of V2 cells was not possible. Additional cell preparation 
techniques for microarray analysis are being tested by the Immgen Consortium that may 
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allow us to sort as few as 1,000 cells per population, compared with the ~30,000 cells 
currently required for adequate analysis. Once these techniques are validated, we may be 
able to further dissect the V2 population to assess its heterogeneity. We are also 
interested in analyzing the gene expression patterns of mutant mice with known defects 
in γδ T cell development. We are preparing to sort subsets of γδ T cells from Sox13-/-
mice to determine its influence on the gene signature of γδ T cell subsets. 
Materials and Methods:
Mice
CCR10 reporter cells were from Na Xiong (Pennsylvania State University, University 
Park, PA) and have been described previously (91). Axin2, Solt, and Sox5 (from 
Veronique Lefebvre) reporter mice have been described previously (92, 93). All mice 
used in these experiments were housed in a specific pathogen free rodent barrier facility. 
All animal experiments were approved by the University of Massachusetts Medical 
School Institutional Animal Care and Use Committee (Worcester, MA). 
Cell sorting
Thymocytes were pooled from 4-20 male 5 week old C57BL/6 mice (Jackson Labs), with 
the number of mice depending on the subset sorted. Thymocyte preparations were 
enriched for γδ T cells by depletion of CD8+ cells using magnetic beads (MACS) and an 
autoMACS sorter. Depleted thymocytes were stained for cell surface markers and 
~20,000-30,000 cells were directly into Trizol (Invitrogen) using a FACSAria sorter. 
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Purity checks were performed on all populations, and only those with greater than 99% 
purity were processed and analyzed. For each population, independent duplicate or 
triplicate samples were sorted. γδ T cell populations were sorted as follows: immV2, 
Vγ2+TCRδ+CD24+CD4-CD8-; immV1, Vγ1.1+Vδ6.3-TCRδ+CD24+; immV6, 
Vγ1.1+Vδ6.3+TCRδ+CD24+. T cell precursors and αβ T cell populations used for 
comparison in these studies were sorted by other members of the Immgen Consortium. 
The sorting details for these populations can be found on the Immgen website
(Immgen.org). 
RNA preparation and microarray processing
RNA was processed from sorted cells in Trizol at the main Immgen processing facility at 
Harvard Medical School (Boston, MA) using standard protocols. Microarray analysis was 
performed at the main Immgen processing facility using the GeneChip Gene 1.0 ST 
Array System (Affymetrix) according to the manufacturers’ protocols. Quality control of 
samples was performed by Immgen (Harvard Medical School, Boston, MA). Samples 
that did not meet the quality control guidelines were resorted. 
Data analysis and visualization
Data analysis was performed using GenePattern (Genepattern.org) analysis modules. 
Expression files were generated from raw microarray CEL files using the 
ExpressionFileCreator module. Unannotated probe sets were removed and data were 
RMA normalized with quantile normalization and background correction. The 
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CollapseDataset module was used to consolidate multiple probesets into a single probeset 
value for each gene. Identification of differentially regulated genes was performed using 
Multiplot. Unless otherwise indicated, genes were considered differentially regulated if 
they differed in expression by more than 2-fold, had a coefficient of variation (cv) among 
replicates of less than 1, and had a p value of less than 0.05. Heatmaps were generated by 
hierarchical clustering (HierarchicalClustering module) of data based on gene (row) and 
subset (column) using the Pearson correlation for distance measurement. Data were log 
transformed and clustered using pair-wise complete linkage. Data were row centered and 
row normalized prior to visualization using the HeatmapViewer module. Principal 
component analysis was performed using the PCA module with subset clustering. 
Pathway analysis was performed using Ingenuity software (Ingenuity.com) and by 
manual inspection. Some functional classifications were performed using AmiGO 
(Amigo.geneontology.org) and KEGG pathways (Genome.kp.kegg).
Flow cytometry
The following cell surface antibodies were purchased from BD Biosciences or 
eBiosciences: CD3, CD4, CD8, CD25, CD44, ckit, Vγ2, Vδ6.3, ckit, CCR6, CCR7, 
CCR9, CD62L, CXCR3, CXCR4, CD122, CD24, IL-17Rα, 2B4, Ly49C/I, NKG2ACE, 
NKG2D, CD9, CD27, CD48, CD73, PD1, Thy1.1, streptavidin APC, and streptavidin 
PE-Cy7. Vγ1.1 antibody was purified from antibody producing cell lines by Bio-XCell 
and biotinylated using the FluoReporter Mini-Biotin-XX Protein Labeling Kit 
(Invitrogen). Intranuclear staining was performed using the FoxP3 staining kit  
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(eBioscience) for the following antibodies: Eomes (eBioscience), GATA3 (BD 
Biosciences), RORγt (eBioscience), Smo (Santa Cruz), PLZF (Santa Cruz), and Ki-67 
(BD Biosciences). FDG was purchased from Invitrogen and staining was performed 
according to standard protocols. All data were acquired on a BD LSRII and analysis was 
performed using FlowJo (Treestar). Some data were concatenated from multiple samples 
using FlowJo to provide enough events for visualization. 
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CHAPTER IV:
γδ T CELL SUBSETS ARISE FROM DISTINCT PRECURSORS AND SUBSET-
SPECIFIC TRANSCRIPTIONAL PROFILES ARE ESTABLISHED 
INDEPENDENTLY OF TCR AND TRANS-CONDITIONING SIGNALS
Introduction:
Having established the molecular signatures of the different γδ T cell subsets at 
the immature stage, we wanted to investigate the role of TCR signaling and trans-
conditioning on the evolution of the immature gene signatures. As discussed previously, 
the strength of TCR signaling has been proposed to play an instructive role in the initial 
lineage commitment of γδ T cells and has also been proposed to regulate some aspects of 
γδ T cell subset specification. It has been suggested that the development of V6 γδNKT 
cells is the result of stronger signals through the TCR that induce PLZF expression (50).
To determine the effect of TCR signals on the acquisition of the immature γδ T cell 
signatures, we sorted and compared γδ T cell subsets from Itk-/- mice. ITK is a kinase that 
is downstream of TCR signaling that is expressed in αβ and γδ T cells, as well as αβNKT 
cells. Itk deficiency leads to decreased phosphorylation of PLCγ and defects in calcium 
mobilization in αβ T cells (56) (Figure S5). ITK is also crucial for transmitting signals 
downstream of the γδTCR, as Itk-/- γδ T cells do not flux calcium after stimulation 
(Catherine Yin, unpublished data). We sorted immV1 and immV2 subsets from the 
thymus of Itk-/- mice, but we were unable to sort immV6 cells, as virtually all V6 cells in 
Itk-/- mice are CD24lo. The molecular signatures of the immV1 and immV2 subsets from 
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Itk-/- mice were compared to that of WT subsets to determine the effect of TCR signaling 
on the immature γδ T cell subset specific signatures. 
In addition, lymphotoxin production by αβ lineage DP cells has been shown to 
affect the development of DN precursors and γδ T cells in a process known as trans-
conditioning (33, 34). In the absence of trans-conditioning in Tcrb-/- mice, which lack 
normal lymphotoxin-producing αβ lineage DP cells, DN precursors and γδ T cells fail to 
express a set of γδ lineage-biased genes, including Rgs1, Rgs2, Nr4a1 (Nur77), Nr4a2
(Nurr1) and Nr4a3 (Nor1), and ICER (Crem). The lack of these genes, and likely others, 
that are normally induced by trans-conditioning resulted in a defect in the function of γδ
T cells from Tcrb-/- mice. Peripheral γδ T cells from Tcrb-/- made less IFNγ, IL-2, and 
TNFα upon stimulation than WT mice. These results indicated that trans-conditioning 
affects the molecular program of γδ T cells in the thymus and influences their function in 
the periphery (33, 34). Additional studies indicated that CD27 expression was associated 
with γδ T cells that expressed the LTβR and appeared to receive trans-conditioning 
signals, as they expressed the above-mentioned panel of γδ lineage-biased genes. In 
contrast, CD27- γδ T cells did not express the γδ lineage-biased genes, including the 
LTβR, indicating that their development was not dependent on trans-conditioning (42).
These results indicated that not all γδ T cell subsets share an equivalent dependence on
trans-conditioning during development. To further clarify the role of trans-conditioning 
on γδ T cell subset specific development, we sorted immature V1, V2, and V6 cells from 
Tcrb-/- mice. 
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Results:
TCR/ITK signaling specifies most of the V2 molecular signature, but does not specify 
the V2 transcription factor profile
Analysis of the gene signature of γδ T cell subsets from Itk-/- mice revealed that 
immV1 cells were relatively unaffected, as they differed from WT immV1 cells in only 
98 genes. In contrast, the difference between immature WT and Itk-/- V2 cells was much 
greater (569 genes) (Figure 4.1A). Interestingly, the lack of ITK signaling resulted in a 
greater similarity in gene expression between Itk-/- immV2 cells and WT immV1 cells 
(Figure 4.1A). By performing principal component analysis on the ~600 genes that 
distinguish WT immV2 cells from Itk-/- immV2 cells, we saw that Itk-/- immV2 cells 
clustered with immV1 cells from WT and Itk-/- mice (Figure 4.1B). This indicated that in 
the absence of ITK, V2 cells assumed the expression pattern of V1 cells. While Itk
deficiency led to the development of V1-like V2 cells, Itk-/- immV2 cells still retained 
expression of V2 transcription factors. Hierarchical clustering of transcription factor 
expression among immature γδ T cell subsets from WT and Itk-/- mice showed that the V2 
transcription factor signature is retained in Itk-/- V2 cells (Figure 4.2). Itk-/- V2 cells 
maintained high expression of V2 transcription factors such as Sox13, Etv5, and Rorc.
Furthermore, there was no aberrant expression of V1 transcription factors such as Eomes
and Plzf in Itk-/- immV2 cells at the molecular level. These results indicate that signals 
through the TCR that involve ITK do not play a major role in setting the expression
pattern of immV1 cells. ITK is critical for establishing many aspects of the immV2 cell 
profile, and in the absence of ITK, much of the immV2 molecular program is not 
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Figure 4.1 The immV2 gene signature is controlled by ITK.
(A) The mean expression of sample replicates for consolidated probe sets was plotted to 
compare populations of cells from WT and Itk-/- mice. Each dot represents one gene 
(mean of all probe sets), and dots highlighted in red represent genes whose expression is 
changed by greater than 2 fold, p<0.05, cv<1. The total number of highlighted genes is 
listed in parenthesis at the top of each plot. (B) Principal component analysis of the 
discriminatory gene signature of immature Itk-/- V2 versus WT V2 cells. The first and 
second principal components are shown and subsets were plotted relative to the 
distribution of the components.
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Figure 4.2 The immV2 transcription factor profile is not defined by ITK.
Heatmap of relative gene expression of select transcription factors (as in Figure 3.6) and 
maturation genes in immature γδ subsets from WT and Itk-/- mice. Data were gene row 
normalized and hierarchically clustered by gene and subset. Genes are color coded (see 
legend) to display relative gene expression.
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engaged and cells resemble immV1 cells. Acquisition of the transcription factor profile of 
immV2 cells, however, is independent of ITK, indicating that other factors are 
responsible for its induction and/or maintenance. 
Lack of trans-conditioning has minimal impact on immature γδ T cell subsets
Trans-conditioning from αβ lineage DP cells to γδ T cells was proposed to have a 
strong impact on the development of DN precursors and γδ T cells (33, 34). In the 
experiments that led to this conclusion, the gene expression patterns of total γδ T cells 
from WT and Tcrb-/- mice were compared and indicated that the development of γδ T 
cells in Tcrb-/- mice was abnormal. γδ T cells from Tcra-/- mice, which have normal DP 
cells, showed no defects in the expression of the genes aberrantly regulated in Tcrb-/- γδ T 
cells (33, 34). However, the composition of γδ T cell subsets in the thymus of Tcrb-/- mice 
is abnormal, as these mice have an expanded population of V6 cells and a decrease in the 
frequency of V2 cells (Figure 4.3). Based on these differences in γδ T cell subset 
distribution and the heterogeneity we now know exists among different subsets of γδ T 
cells, the impact of trans-conditioning on different subsets of γδ T cells remains unclear. 
Therefore, to determine the influence of trans-conditioning on the signature of γδ
T cells, we compared the gene expression patterns of immature γδ T cell subsets from 
Tcrb-/- mice to that of WT mice. Surprisingly, there was very little impact as a result of 
the loss of trans-conditioning in immature γδ T cells, as all immature subsets from Tcrb-/-
mice were very similar to WT subsets, with fewer than ~55 genes changed in any pair-
wise comparison (Figure 4.4A). The expression of only 6 genes was altered in all three 
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Figure 4.3 The frequency of γδ T cell subsets in Tcrb-/- mice is aberrant.
(A) Representative FACS profiles showing Vγ1.1 and Vδ6.3 staining (left) or Vγ2
staining (right) on WT and Tcrb-/- γδ thymocytes. (B) Frequencies of V2, V1, and V6 
cells among γδ T cells in the thymus for all mice analyzed were graphed. The mean 
frequency ±SD is shown along with the Student t-test p value. Data were combined from 
2 independent experiments. 
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Figure 4.4 Minimal impact of trans-conditioning on the gene signatures of immature 
γδ T cell subsets.
(A) The mean expression of sample replicates for consolidated probe sets was plotted to 
compare populations of cells from WT and Tcrb-/- mice. Each dot represents one gene 
(mean of all probe sets), and dots highlighted in red represent genes whose expression is 
changed by greater than 2 fold, p<0.05, cv<1. The total number of highlighted genes is 
listed in parenthesis at the top of each plot. (B) Venn diagram showing the intersection of 
the genes differentially expressed in immature WT versus Tcrb-/- V2 cells (ImmV2), WT 
versus Tcrb-/- V1 cells (ImmV1), and WT versus Tcrb-/- V6 cells (ImmV6). Numbers 
represent the number of genes that were differentially regulated in each comparison. The 
genes that were differentially expressed in multiple subsets (intersection of circles) are 
listed. 
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pair-wise comparisons (Figure 4.4B). One of those genes, Jun, is part of the AP1 complex 
that is downstream of many signaling pathways such as WNT, TCR, and cytokine 
signaling (94), and was downregulated in Tcrb-/- γδ T cells. As Jun deficiency has been 
linked to enhanced γδ T cell development (95), this difference in expression may have 
consequences for the differences in γδ T cell development observed in these mice. None 
of the γδ lineage-biased genes that were identified as dependent on trans-conditioning 
were commonly downregulated in all three populations (Figure 4.4B). Overall, we saw 
little effect of the lack of trans-conditioning on immature Tcrb-/- γδ T cells, indicating that 
this signal does not significantly impact the development of immature γδ T cell subsets.    
Distinct developmental origin of γδ T cell subsets
As trans-conditioning does not appear to be important for determining the 
expression pattern of immature γδ T cell subsets and ITK/TCR signals also do not control 
the transcription factor profile of immV2 cells, we considered what other factors might 
influence the acquisition of the molecular profile of immature γδ T cell subsets. We 
previously identified traces of the gene expression pattern of different precursors in the 
signatures of immV2 and immV1//V6 cells (Figure 3.4 and 3.5). It has been assumed that 
all γδ T cells arise from the same progenitors during development, but it is possible that
V2 and V1/V6 cells diverge at different points during precursor development, leading to 
a different base gene expression pattern that is inherited from the precursor stage. One 
possibility is that the Vγ2-Cγ1 locus rearranges earlier than the Vγ1.1-Cγ4 locus, leading 
to the more rapid commitment of V2 cells to the γδ lineage (Figure S6). The remaining γδ
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T cell precursors would continue developing through the precursor stages until they 
rearranged their TCR at a later stage. TCR rearrangement may fix the gene expression 
program to some degree such that the resultant γδ T cell subsets retain elements of 
expression from the precursors from which they developed. It has been shown that 
immature γδTCR+ cells are present at the CD25+ DN3 stage. CD25+γδTCRlo cells
represent an earlier stage of development, which is followed by the transition to the 
CD25+γδTCRhi stage (96). Interestingly, Vγ2 staining is evident on the less mature 
CD25+γδTCRlo cells whereas Vγ1.1 staining was not evident until later in the more 
mature CD25+γδTCRhi stage (Figure 4.5). These results indicate that Vγ1.1+ and Vγ2+
may emerge at different points during development. Disruption of TCR signaling through 
Itk deficiency had no impact on timing of the emergence of Vγ2+ and Vγ1.1+ cells, 
indicating that TCR signals are not involved in the temporally distinct generation of these 
cells (Figure 4.5). 
To directly test the possibility that V2 and V1/V6 arise from different precursors, 
we sorted early precursors (ckit+ DN1/DN2) and late precursors (DN3) and cultured them 
using the OP9-DL1 system to determine their potential to develop into V2 or V1/V6 cells 
(Figure S7). If all precursors were equally efficient at generating all subsets, one would 
expect that there would be no bias in γ gene usage. However, we saw that early 
precursors generated significantly more V2 cells than V1/V6 cells, indicating that 
DN1/DN2 cells are biased toward their generation (Figure 4.6). In contrast, we did not 
see any bias toward either lineage among late precursors (Figure 4.6). These results 
suggest that the Vγ2-Cγ1 locus may indeed be more active in early precursors, leading to 
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Figure 4.5 V2 cells emerge at an earlier stage during γδ T cell maturation than 
V1/V6 cells in WT and Itk-/- mice.
(A) Thymocytes from WT and Itk-/- mice were stained with cell surface markers against 
CD4, CD8, CD25, TCRδ, Vγ2, and Vγ1.1. FACS plots were gated on CD4-CD8- (DN) 
cells and expression of CD25 versus TCRδ is shown (top). Boxes are drawn to designate 
the CD25+TCRδlo and CD25+TCRδhi populations. FACS plots were then gated on either 
the CD25+TCRδlo  (middle) or CD25+TCRδhi (bottom) population and expression of Vγ2
versus Vγ1.1 is shown. 
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Figure 4.6 Early precursors are biased toward the generation of V2 cells.
Sorted ckit+ DN1/DN2 cells and DN3 cells were plated on OP9-DL1 monolayers at 500 
and 1000 cells per well, respectively, and analyzed for subset distribution after 6 days of 
culture. The frequency of Vγ1.1+ or Vγ2+ cells among γδ cells from each well was plotted 
along with the mean ±SD. ns, not significant. ckit+DN1/DN2, n=36; DN3, n=32. Results 
are representative of two independent experiments. 
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the enhanced development of some V2 cells from early T cell precursors. This biased 
generation of γδ T cell subsets from different precursors may imprint γδ T cells with 
traces of the different precursor signatures, in part setting the unique signatures of V2 and 
V1/V6 cells. 
Summary and future studies:
TCR signaling and trans-conditioning are two signals that are thought to play a 
significant role in γδ T cell development. Our data indicate that there are two stages in the 
acquisition of the immature gene signatures of γδ T cell subsets. The fist stage is the 
establishment of the core transcription factor network that determines subset specific 
effector functions and is evident at the onset of γδTCR expression. This stage is 
independent of ITK signaling and involves the regulation of ~100 transcription factors. 
The second stage is the divergence of gene signatures of immature γδ T cell subsets, 
which involves unique signals through the Vγ2 TCR that result in establishing a quiescent 
state, similar to the transition of αβ lineage DN3 cells to DP thymocytes mediated by the 
preTCR. This stage is dependent on TCR signals mediated by ITK, and involves the 
coordination of ~500 genes. These results suggest that the default pathway for γδ T cell 
differentiation is a V1/V6 like state, and that signals through the TCR mediated by ITK 
are necessary to fully activate the V2 molecular program (Figure S8). 
Analysis of Tcrb-/- γδ T cells indicates that trans-conditioning has very little 
impact on either of the first two stages of immature γδ T cells development that we have 
identified. This result appears to contradict results reported previously (33, 34). However, 
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as previous studies compared total γδ T cells from WT and Tcrb-/- mice, which differ in 
their γδ T cell subset distribution, and we sorted immature subsets of γδ T cells, it is 
difficult to directly compare our results. We did not see any significant differences in the 
expression of Hayday’s γδ lineage biased genes in our analysis of immature Tcrb-/-
subsets (Figure 4.7), although we did see that most of these genes were expressed at 
higher levels in WT and Tcrb-/- immV1 and immV6 cells compared to immV2 cells. 
As TCR signals and trans-conditioning do not appear to specify the transcription 
factor program of immV2 cells, we considered other options that may influence the gene 
signature of γδ T cell subsets. Many genes expressed in γδ T cells are also expressed in 
precursors, and the similarity of the gene expression pattern of immV2 cells with early 
precursors, and that of V1/V6 with later precursors indicated that these two subsets may 
originate from different points in development. V2 cells do appear to emerge earlier, at 
the less mature CD25+γδTCRlo stage, while V1 cells do not emerge until the later 
CD25+γδTCRhi stage. Further, it is known that gene rearrangement of many Vγ gene 
segments is temporally regulated (2). Our test of the developmental potential of early 
(ckit+ DN1/DN2) and late (DN3) precursors indicated that early precursors preferentially 
gave rise to V2 cells. These results indicated that V2 and V1/V6 cells might inherit some 
of their gene expression signatures from different precursors. However, we did still see 
development of V1 cells from early precursors and V2 cells from late precursors. In the 
former case, the V1 cells could be arising mainly from precursors that have differentiated 
to the DN3 stage and then gone on to generate V1 cells. In the latter case, it is possible 
that the V2 cells that develop from late precursors are molecularly distinct from those that 
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Figure 4.7 No difference in expression of genes induced by trans-conditioning in 
immature γδ T cell subsets from Tcrb-/- mice.
Heatmap of relative expression of genes identified as being γδ lineage-biased and 
dependent on lymphotoxin signaling in immature γδ subsets from WT and Tcrb-/- mice. 
Data were gene row normalized and hierarchically clustered by gene and subset. Genes 
are color coded (see legend) to display relative gene expression.
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develop from early precursors. It is known that V2 cells are made up of multiple subsets 
as some are CD27- and make IL-17 while others are CD27+ and can make IFNγ (42).
Therefore, it is possible that differentiation of V2 cells from early versus late precursors 
plays a role in specifying different functions of V2 cells. This possibility could be 
assessed by more fully characterizing the phenotype of V2 cells that arise from early and 
late precursors in the OP9-DL1 assay to determine whether they have different levels of 
expression of markers such as CD27. In addition, we could also sort V2 cells derived 
from early and late precursors to determine whether they manifest different gene 
expression profiles based on their precursor source. A more rigorous test of this theory 
would involve manipulations to alter the germline locations of the Vγ2Cγ1 and Vγ1.1Cγ4
segments and analysis of γδ T cell development and the molecular signatures of γδ T cell 
subsets.
Materials and methods:
Cell sorting
Samples were sorted and prepared as described in Chapter 3. Briefly, thymocytes were 
pooled from 4-10 male 5 week old Tcrb-/- mice (Jackson Labs) and Itk-/- mice (Leslie 
Berg, UMass Medical School, Worcester, MA), with the number of mice depending on 
the subset sorted. Cells were stained for cell surface markers and ~20,000-30,000 cells 
were directly into Trizol (Invitrogen) using a FACSAria sorter. For each population, 
independent duplicate or triplicate samples were sorted. Tcrb-/- γδ T cell populations were 
sorted as follows: immV2, Vγ2+TCRδ+CD24+CD4-CD8-; immV1, Vγ1.1+Vδ6.3-
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TCRδ+CD24+; immV6, Vγ1.1+Vδ6.3+TCRδ+CD24+. Itk-/- γδ T cell populations were 
sorted as follows: immV2, Vγ2+TCRδ+CD24+CD4-CD8-; immV1, Vγ1.1+Vδ6.3-
TCRδ+CD24+. Additional non-γδ T cell populations used for comparison in these studies 
were sorted by other members of the Immgen Consortium. The sorting details for these 
populations can be found on the Immgen website (Immgen.org).
RNA preparation and microarray processing
RNA preparation and microarray processing was performed as described in Chapter 3.
Data analysis and visualization
Data analysis was performed as described in Chapter 3.
Differentiation of γδ T cells from precursors
OP9-DL1 cells (provided by Juan Carlos Zuniga-Pflucker, University of Toronto, 
Toronto, Canada) were plated in 96 well flat bottom plates prior to cell sorting. 
Thymocytes were pooled from 10-15 4 week old C57BL/6 mice (Jackson Labs) and 
depleted with CD4 and CD8 magnetic beads (Dynal). Ckit+ DN1 (CD4-CD8-CD3-CD25-
CD44+ckit+) and ckit+ DN2 (CD4-CD8-CD3-CD25+CD44+ckit+), and DN3 (CD4-CD8-
CD3-CD25+CD44-) cells were sorted using a FACSAria onto confluent OP9-DL1 
monolayers at 500 and 1000 cells per well, respectively in 200ul of αMEM media 
containing 20% defined FBS (Gibco), PenStrep, 1ng/ml IL-7 (R&D Systems), and 
5ng/ml Flt3L (R&D Systems). During culture, half the media was replaced every 3-4
135
days with fresh media containing cytokines. After 6 days of culture, cells were collected 
from wells and stained to analyze γδ T cell subset distribution.  
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CHAPTER V:
FINAL MATURATION OF γδ T CELL SUBSETS DEPENDS ON TCR/TRANS-
CONDITIONING AND RESULTS IN THE FULL ACQUISITION OF 
EFFECTOR FUNCTIONS 
Introduction:
Our analysis of the gene expression profiles of immature γδ T cell subsets 
revealed that immV1 and immV6 cells were very similar in gene expression and very 
distinct from immV2 cells. This did not appear to be the result of trans-conditioning, and 
loss of ITK signaling did not affect expression of the core transcription factor network of 
V2 cells. We showed evidence for a different precursor origin for V2 and V1/V6 cells, 
which may contribute to their unique expression patterns. Our data indicated that the 
effector program of γδ T cell subsets was established at the immature stage. We next 
wanted to look at how these initial effector programs evolved and were fixed in mature γδ
T cells. To do this, we sorted mature (CD24lo) populations of V1, V2, and V6 cells from 
WT mice and analyzed the evolution of gene signatures of individual subsets and γδ T 
cells as a whole. 
We also sorted mature cells from Itk-/- and Tcrb-/- mice to assess the impact of 
TCR signaling and trans-conditioning on the maturation and effector specification of γδ T 
cell subsets. Itk-/- mice are known to have an aberrant distribution of γδ T cells in the 
thymus and periphery, with an expanded population of mature V6 cells that produce large 
amounts of IL-4 and lead to the hyper-IgE phenotype of the mice (53, 54). Very little is 
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known about the phenotype and function of V1 cells in Itk-/- mice, and the molecular 
signatures of these cells have not been studied. Tcrb-/- γδ T cells have been shown to 
make less IFNγ, TNFα, and IL-2 upon in vitro stimulation, indicating that these cells may 
not fully acquire functional maturation (33, 34). We saw very little difference in the 
initial programming of immature γδ T cell subsets from Tcrb-/- mice, but it is possible the 
effects of trans-conditioning have more of an influence on the maturation of γδ T cells. 
Results:
The γδ maturation signature is shared with αβ lineage cells
To determine the impact and duration of the immature subset-specific gene 
networks, we examined the gene expression profiles of mature (CD24lo) γδ T cell subsets 
in the thymus. Upon maturation, the gene expression profile of all γδ T cell subsets 
changed dramatically compared to their immature counterparts (Figure 5.1). We 
identified a common γδ maturation signature of 150 genes that were upregulated and 
~450 genes that were downregulated upon maturation of all γδ subsets (Figure 5.2A and 
Table 5.1). Hierarchical clustering of the these γδ maturation signature genes with 
precursors and αβ T cells clearly showed that the γδ maturation signature was conserved 
during αβ T cell maturation? as precursors and immature subsets formed a distinct cluster, 
as did mature subsets, irrespective of T cell lineage (Figure 5.2B). Similarly, principal 
component analysis of the γδ maturation signature resulted in the clustering of all 
immature and mature subsets, regardless of lineage (Figure 5.2C). Therefore, the genes 
that mark the transition of γδ T cells from CD24hi to CD24lo can also characterize the 
139
Figure 5.1 The expression patterns of V1 and V6 cells diverge at the mature stage.
The mean expression of sample replicates for consolidated probe sets was plotted to 
compare populations of mature (CD24lo) cells from WT mice using Multiplot. Each dot 
represents one gene (mean of all probe sets), and dots highlighted in red represent genes 
whose expression is changed by greater than 2 fold, p<0.05, cv<1. The total number of 
highlighted genes is listed in parenthesis at the top of each plot.
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Figure 5.2 Shared maturation signature among γδ and αβ T cells. 
(A) To identify genes associated with the maturation of all γδ T cells, genes upregulated 
or downregulated upon transition from CD24hi to HSAlo in all subsets were identified (2-
fold change in matV2 vs. immV2, 1.5-fold change in matV1 vs. immV1, and 1.5-fold 
change in matV6 vs. immV6, cv<0.5 for all comparisons). Shown are fold change versus 
fold change plots with the 150 upregulated genes highlighted in red and the 435 
downregulated genes highlighted in blue. (B) The expression of the 585 γδ maturation 
signature genes in immune subsets is shown as a heatmap. Data were gene row 
normalized and hierarchically clustered by gene and subset, and show that 
precursor/immature subsets (green box) and mature subsets (pink box) segregate together 
irrespective of lineage. Genes are color coded (see legend) to display relative gene 
expression. (C) Principal component analysis was performed on the 585 γδ maturation 
signature genes. The first and second principal components are shown and immune 
subsets were plotted relative to the distribution of the components. Precursor/immature 
subsets and mature subsets cluster together on either side of the red line irrespective of 
lineage.
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Table 5.1 List γδ maturation signature genes.
List of genes increased or decreased upon maturation of γδ T cell subsets (2-fold change 
in matV2 vs. immV2, 1.5-fold change in matV1 vs. immV1, and 1.5-fold change in 
matV6 vs. immV6, cv<0.5 for all comparisons). A total of 150 genes were upregulated 
and 435 genes were downregulated in these comparisons. 
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Bhlhb9
Birc5
Bivm
Bmp2k
Brca1
Brip1
C330027C09Rik
Calcrl
Cand2
Casc5
Casp3
Cbx1
Cbx5
Ccdc18
Ccdc34
Ccna2
Ccnb2
Ccne1
Ccne2
Ccnf
Ccng2
Ccnj
Ccr9
Cd200
Cd24a
Cd27
Cd93
Cdc20
Cdc25a
Cdc25c
Cdc45
Cdc6
Cdca2
Cdca3
Cdca5
Cdca7
Cdca8
Cdk2
Cdk6
Cdkl3
Cdkn2c
Celsr1
Cenpe
Cenph
Cenpi
Cenpj
Cenpk
Cenpn
Cenpp
Cep55
Chaf1a
Chaf1b
Chchd3
Chek1
Chek2
Chst15
Cit
Ckap2l
Ckap5
Cks1b
Cks2
Clec12a
Clspn
Cnn3
Colq
Coro7
Cpa3
Csnk1e
Csrnp2
Csrp1
Cuedc1
Cul7
Cux1
D2Ertd750e
D930015E06Rik
Dapk1
Dbf4
Dclk2
Depdc1a
Depdc1b
Dhfr
Dlgap5
Dmwd
Dna2
Dnajc6
Dnmt1
Dnmt3a
Dntt
Dpp4
Dscc1
Dtl
Dusp10
Dusp4
Dusp6
Dzip1
E2f1
E2f2
Ect2
Endou
Epcam
Ephb2
Ephb6
Esco2
Espl1
Ets2
Etv5
Exo1
Ezh2
F630043A04Rik
Fads2
Fam169b
Fam33a
Fam54a
Fam64a
Fam73a
Fancd2
Fanci
Fbxo5
Fignl1
Fmnl3
Fnbp1l
Foxm1
Galnt3
Gas2l3
Gcnt4
Gdpd1
Gen1
Gfra1
Gk5
Gm11276
Gm11277
Gm12260
Gm12387
Gm16494
Gm8681
Gpr125
Gpr174
Gpr56
Gprc5b
Gria3
Gsn
Gtse1
Gzma
H2afx
H2afz
Hcfc1
Hdac2
Hdac7
Hdac9
Heatr5b
Hectd2
Hells
Hist1h1a
Hist1h2ae
Hist1h2af
Hist1h2an
Hist1h2ao
Hist1h2bb
Hist1h2be
Hist1h2bg
Hist1h2bm
Hist1h3a
Hist1h3d
Hist1h4b
Hist1h4f
Hist1h4m
Hist2h2aa1
Hist2h2ab
Hist2h3c1
Hist3h2a
Hjurp
Hmgb2
Hmgb3
Hmgn2
Ick
Id3
Idh2
Ift80
Igfbp4
Il20ra
Il6st
Incenp
Ints7
Iqgap3
Itih5
Itm2a
Kdm6b
Kif14
Kif15
Kif18a
Kif18b
Kif20a
Kif20b
Kif22
Kif23
Kif24
Kif2c
Kif4
Kit
Kntc1
Kpna2
Lass6
Ldoc1l
Lef1
Lig1
Lig4
Lman2l
Lmnb1
Lrp12
Lrrc42
Lztfl1
Lzts1
Mad2l1
Marcks
Marcksl1
Mastl
Mcm10
Mcm2
Mcm3
Mcm4
Mcm5
Mcm6
Mcm7
Mcoln3
Mdm1
Med14
Melk
Mex3a
Mex3b
Midn
Mns1
Mpp1
Mpp4
Decreased upon ?? Maturation
Tnf
Tnfrsf25
Tns4
Traf1
Ttc39b
Ttc39c
Ust
Xkrx
Zbtb16
Zbtb7b
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Table 5.1 continued
Slc16a1
Slc16a5
Slc22a3
Slc31a1
Smarcc1
Smarcd1
Smc2
Smc4
Smo
Snx9
Sord
Sort1
Sox4
Sox5
Spag5
Spats2
Spc24
Spc25
Spns3
Spred1
Sstr2
St3gal2
St3gal5
St8sia1
Stap1
Stat5a
Stat5b
Stil
Stmn1
Strbp
Susd1
Tacc3
Tcf3
Tcf4
Tcf7
Tdg
Tet1
Tfdp1
Tfrc
Themis
Tia1
Tipin
Tle3
Tlr12
Tmem120b
Tmem121
Tmem48
Tmpo
Tns1
Tns3
Tox2
Tpcn1
Tpx2
Traf4
Trat1
Trim13
Trim28
Trim59
Trip13
Tspan13
Tspan9
Ttc3
Ttk
Tuba8
Tyms
Ube2c
Ube2e3
Usp11
Vangl2
Vezf1
Wdr6
Wdr78
Whsc1
Yeats2
Zbed3
Zbed4
Zcwpw1
Zfp219
Zfp358
Zfp422
Zfp821
Zmym3
Zranb3
Zswim4
Zwilch
Mprip
Msh6
Mtf2
Myb
Mybl2
N4bp2
Ncapd2
Ncapg
Ncapg2
Ncaph
Nck2
Ndc80
Nedd4
Nf1
Nr4a3
Nrip1
Nt5c2
Nt5dc2
P2rx7
Pask
Patz1
Pbk
Pdgfrb
Pecam1
Phc1
Pigx
Pik3c2b
Plac8
Pld4
Plk4
Plscr3
Pole
Pole2
Ppm1l
Prkar2b
Prkcb
Prr11
Psd3
Ptgir
Ptprf
Ptprs
Rabl2a
Racgap1
Rad51
Rad51ap1
Rad51c
Rad54l
Rcor2
Renbp
Rere
Rgs12
Rhoh
Rnf216
Rps6ka2
Rrm1
Rrm2
Sass6
Scd2
Scin
Sell
Sestd1
Sgk3
Sgol1
Sgol2
Sh3pxd2a
Sh3rf1
Shcbp1
Sipa1l1
Skp2
Slc15a1
Decreased upon ?? Maturation
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maturation of αβ T cell subsets. These results indicate that the CD24hi to CD24lo
transition of γδ T cells during development does indeed represent a true maturational 
step, an issue that has been debated. 
Upon maturation, three major trends became evident. First, the gene signatures of 
V2 and V1 cells became more similar, decreasing from a difference of 7.9% of expressed 
genes (9909 genes with expression values of over 100 in at least one γδ T cell subset) in 
comparisons of immature subsets to 4.8% in comparison of mature subsets (Figure 3.1 
and 5.1). This similarity evolved in part from the convergence in their expression of 
metabolic genes, as mature (mat)V2 cells upregulated expression of metabolic genes and 
matV1 cells downregulated expression compared to immature populations (Figure 5.3A). 
Additionally, V2 cells downregulated expression of transcription factors to levels that 
more closely resembled V1 cells (Figure 5.3B). Second, the gene signatures of matV1 
and matV6 cells diverged significantly, differing in the expression of ~350 genes (Figure 
5.1).  Third, the majority of differences remaining between cell subsets resulted from 
induction of genes that specify the effector function of γδ subsets in the periphery. The 
second and third trends will be discussed in further detail below. 
Upon maturation, V6 cells become more similar to αβNKT cells
V2 and V1/V6 cells have very different gene expression patterns at the immature 
stage, whereas V1 and V6 cells are very similar at the immature stage. Upon maturation, 
the molecular profiles of V1 and V6 cells greatly diverge. This indicates that V1/V6 cells 
are distinct from V2 cells at the immature stage, immediately after γδTCR expression, but 
147
Figure 5.3 Convergence of the gene signatures of matV2 and matV1 cells.
Heatmap of the relative expression of transcription factors (as in Figure 3.1) and genes 
involved in metabolism (Table 3.3) in immature and mature γδ T cell subsets. Data were 
gene row normalized and hierarchically clustered by gene and subset.
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V1 and V6 cells separate only after maturation (Figure S9). Some distinctions between 
V1 and V6 cells at the immature stage, such as higher Plzf and CCR10 expression in V6 
cells, were already present, indicating effector lineage separation had begun prior to 
maturation (Figure 3.6 and 3.2). Upon maturation, PLZF expression was induced much 
more highly in V6 cells compared to V1 cells (Figure 3.2 and 5.3A). This unique 
expression of PLZF has led to a focus on V6 cells as an NKT-like subset, often referred 
to as γδNKT cells. As mentioned previously, these PLZF-expressing γδNKT cells can 
also express NK1.1 and CD4, similar to αβNKT cells. They can also produce both IL-4
and IFNγ simultaneously upon stimulation, a characteristic unique to αβNKT cells (50, 
51). Based on the phenotypic and functional similarities, we predicted that V6 cells 
would be closely related to αβNKT cells at the molecular level. 
To test this, we derived the αβNKT signature by identifying genes that were 
differentially expressed between αβNKT cells (CD1d tetramer+CD44+NK1.1+) and 
mature conventional single-positive αβ T cells from the thymus (Table 5.2). Hierarchical 
clustering of the αβNKT signature with mature and immature γδ T cell subsets showed 
that of γδ T cell subsets, matV6 cells were most similar to αβNKT cells (Figure 5.4A). 
The 328 upregulated genes of the NKT signature were also specifically increased in 
matV6, but not in matV1 cells, compared to matV2, indicating that this similarity with 
αβNKT cells is specific to matV6 cells and does not simply correlate with Vγ1 TCR 
usage (Figure 5.4B). 
As further evidence of the shared molecular network of αβNKT cells and V6 
cells, mutations in many genes that affect αβNKT cell development also impact V6 cells. 
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Table 5.2 List αβNKT signature genes.
List of genes increased or decreased in αβNKT (CD1d tetramer+NK1.1+CD44+) cells 
versus matCD4 (CD4+CD24lo/-) and matCD8 (CD4+CD24lo) cells. Genes were identified 
based on being altered by 2-fold or more in both αβNKT versus matCD4 and αβNKT 
versus matCD8 comparisons, and having a cv<0.5.
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2810474O19Rik
4930486L24Rik
5031414D18Rik
5430427O19Rik
5830416P10Rik
6330403K07Rik
6330512M04Rik
A430084P05Rik
AB041803
Abcb1a
Acsbg1
Adora2a
Adssl1
Agpat2
Ahnak
Ahr
Ang
Anxa1
Anxa2
Apob48r
Arap3
Arhgap18
Arhgap26
Arsb
Asb2
Atf3
Atf4
Atf6
Atp2b1
Atp2b4
Atp8a2
Atxn1
AW112010
B4galnt4
B930095G15Rik
BC005685
Bcl2a1a
Bcl2a1b
Bcl2a1c
Bcl2a1d
Bhlhe40
Blk
Bmp7
Bspry
Btg2
C230081A13Rik
Cables1
Calhm2
Cap2
Capg
Ccdc50
Ccl3
Ccl4
Ccl5
Ccr2
Ccr5
Ccrl2
Cd160
Cd244
Cd38
Cd44
Cd93
Cd97
Cdc42ep3
Cdh1
Cebpb
Chad
Chn2
Chst11
Chsy1
Cited2
Clnk
Cobll1
Coro2a
Crim1
Crmp1
Csda
Csf1
Ctla2a
Ctla2b
Ctsd
Cxcr3
Cxcr6
Cyfip1
Cyp4f16
Cysltr2
Dapk2
Dennd4a
Dennd4c
Dhrs11
Dmrta1
Dnajb9
Dock5
Dusp1
Dusp2
Eea1
Efhd2
Ehd4
Endod1
Enpp1
Entpd1
Errfi1
Evi2a
F2r
F2rl2
Fam125b
Fam129a
Fam82a1
Farp1
Fasl
Fcer1g
Fcho2
Fgd5
Fgd6
Fgl2
Fhl2
Gadd45b
Gcnt1
Gdpd5
Gem
Gm10008
Gm10786
Gm129
Gm13970
Gm156
Gm4759
Gm5068
Gm8936
Gm8979
Gna15
Gpnmb
Gvin1
Gzma
Gzmb
Gzmc
H2-Q6
Hbegf
Hhex
Hip1
Hopx
Hrh4
Hsf4
Hspa1a
Hsph1
Id2
Ide
Ifitm1
Ifitm2
Ifitm3
Ifngr1
l10ra
l12rb1
l12rb2
l18r1
l18rap
l1r1
l23r
l2rb
l4
l7r
tga1
tga2
tgb1
tpripl2
Jag1
Junb
Kcnj8
Kcnk5
Kcnq5
Kctd12
Klf4
Klf6
Klra1
Klra10
Klra3
Klra5
Klra6
Klra8
Klra9
Klrb1a
Klrb1b
Klrb1c
Klrb1f
Klrc1
Klrc2
Klrc3
Klrd1
Klre1
Klri2
Klrk1
Lat2
Lax1
Lgals3
Litaf
LOC641050
Lpar6
Lpcat2
Lpcat4
Lrig3
Ly6c1
Ly6c2
Ly6g5b
Lyn
Maf
Mapre2
March8
Marveld2
Mcart6
Mdfic
Myo1e
Myo1f
Myo6
Naip2
Naip3
Nr4a2
Nrarp
Nt5e
Nucb1
Osbpl3
Pbx3
Pcgf2
Pctp
Pde2a
Pde4a
Pdgfb
Pear1
Pglyrp1
Pgm2l1
Pik3ap1
Pion
Pip5k1b
Plce1
Plekhg3
Plk2
Plk3
Pls1
Pmm2
Podnl1
Ppm1j
Ppp1r12a
Ppp1r15a
Prkar2a
Prkx
Prr13
Ptpn13
Ptpn22
Ptpn4
Ptprj
Pygl
Rab4a
Rabgap1l
Rbpms
Rcbtb2
Rgs1
Rgs2
Rhob
Rhoc
Rhoq
Rin2
Rnf144b
S100a11
S100a4
S100a6
Samd3
Samsn1
Sccpdh
Sepn1
Serinc3
Serpina3f
Serpinb6b
Serpinb9
Setbp1
Slamf7
Slc22a15
Slc25a24
Slc41a2
Slc4a7
Slc9a9
Smc5
Smpdl3a
Snora28
Snord14d
Socs2
Sos2
Spin2
Spry2
Srgap3
Srgn
St3gal6
Styk1
Sulf2
Swap70
Syngr2
Sytl2
Tbc1d4
Tbkbp1
Tbx21
Tcrg-V3
Tdrd7
Tec
Tigit
Tirap
Tjp1
Tjp2
Tm6sf1
Tmbim1
Tmem154
Tmem2
Tnfaip3
Tnfsf10
Tnfsf14
Trf
Trim36
Trip4
Trpm6
Ttc39b
Ttc39c
Unc119
Unc93b1
Ust
Vav3
Xcl1
Zbtb10
Zbtb16
Zcchc18
Zfp120
Zfp36
Zfp36l2
Increased in NKT cells
Table 5.2
1110038D17Rik
2410066E13Rik
2610019F03Rik
2810417H13Rik
9330175E14Rik
A130082M07Rik
A530021J07Rik
Abtb2
Acss1
Actn1
Adcy6
Adk
Afap1
Aff3
Airn
Als2cl
Amigo2
Ampd1
Ampd3
Arhgef11
Arl4c
Arl5c
Arl6ip6
Art2b
Atp1b1
Atrnl1
Bach2
BC021614
Bcl11b
Bcl9
Bdh1
Bend5
Bub1
Calcrl
Car2
Ccdc22
Ccdc64
Ccna2
Ccnb1
Ccnb2
Ccnf
Ccr7
Ccr9
Cd200
Cd3d
Cd86
Cd8b1
Cdc14b
Cdc6
Cdkn2d
Cep97
Cks1b
Cmah
Cnn3
Cpm
Ctss
Cyb5
Dapl1
Dck
Ddit4
Dennd2d
Depdc1b
Dgka
Dhx58
Dirc2
Dlg4
Dnahc8
Dph5
Dpp4
Dusp10
Dzip1
E2f2
Elovl7
Emb
Emp3
Ephb6
Ezh2
Fam158a
Fam169b
Fam65b
Fam78a
Fmnl3
Fntb
Foxo1
Foxp1
Fry
Gen1
Gm10673
Gm10688
Gm10866
Gm10893
Gm11277
Gm13892
Gm13907
Gm13949
Gm13959
Gm26
Gm2a
Gm6907
Gm7079
Gm7174
Gm8736
Gm8740
Gm885
Gpr146
Gpr83
Gprc5b
Gpsm2
Gramd3
Grap2
Grk6
Gsn
H2afj
H2afx
H2-Ob
H2-T24
Hist1h1a
Hist1h2be
Hist1h3a
Hist1h3d
Hist1h3f
Hist1h3g
Hist1h4b
Hist1h4d
Hist1h4f
Hist1h4h
Hist1h4m
Hist2h3b
Hist2h3c1
Hist2h4
Hspb11
Id3
Ifi27l2a
Ifit1
Ifngr2
Ift80
Igfbp4
Il21r
Il6ra
Il6st
Itga4
Kcnn4
Kif20a
Kif23
Lass6
Lef1
Lfng
Lipa
LOC625360
Lrig1
Lrrc42
Lrrc8a
Lypd6b
Lztfl1
Marcks
Mcoln3
Mid1
Ms4a4c
Ms4a6b
Mtss1
N4bp2
Ndrg1
Ndufs5
Nek2
Nipal1
Npc2
Npm3
Npm3-ps1
Nsg2
Nudcd2
Oas2
P2rx4
Pdk1
Pdlim1
Pecam1
Pgap1
Phpt1
Plscr3
Pole2
Prrg1
Psmg1
Pycard
Rab3ip
Rapgef4
Rasa3
Rasgrp2
Rhoh
Rnu3a
Rpl31
Rps21
Rps29
Rtp4
S1pr1
Sbk1
Scd2
Scml4
Scp2
Sell
Sepp1
Sfmbt2
Sgk3
Sipa1l1
Skp1a
Slamf1
Slamf6
Slc15a1
Slc16a5
Slc30a4
Smc4
Snora65
Snord35b
Snord87
Snrpd3
Sox4
St3gal1
St8sia1
Stmn1
Suox
Tank
Tbc1d19
Tbxa2r
Tcf7
Tcra
Tcrb-J
Tet1
Tgfbr3
Themis
Timeless
Tle3
Tlr1
Tmem50b
Tmie
Tnfaip8l1
Tnfsf8
Trav9-4
Treml2
Trib2
Trim59
Tspan13
Tspan3
Tspan31
Ubash3a
Uhrf1
Usp18
Vmn2r96
Xkrx
Zbed4
Zbtb26
Decreased in NKT cells
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Figure 5.4 MatV6 cells share elements of the αβNKT gene signature.
(A) Heat maps of relative expression of the NKT gene signature in the indicated 
thymocyte subsets. Data were gene row normalized and hierarchically clustered by gene 
and subset. CD8 innate, Itk-/- CD8+ T cells; NKT, CD1d tetramer+NK1.1+CD44+;
MatCD8, CD8+CD24-/lo; MatCD4, CD4+CD24-/lo; DP, CD4+CD8+TCR-/loCD69- (B) Fold 
change versus p-value (volcano) plots with the genes increased in the NKT signature 
marked in red. Red boxes designate the portion of the plot where genes increased in the 
plotted comparison lie. Chi-square test p value is shown. 
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For example, as mentioned previously, Plzf deficiency has a similar negative impact on 
the functional capabilities of both αβNKT and V6 cells. Further, deficiency of Id3, Itk,
SLAM associated adaptor protein (Sap), cathepsin L (CatL), and the invariant chain (Ii,
CD74) all have a negative impact on αβNKT cell development (97-100). These mutations 
also affect the development of V6 cells, although not always negatively. Id3-/- and Itk-/-
V6 cells are expanded and aberrant, as discussed previously. αβNKT are selected on DP 
cells through homotypic interactions with SLAM family receptors that depend upon the 
adaptor SAP (97, 98). Decreased V6 frequencies and numbers have been reported in Sap
deficient mice, and SAP was required for the activated phenotype of Id3-/- V6 cells (51, 
55). Analysis of Ii-/- mice showed a decrease in the frequency of V6 cells, while CatL
deficient mice had an increase in V6 cells (Figure 5.5). These data indicate that the 
development and function of αβNKT cells and V6 cells depends on common gene 
networks and cellular processes. Therefore, the type of TCR does not define effector 
lineages, but they are instead defined as the result of similar molecular programming 
based on gene signatures inherited from precursors, or from a similarity in the signals 
received through their TCRs that is independent of TCR type.  
Induction of chemokine, cytokine, and growth factor receptors to specify effector 
function
Chemokines play a crucial role in regulating the trafficking of immune cells to 
their target organs and to sites of infection (101). Maturation of γδ T cell subsets results 
in the coordinate induction of combinations of chemokine and cytokine receptors that 
155
Figure 5.5 Mutations that impact αβNKT cell development also affect V6 cells.
Representative FACS plots showing Vγ1.1 and Vδ6.3 staining on WT and Ii-/- (A) or 
CatL-/- (B) γδ T cells (left). Frequencies of V6 cells among γδ T cells for all mice 
analyzed are graphed (right). Student t-test p value is shown. Data are representative of 
two independent experiments.    
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specify effector function. Overall, there were two major patterns of chemokine receptor 
expression: those that were highly expressed in immature γδ T cell subsets and 
downregulated upon maturation (designated as “I” in Figure 5.6A), and those that were 
expressed at low levels in immature γδ T cell subsets and upregulated upon maturation 
(“M” in figure 5.6A). Among the I cluster are Ccr8, and Ccr9, which are expressed more 
highly in immV2 cells, while Ccr10 is expressed most highly in V6 and V1 cells. High 
expression of CCR9 was recently identified as a marker of immature, potentially antigen 
naïve cells (44). Consistent with that possibility, all γδ T cell subsets transition to a Ccr9lo
phenotype upon maturation (Figure 5.6), although at the protein level, a substantial 
frequency of matV2 cells remain CCR9hi (Figure 3.2). CCR8 has been shown to be 
expressed on regulatory T cells, CD4+ thymocytes, and on Th2, but not Th1, cells (102).
Interestingly, upon maturation, Ccr8 expression is maintained on V6 cells, which are the 
only γδ T cell subset to produce the Th2 cytokine IL-4. Ccr10, which promotes migration 
to the gut and skin (91), is expressed is mainly on immature V1 and V6 cells, and is 
highly expressed on V6 cells after maturation (Figure 5.6A). We confirmed these gene 
expression profiling results by analyzing Ccr10-Gfp reporter, which showed that immV6 
cells were the population with the highest frequency of CCR10-expressing cells among 
immature thymic γδ T cell subsets, while upon maturation a similar frequency of V1 and 
V6 subsets expressed CCR10 (Figure 3.2). 
Upon maturation, chemokine expression correlated with effector function. CCR8 
and CCR4, which are both expressed on Th2 cells (102), were also highest on matV6 
cells. Also in the M cluster, Ccr6 was expressed at highest levels in matV2 cells, while 
158
Figure 5.6 Acquisition of distinct tissue homing markers as γδ T cell subsets mature 
in the thymus.
Heat maps of relative expression of chemokine receptors (A), and cytokine/growth factor 
receptors (B) in T cell precursors and γδ T cell subsets. Data were gene row normalized 
and hierarchically clustered by gene and subset. Genes mentioned in text are marked with 
arrows. IL-17 related genes are marked with blue arrows in (B). I, immature. M, mature.
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Cxcr3 was expressed highly in V1 and V6 cells (Figure 5.6A). CCR6 expression, as 
mentioned previously, has been highly correlated with IL-17 producing γδ T cells (43),
while CXCR3 expression is regulated in part by expression of Eomes in CD8+ T cells 
(103), which is expressed at highest levels in V1 cells, and allows for trafficking to non-
lymphoid tissues. The distinct segregation of homing markers in V2 and V1/V6 cells and 
the subset specific expression of a distinct panel of chemokine receptors upon maturation 
underscore the lineage separation of V2 and V1/V6 cells. 
Cytokine receptor and growth factor receptor expression was also dynamically 
regulated upon maturation of γδ T cell subsets. MatV2 cells appear poised to become 
effector cells based on the high induction of cytokine receptors related to IL-17
production and responsiveness. Il23r, Il17re, and Il1r1 were among the most highly 
induced genes in matV2 cells versus immature cells (Figure 5.6B). IL-23 induces the 
expansion of αβ Th17 cells, and culture of γδ T cells with IL-1β and IL-23 has been 
shown to induce their production of IL-17 in the absence of TCR stimulation (104, 105).
These results indicate that mature V2 cells are specifically and simultaneously 
programmed to respond to IL-23, which promotes their production of IL-17, and to 
subsequently respond to autocrine IL-17 as well. V1 cells mainly upregulate Il18r
expression upon maturation, as do all mature subsets. While Il23r expression is also 
higher in matV1 cells relative to immV1, its expression is much lower than in matV2 
cells (~10% of matV2). Expression of Il17rb, part of the IL-25R, is specifically increased 
in matV6 cells and may be represent the presence of a suppressive circuit for IL-17 
production, while the reverse pattern is seen in V2 cells (Figure 5.6B) (106). Overall, 
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these data show that subset-specific functions are programmed at the immature stage, but 
these programs are elaborated at the mature stage, when γδ T cell subsets acquire their 
unique tissue homing properties and the ability to quickly respond relevant cytokine cues. 
ITK signaling is not required for the maturation of V1 or V6 γδ T cell subsets
To determine whether the loss of ITK has an impact on the maturation of γδ T cell 
subsets, we compared the gene expression profiles of mature WT subsets to Itk-/- matV1 
and total V6 cells, as virtually all V6 cells in Itk-/- mice were CD24lo (data not shown). 
The expression pattern of V1 cells was very similar between WT and Itk-/- mice at the 
immature stage, but diverged from that of WT cells upon maturation, with over 300 genes 
differentially regulated. A similar magnitude of gene expression difference was seen 
between WT matV6 and Itk-/- total V6 cells (Figure 5.7A). 
To ascertain whether γδ T cells in Itk-/- mice were maturing normally, we 
determined whether expression of the γδ maturation signature we had identified 
previously (Figure 5.2) was properly expressed. Hierarchical clustering of the γδ
maturation signature genes in immature and mature subsets of γδ T cells from WT and 
Itk-/- mice showed that immature subsets clustered together as did mature subsets, 
irrespective of WT or Itk-/- origin (Figure 5.7B). This result was confirmed by principal 
component analysis, which also showed the clustering of immature and mature subsets 
from WT and Itk-/- mice, indicating that Itk-/- V1 and V6 cells were able properly express 
the genes associated with γδ T cell maturation (Figure 5.7C). 
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Figure 5.7 ITK signaling is not required for the maturation of V1 or V6 γδ T cell 
subsets.
(A) Scatter plots for mature subsets of Itk-/- mice are shown. The mean expression of 
sample replicates for all genes was plotted to compare populations of cells from WT and 
Itk-/-mice using Multiplot. Each dot represents one gene (mean of all probe sets), and dots 
highlighted in red represent genes whose expression is changed by greater than 2 fold, 
p<0.05, cv<1. The total number of highlighted genes is listed in parenthesis at the top of 
each plot. (B) The expression of the 585 γδ maturation signature genes in immune subsets 
is shown as a heatmap. Data were gene row normalized and hierarchically clustered by 
gene and subset, and show that immature subsets (green box) and mature subsets (pink 
box) segregate together irrespective of WT or Itk-/- origin. Genes are color coded (see 
legend) to display relative gene expression. (C) Principal component analysis was 
performed on the 585 γδ maturation signature genes. The first and second principal 
components are shown and immune subsets were plotted relative to the distribution of the 
components. Immature subsets and mature subsets cluster together on either side of the 
red line irrespective of WT or Itk-/- origin.
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ITK signaling is required for the divergence of the mature V1 and V6 signatures
Upon comparison of subsets of mature Itk-/- γδ T cells, we noticed that Itk-/-
matV1 cells appeared to more similar to WT matV6 cells than they were to WT matV1 
cells (154 genes changed versus 335 genes changed, Figure 5.7A). We performed 
principal component analysis on the genes that were differentially expressed between WT 
matV1 and WT matV6 cells (345 genes) and found that Itk-/- matV1 cells clustered with 
matV6 cells, indicating that they had assumed the V6 gene expression pattern (Figure 
5.8A). Hierarchical clustering of the genes that distinguish matV1 and matV6 cells also 
indicated that Itk-/- matV1 cells were most similar to matV6 cells. A large segment of V6 
genes were upregulated in Itk-/- matV1 cells, including Plzf, which was expressed at 
levels equivalent to that of matV6 cells (Figure 5.8B). These data indicated that while 
loss of Itk did not greatly impact the development of immature V1 cells, ITK signaling is 
essential for the later divergence of the V1 and V6 signatures upon maturation.
Trans-conditioning is required for full maturation of V2 and V1 γδ subsets
While we saw that the lack of trans-conditioning had very little effect on the 
development of immature γδ T cells, it was possible that mature cells would be more 
affected by the lack of lymphotoxin signaling. To determine the effect of trans-
conditioning on mature γδ T cells, we compared the gene expression patterns of 
immature γδ T cell subsets from Tcrb-/- mice to that of WT mice. The difference in the 
gene expression pattern of γδ T cell subsets from Tcrb-/- mice versus WT mice was far 
greater upon maturation. Mature V6 cells were the least affected, differing in the 
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Figure 5.8 ITK signaling is required for the divergence of the mature V1 and V6 
signatures.
(A) Principal component analysis was performed on genes differentially expressed 
between matV1.WT and matV6.WT (2-fold change, p<0.05, cv<1, 345 genes). The first 
and second principal components are shown and immune subsets were plotted relative to 
the distribution of the components. Subsets clustered with V6 cells are indicated by a red 
box. (B) The expression of the 345 genes differentially expressed between matV1.WT 
and matV6.WT in immune subsets is shown as a heatmap. Data were gene row 
normalized and hierarchically clustered by gene and subset, and show that MatV1.Itk-/-
cells cluster with MatV6 cells from WT and Itk-/- mice. Shared V6 signature genes are 
indicated by a blue box. 
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expression of only ~150 genes between Tcrb-/- and WT, while mature V1 cells showed a 
difference in the expression of ~300 genes. Strikingly, mature V2 cells from Tcrb-/- mice 
were very different their WT counterparts, with over 500 differentially expressed genes 
(Figure 5.9). These results indicate that while trans-conditioning plays little role in the 
development of immature γδ T cell subsets, it affects mature subsets to varying degrees.
To determine whether γδ T cell subsets were maturing properly in Tcrb-/- mice, 
we looked at the expression of the γδ maturation signature we had identified previously 
(Figure 5.2). Hierarchical clustering and principal component analysis of the expression 
of the maturation signature showed that immature and mature γδ T cell subsets clustered 
together, irrespective of whether they were derived from WT or Tcrb-/- mice, indicating 
appropriate upregulation and downregulate of maturation associated genes (Figure 5.10). 
However, we did notice that mature subsets form Tcrb-/- mice seemed to have a more 
intermediate expression for some maturation associated gene clusters (Figure 5.10, purple 
boxes). Therefore we looked at the acquisition of the γδ maturation signature in mature 
populations of Tcrb-/- subsets in more detail. 
To look at the maturation signature of individual subsets, we plotted the fold 
change of mature versus immature WT subsets against the fold change of mature versus 
immature Tcrb-/- subsets and highlighted genes that increased in the γδ maturation 
signature in red and those that decreased in blue. Genes that are increased in mature 
versus immature subsets for both WT and Tcrb-/- mice are found in the upper right 
quadrant (red box) while those that decrease in mature versus immature subsets for both 
WT and Tcrb-/- are found in the lower left quadrant (blue box). The green diagonal line 
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Figure 5.9 Trans-conditioning impacts the gene expression signatures of mature γδ
T cell subsets.
(A) Scatter plots for mature subsets of Tcrb-/- mice are shown. The mean expression of 
sample replicates for all genes was plotted to compare populations of cells from WT and 
Tcrb-/- mice using Multiplot. Each dot represents one gene (mean of all probe sets), and 
dots highlighted in red represent genes whose expression is changed by greater than 2 
fold, p<0.05, cv<1. The total number of highlighted genes is listed in parenthesis at the 
top of each plot.
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Figure 5.10 Qualitative expression of the γδ maturation signature is conserved in 
Tcrb-/- γδ T cell subsets.
(A) The expression of the 585 γδ maturation signature genes in immune subsets is shown 
as a heatmap. Data were gene row normalized and hierarchically clustered by gene and 
subset, and show that immature subsets (green box) and mature subsets (pink box) 
segregate together irrespective of WT or Tcrb-/- origin. Genes are color coded (see 
legend) to display relative gene expression. Areas with quantitative differences in the 
expression of the maturation signature are highlighted with a purple box (C) Principal 
component analysis was performed on the 585 γδ maturation signature genes. The first 
and second principal components are shown and immune subsets were plotted relative to 
the distribution of the components. Immature subsets and mature subsets cluster together 
on either side of the red line irrespective of WT or Tcrb-/- origin. 
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represents the point at which the fold changes of both comparisons are equal. Therefore, 
the closer genes lie to the diagonal, the more similarly they are regulated in WT and Tcrb-
/- populations (Figure 5.11A). Looking at these comparisons, it was clear that overall, 
mature Tcrb-/- V2, V1, and V6 cells had no defect in the upregulation or downregulation 
of maturation associated genes, as all genes increased in maturation (red dots) were also 
increased in both WT and Tcrb-/- comparisons, and all genes decreased in maturation 
(blue dots) were also decreased in both WT and Tcrb-/- comparisons (Figure 5.11B). The 
fold change of maturation-associated genes was roughly equivalent in WT and Tcrb-/- V6 
cells, as most of these genes lay close to the diagonal (Figure 5.11B). In contrast, V1 cells 
had a skewed distribution of genes that are normally decreased upon maturation, as most 
of these genes were decreased to a lesser degree in Tcrb-/- V1 cells compared to WT cells. 
Further, V2 cells had a skewed distribution of both genes that were increased and 
decreased upon maturation, and in each case, Tcrb-/- V2 cells trended toward smaller fold 
changes (Figure 5.11B). These data indicated that while the overall γδ maturation 
signature is conserved in a qualitative manner, in the absence of trans-conditioning, 
maturation genes are not downregulated and upregulated to as great an extent in 
matV2/V1 and matV2 cells, respectively, as they were in WT mice, indicating a
quantitative difference in the maturation signature. These results can also be seen in the 
closer similarity of immV2 and matV2 cells from Tcrb-/- mice, which differ in the 
expression of only 365 genes, while cells from WT mice differ in expression in over 1300 
genes (Figure 5.9 and 5.1). Similarly, the difference between Tcrb-/- immV1 and matV1 
cells is less than that of WT cells (514 genes versus 865 genes) (Figure 5.9 and 5.1). 
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Figure 5.11 Trans-conditioning is required for full maturation of V2 and V1 γδ
subsets. 
 (A) Example of fold change (FC) versus FC plot. The FC between a WT mature and 
immature γδ T cell subset is plotted on the x axis, and the FC between a Tcrb-/- mature
and immature γδ T cell subset is plotted on the y axis. Dots represent a single gene, and 
its location on the graph represents the FC of that gene in the WT and Tcrb-/-
comparisons. Dots highlighted in red represent genes that were shown to be upregulated
upon maturation of all γδ T cell subsets and dots highlighted in blue represent genes that 
were shown to be downregulated upon maturation of all γδ T cell subsets (as identified in 
Figure 5.2). Genes that are increased in mature versus immature subsets for both WT and 
Tcrb-/- mice are found in the upper right quadrant (red box) while those that decrease in 
mature versus immature subsets for both WT and Tcrb-/- are found in the lower left 
quadrant (blue box). The green diagonal line represents the points at which the FCs of 
both comparisons are equal. (B) FC versus FC plots of mature versus immature γδ T cell 
subsets from WT (x axis) and Tcrb-/- (y axis) mice for V2 (top), V1 (middle), and V6 
(bottom) cells are shown. 
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Thus, in the absence of trans-conditioning, matV2 and matV1 cells retain a more 
immature gene signature. 
Trans-conditioning is required for the divergence of the mature V1 and V6 signatures
As mentioned previously, the V1 and V6 γδ T cell subsets are very similar at the 
immature stage but diverge upon maturation. Itk-/- matV1 cells were unable to diverge 
from matV6 cells, and assumed the gene signature of matV6 cells (Figure 5.8). We saw a 
similar inability to specify the matV1 fate in Tcrb-/- mice. Principal component analysis 
of the genes differentially expressed between matV1 and matV6 cells from WT mice 
showed that matV1 cells from Tcrb-/- mice clustered most closely with matV6 cells from 
WT and Tcrb-/- mice (Figure 5.12A). Similarly, hierarchical clustering of these genes 
showed that Tcrb-/- matV1 cells assume the gene expression pattern of matV6 cells 
(Figure 5.12B). These data indicate that both TCR/ITK signals and trans-conditioning 
signals are required for the divergence of matV1 cells from matV6 cells. In the absence 
of either signal, V1 cells fail to acquire the V1 gene signature and instead remain similar 
to V6 cells in their gene expression. 
Trans-conditioning is required for establishing the V2 IL-17 effector program
Total γδ T cells from Tcrb-/- mice have been shown to make less IFNγ upon 
stimulation. This could be due to improper maintenance of transcription factor expression 
that specifies effector function. When we looked at the transcription factor profile of 
Tcrb-/- γδ T cell subsets, we found several noteworthy clusters of expression (Figure 
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Figure 5.12 Trans-conditioning is required for the divergence of the mature V1 and 
V6 signatures.
(A) Principal component analysis was performed on genes differentially expressed 
between matV1.WT and matV6.WT cells (2-fold change, p<0.05, cv<1, 345 genes). The 
first and second principal components are shown and immune subsets were plotted 
relative to the distribution of the components. Subsets clustered with V6 cells are 
indicated by a red box. (B) The expression of the 345 genes differentially expressed 
between matV1.WT and matV6.WT cells in immune subsets is shown as a heatmap. Data 
were gene row normalized and hierarchically clustered by gene and subset. Shared V6 
signature genes are indicated by blue boxes. 
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5.13A). The genes in cluster 1 are normally highly expressed in matV6 cells, and Tcrb-/-
matV6 cells expressed these genes equivalently, including Plzf, Id2, Id3, and Egr2.
Overall, the transcription factor profile of Tcrb-/- matV6 was similar to that of WT 
matV6, except that they had higher expression of the transcription factors in cluster 2, 
including Gata3. Tcrb-/- V1 cells were also mostly normal, but had a specific increase in 
Eomes and Stat4 expression, as well as a few other genes (cluster 4). In contrast, the 
transcription factor profile of Tcrb-/- V2 cells was aberrant, with high expression of many 
transcription factors that are normally downregulated upon maturation (cluster 3). Tcrb-/-
matV2 express high levels of Eomes, similar to the level seen in matV1 cells. In addition, 
Tcrb-/- matV2 cells also fail to express some transcription factors, including those 
associated with IL-17 production, including Rorc and Maf (cluster 5) (85, 107). In fact, a 
most of the genes associated with IL-17 production were decreased in expression in 
matV2 Tcrb-/- cells (Figure 5.13B). These genes include Blk, which has been shown to be 
important for the development of IL-17 producing cells (84), Ccr6, Il17re, and Il23r,
Cd163l1 (SCART1), and 5830411N06Rik (SCART2) discussed previously. These data 
indicated that the overall transcription factor profiles of Tcrb-/- matV6 and V1 cells were 
normal, but V2 cells were very aberrant, with a specific loss in genes related to IL-17 
production.  
Summary and future studies:
Analysis of the gene signatures of mature γδ T cell subsets has revealed important 
information about the development and divergence of γδ T cells. We identified a 
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Figure 5.13 Trans-conditioning is required to establish the V2 IL-17 effector 
program.
(A) Heatmap of the relative expression of transcription factors in mature γδ T cell subsets 
from WT and Tcrb-/- mice. Data were gene row normalized and hierarchically clustered 
by gene and subset. Different clusters of gene expression mentioned in the text are 
highlighted and numbered. (B) Heatmap of the relative expression of select genes related 
to IL-17 function in mature γδ T cell subsets from WT and Tcrb-/- mice. Data were gene 
row normalized and hierarchically clustered by gene and subset.
180
12
3
4
5
Figure 5.13
M
at
V
1.
B
6
M
at
V
6.
B
6
M
at
V
2.
B
6
M
at
V
6.
TC
R
b-
/-
M
at
V
1.
TC
R
b-
/-
M
at
V
2.
TC
R
b-
/-
M
at
V
2.
B
6
M
at
V
2.
TC
R
b-
/-
Im
m
V
2.
B
6
Im
m
V
2.
TC
R
b-
/-A B
hi
lo
181
common molecular signature of γδ T cell maturation that was shared among all subsets. 
Importantly, this signature was also capable of accurately classifying precursor and αβ T 
cell subsets into mature and immature populations. These data indicate that the transition 
of from CD24hi to CD24lo does in fact mark a true maturation step in γδ T cells. Further, 
it indicates that a shared maturation profile exists among αβ and γδ T cells. The γδ
maturation signature was not significantly altered in the absence of ITK, but the lack of 
trans-conditioning resulted in the inability to fully upregulate and downregulate 
maturation-associated genes. Maturation of γδ T cell subsets also resulted in the 
regulation of specific chemokines and cytokines that specify effector functions, further 
elaborating and fixing the effector program that was established at the immature stage. 
Upon maturation, the gene signatures of V1 and V6 cells diverged, and V6 cells 
became more similar to αβNKT cells, with high levels of Plzf expression and other genes 
of the αβNKT signature.  This separation of matV1 and matV6 cells was dependent upon 
ITK signals and trans-conditioning. Strikingly, in the absence of either signal, matV1 
cells closely resembled the gene expression pattern of matV6 cells. This indicates that the 
default pathway for V1 γδ T cells may be toward the V6 phenotype unless TCR/trans-
conditioning signals are received that redirect cells to the V1 fate. The fact that loss of 
either ITK or trans-conditioning resulted in such a similar phenotype was surprising, and 
brings forth the possibility that these two signals may somehow be linked during γδ T cell 
development. 
The absence of trans-conditioning had a significant impact on the transcription 
factor profile of matV2 cells. Specifically, V2 cells maintained expression of many 
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transcription factors that are normally downregulated upon maturation, and they lost 
expression of many of the transcription factors and genes associated with IL-17
production. In addition, Tcrb-/- matV2 cells also showed low expression of Sox13, which 
is also important for IL-17 production, as will be discussed in the next chapter. Overall, 
these results indicate that the regulation of the V2 transcriptional profile is dependent on 
trans-conditioning signals.  
To fully determine the effect of ITK on subset development, we plan on sorting 
Itk-/- matV2 and matV6 cells. Due to the low frequency of immature (CD24hi) V6 cells in 
Itk-/- mice, we may not be able to isolate enough of these cells for adequate analysis. 
However, we may be able to analyze these subsets once we begin sorting on the 1000 cell 
protocol mentioned previously. These additional pieces of data will allow us to determine 
whether Itk-/- V2 cells, which were more similar to V1 at the immature stage, also assume 
a V6-like phenotype upon maturation. 
Analysis of the gene signatures of immature γδ T cells identified two stages of 
development, as outlined in the previous chapter. First, an ITK-independent stage in 
which the core transcription factor profile of immature γδ T cell subsets is set, evident 
immediately upon TCR expression. Second, an ITK-dependent stage in which the 
signatures of immature γδ T cell subsets diverge. Our analysis of mature γδ T cell subsets 
has identified a third stage of γδ T cell development, in which the terminal maturation of 
γδ T cell subsets occurs. During this stage, V1 and V6 cells diverge, with the latter subset 
acquiring similarities to αβNKT cells, and γδ T cell subsets modify expression of the 
chemokines and cytokines that specify effector functions. The divergence of matV1 and 
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matV6 cells is dependent upon TCR/ITK signaling and trans-conditioning, as is the V2 
effector program. The final chapter in this thesis will examine the effects of altering 
genes involved in the transcriptional networks of γδ T cell subsets that were established 
early in the development of immature cells.
Materials and methods:
Mice
CatL-/- mice were provided by Kenneth Rock and Ii-/- mice were provided by Eric Huseby 
(UMass Medical School, Worcester, MA). All mice used in these experiments were 
housed in a specific pathogen free rodent barrier facility. All animal experiments were 
approved by the University of Massachusetts Medical School Institutional Animal Care 
and Use Committee (Worcester, MA). 
Cell sorting
Samples were sorted and prepared as described in Chapter 3. Briefly, thymocytes were 
pooled from 4-20 male 5 week old C57BL/6 (Jackson Labs), Tcrb-/- mice (Jackson Labs) 
and Itk-/- mice (Leslie Berg, UMass Medical School, Worcester, MA), with the number of 
mice depending on the subset sorted. Cells were stained for cell surface markers and 
~20,000-30,000 cells were directly into Trizol (Invitrogen) using a FACSAria sorter. For 
each population, independent duplicate or triplicate samples were sorted. C57BL/6 and 
Tcrb-/- γδ T cell populations were sorted as follows: matV2, Vγ2+TCRδ+CD24-CD4-CD8-
; matV1, Vγ1.1+Vδ6.3-TCRδ+CD24-; matV6, Vγ1.1+Vδ6.3+TCRδ+CD24-. Itk-/- γδ T cell 
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populations were sorted as follows: immV1, Vγ1.1+Vδ6.3-TCRδ+CD24-; total V6, 
Vγ1.1+Vδ6.3+TCRδ+. Additional non-γδ T cell populations used for comparison in these 
studies were sorted by other members of the Immgen Consortium. The sorting details for 
these populations can be found on the Immgen website (Immgen.org).
RNA preparation and microarray processing
RNA preparation and microarray processing was performed as described in Chapter 3.
Data analysis and visualization
Data analysis was performed as described in Chapter 3.
Flow cytometry
The following cell surface antibodies were purchased from BD Biosciences or 
eBiosciences: Vγ2, Vd6.3 and TCRδ. Vγ1.1 antibody was purified from antibody 
producing cell lines by Bio-XCell and biotinylated using the FluoReporter Mini-Biotin-
XX Protein Labeling Kit (Invitrogen). All data were acquired on a BD LSRII and 
analysis was performed using FlowJo (Treestar). 
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CHAPTER VI:
TRANSCRIPTION FACTOR NETWORKS ESTABLISHED AT THE 
IMMATURE STAGE PROGRAM γδ T CELL SUBSET-SPECIFIC EFFECTOR 
FUNCTIONS
Introduction:
Our analysis of the gene expression signatures of γδ T cell subsets indicates that 
the initial transcriptional profile is set early in the thymus during the immature stage of 
development and is independent of TCR signaling and trans-conditioning. To determine 
whether the subset-specific transcription factor networks established during the immature 
stage play a role in programming the subset differentiation and effector function, we 
analyzed effector cell generation in mice lacking prototypic subset-specific genes. For 
V1/V6 cell differentiation, we investigated the role of ID3 in effector cell generation, and
for V2 cell differentiation, we determined the role of the γδ T cell lineage-specific 
transcription factor SOX13. As we had previously identified a defect in the expression of 
genes related to IL-17 production in Tcrb-/- matV2 cells and an increase in Eomes
expression, we analyzed cytokine production in Tcrb-/- γδ T cells. 
ID3 is induced by EGR downstream of TCR signaling. ID3 is a helix-loop-helix 
protein that antagonizes the function of E proteins such as E2A and HEB, which play 
important roles throughout T cell development (108). As discussed previously, Id3-/- mice 
have defects in γδ T cell development, resulting in the specific expansion of PLZF+ V6 
cells in the thymus and periphery (51). Our microarray data indicated that Id3 was 
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specifically expressed in immV1 and immV6 cells, while expression was low in V2 cells, 
making it a good candidate for the study of early transcriptional pathways in V1/V6 cells. 
Genes that are part of, or regulate, the WNT signaling pathway were highly 
expressed in immV2 cells compared to V1/V6 cells (Table 3.5). WNT signaling is critical 
for the proper development of many diverse types of cells and tissues (90). The canonical 
WNT signaling pathway is mediated by activation of WNT target genes through 
activation of β-catenin. In the absence of WNT ligands, β-catenin is sequestered in the 
cytoplasm in a complex that includes GSK3β and AXIN2 and targeted for destruction by 
the proteasome. When WNT ligands are present, β-catenin is released from the 
destruction complex and translocates to the nucleus where it interacts with TCF1 and
LEF1 to activate transcription of WNT target genes (90). The transcription factors 
TCF1/LEF1 are critical for the development of αβ lineage cells, and both are also 
expressed in γδ T cells (31). SOX13, which we previously identified as a γδ lineage-
specific transcription factor, binds to and antagonizes the activity of TCF1, thereby 
inhibiting WNT signaling (29). SOX13 expression promotes the development of γδ T 
cells at the expense of αβ T cells, and Sox13-/- mice have defects in γδ T cell 
development (29). While all immature γ δ T cells express Sox13 in the thymus as 
determined by scRT-PCR, its expression varies quantitatively in γδ T cell subsets, with 
V2 cells expressing the highest levels of Sox13 in the thymus and periphery (Figure 3.6 
and data not shown) and V1/V6 expressing lower levels of Sox13, consistent with a 
previous report (23). Therefore, we studied Sox13-/- mice in the context of V2 effector 
differentiation. 
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Results:
Subset-specific effector cytokine production during an in vivo infection 
We have shown that the transcription factor profile of immature γδ T cell subsets 
is already distinctly skewed toward the function of mature cells. In the periphery, 
CCR6+CD27- V2 cells have been shown to be biased toward IL-17 production, while 
CD27+V1 and CD27+ V2 cells are biased toward IFNγ production (42). Vγ4+ cells, most 
of which home to the uterovaginal lining, can also be found in the lung, paired with the 
Vδ1 chain, and have been shown to produce IL-17 (40). To further verify the effector 
response of γδ T cell subsets, we characterized the γδ T cell response to Mycobacterium 
Tuberculosis (m.Tb) infection. We chose this model because γδ T cells are known to be 
early responders to m.Tb infection, and they provide a source of IL-17 prior to the 
generation of the CD4+ Th17 response (109). γδ T cell deficient mice infected with m.Tb
have a more pyogenic granulomatous response (110), indicating that γδ T cells may play 
a regulatory role in granuloma formation in the lung during infection. Therefore, we 
infected WT mice with a high dose of m.Tb by aerosol infection, sacrificed them 2 weeks 
later, and measured cytokine production of cells from the lung and spleen of infected 
mice. V2, V1/V6, and Vδ1+ subsets of γδ T cells in the lung and spleen made roughly 
equivalent amounts of IFNγ, as roughly ~20% of cells from each subset were IFNγ+
(Figure 6.1A). In contrast, IL-17 production was restricted to V2 and Vδ1+ cells, while 
the number of V1/V6 cells producing IL-17 was negligible (Figure 6.1B). The V2 and 
Vδ1+ subset of γδ T cells contributed roughly equally to the total amount of IL-17 
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Figure 6.1 V2 and Vδ1+ cells that express BLK are the major producers of IL-17
after in vivo m.Tb infection.
Mice infected with 2 x 103 CFU m.Tb (n=10) were sacrificed 2 weeks post infection. 
Cells from the lung and spleen were stimulated ex vivo with PMA and ionomycin for 4 
hours. Cells were stained for surface markers and intracellular cytokine production. (A) 
Intracellular staining of IFNγ in cells from the lung (left) and spleen (right). Cells were 
gated on total γδ, V1/V6, V2, or Vδ1+ γδ T cells and the proportion of IFNγ+ cells in each 
subset was plotted. (B) Intracellular staining of IL-17 in cells from the lung (left) and 
spleen (right). Cells were gated on total γδ, V1/V6, V2, or Vδ1+ γδ T cells and the 
proportion of IL-17+ cells in each subset was graphed. (C) To show the contribution of 
each subset to the total IL-17 production, cells were gated on IL-17+γδ T cells in the lung 
(left) and spleen (right) and the proportion of IL-17+ cells that were V1/V6, V2, or Vδ1+
was graphed. (D) Representative FACS plots of cells from the spleen of m.Tb infected 
mice stained for surface markers, intracellular IL-17 and/or IFNγ, and intranuclear BLK. 
Left, gated on γδ+; right, gated on γδ+BLK+. All data is representative of 2 independent 
experiments.
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produced by γδ T cells in the lung (Figure 6.1C). In the spleen, V2 cells were the 
predominant subset of γδ T cells making IL-17, with 80% of the IL-17 coming from V2 
cells (Figure 6.1C). These data confirm that V2 and Vδ1+ are the main IL-17 producers 
during a natural infection, while V1/V6 cells are restricted to IFNγ production, consistent 
with their molecular programming in the thymus. To further characterize the phenotype 
of IL-17 producing cells during m.Tb infection, we analyzed expression of BLK. BLK is 
a member of the Src family of kinases and its expression was previously thought to be B 
cell specific. BLK was expressed primarily in CCR6+ cells and its expression was low in 
CD27+ cells. It was recently shown that Blk-/- mice are deficient in the generation of 
CCR6+ γδ T cells and have a severe defect in IL-17 producing γδ T cells, while IFNγ
production is unaffected (84). Our gene expression analysis has also shown Blk to be 
expressed specifically in immature V2 cells and significantly upregulated on matV2 cells 
(Figure 5.13 and data not shown). In m.Tb infected lungs, virtually all IL-17+ γδ T cells 
were also BLK+ (Figure 6.1D). Interestingly, gating on BLK+ γδ T cells indicated that 
they exclusively produce IL-17 and do not make any IFNγ, indicating that BLK is a 
marker of programmed subset specific cytokine production.
Aberrant cytokine production by Tcrb-/- γδ T cells
Our analysis of the gene expression profile of γδ T cell subsets from Tcrb-/- mice 
indicated a specific defect in the expression of genes related to IL-17 production, 
including Rorc, Ccr6, Il23r, and Blk. We also saw high expression of Eomes, which is 
normally only expressed highly by V1 cells. To determine the effect of these molecular 
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differences on the γδ T cell effector function, we stimulated cells from the LN and 
thymus of Tcrb-/- mice and analyzed their cytokine production. Consistent with our gene 
expression data (Figure 5.13B), IL-17 production from Tcrb-/- V2 cells in the LN was 
defective, as they produced much less IL-17 than WT mice (Figure 6.2A). Interestingly, 
Tcrb-/- V2 cells made more IFNγ than WT V2 cells (Figure 6.2A). This may be due to the 
increased expression of Eomes in Tcrb-/- V2 cells that was evident at the molecular level 
(Figure 5.13A) and was also detected upon intranuclear staining for Eomes protein (Nidhi 
Malhotra, unpublished data). Tcrb-/- V1/V6 cells also made more IFNγ than WT cells, 
contrary to previously published data that was based on the stimulation of total γδ T cells 
and indicated a defect in IFNγ production. The defects in cytokine production from Tcrb-
/- γδ T cells were evident in the thymus, as Tcrb-/- matV2 cells produced less IL-17 than 
WT matV2 cells, although we did not see a difference in thymic IFNγ production. Tcrb-/-
V1/V6 cells, however, did make more IFNγ in the thymus, perhaps due to the increased 
expression of Eomes in matV1 cells (Figure 5.13A). These data indicate that Tcrb-/- mice 
are defective in the generation of IL-17 effector V2 cells, a defect that is molecularly 
programmed in the thymus (Figure 5.13B and 6.2B). Furthermore, we saw an increase in 
the production of IFNγ from V2 and V1/V6 cells, possibly due to the increased Eomes
expression in these populations, which was unexpected given previously published 
results (33, 34).
Deregulation of effector function of V1/V6 cells in Id3-/- mice
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Figure 6.2 Aberrant cytokine production by Tcrb-/- γδ T cells.
Cells from the LN (A) and thymus (B) of WT and Tcrb-/- mice were stimulated for 4 
hours with PMA and Ionomycin and stained for cell surface markers and intracellular 
cytokine production. FACS plots were gated on V1/V6 or V2 γδ T cells and cells from 
the thymus were further gated on CD24lo cells. Data are representative of 2-3
independent experiments.  
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We next analyzed the impact of perturbation of the transcription factor network 
established in immature γδ cells. Analysis of cytokine production from the lymph nodes 
of Id3-/- mice showed that close to 90% of V1 cells were making IFNγ, compared to 
~20% of WT V1 cells. Furthermore, 15% of Id3-/- V6 cells were making IL-17, which is 
not normally made by WT V6 cells. This altered cytokine production was evident as 
early as the immature stage of development in the thymus, where increased production of 
IFNγ could be seen in Id3-/- V1 and V6 cells, along with IL-17 production by V6 cells, 
including some cells that were dual IL-17 and IFNγ producers (Figure 6.3A). EOMES 
expression was induced ectopically on V6 cells in the thymus (Figure 6.3B), possibly due 
to the increased availability of IL-4, which has been shown to induce EOMES expression 
on CD8 T cells (103). However, in the absence of Id3, EOMES expression was not 
maintained in the periphery. Despite this lack of EOMES, peripheral V1 and V6 cells 
showed enhanced IFNγ production (Figure 6.3A), indicating that the misregulation of 
other transcription factors may be compensation for lack of EOMES. As the level of Id3
expression decreases in V1/V6 cells upon maturation (Figure 5.3), these data indicate that 
key regulatory networks are established in the thymus in immature cells that are required 
to maintain EOMES expression in the periphery. These results suggest that γδ T cell 
subset-specific expression of Id3 is crucial for preventing aberrant effector cytokine 
production and sustaining subset specific transcription factor expression. 
Sox13 programs V2 effector differentiation
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Figure 6.3 Deregulation of effector function of V1/V6 cells in Id3-/- mice.
(A) Cells from the LN and thymus of WT and Id3-/- mice were stimulated for 4 hours 
with PMA and Ionomycin and stained for cell surface markers and intracellular cytokine 
production. FACS plots were gated on V1 or V6 γδ T cells and cells from the thymus 
were further subsetted based on CD24 expression. (B) Cells from the thymus, spleen and 
liver of WT and Id3-/- mice were stained for cell surface markers and intranuclear 
EOMES expression. FACS plots were gated on total γδ T cells or V6 cells. Data are 
representative of 2-3 independent experiments.  
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We previously identified SOX13 as a γδ lineage specific gene in the thymus (29).
Our gene expression analysis of γδ T cell subsets indicated that Sox13 expression was 
highest in immV2 and matV2 cells (Figure 3.6 and 5.3). Sox13-/- mice had a two-fold 
reduction in γδ T cell numbers in the thymus (Nidhi Malhotra and Katelyn Sylvia, 
unpublished data). Strikingly, V2 cells were specifically lost in the spleen of Sox13-/-
mice (Figure 6.4A). The V2 cells that remained in the periphery expressed lower levels of 
TCR on their cell surface and could not produce IL-17 upon stimulation (Figure 6.4A). 
This defect arose from the thymus, which had normal frequencies of V2 cells in young 
mice, but showed a specific loss of mature RORγt+CCR6+ cells. Additionally, almost all 
cells were CD27+ and EOMES expression was unaffected. When Sox13-/- thymocytes 
were stimulated, IL-17 production was severely defective, while IFNγ production was 
relatively normal (Figure 6.4B). Interestingly, Sox13-/- cells also showed a loss of BLK+
cells (Figure 6.4C), which we showed were the sole IL-17 producing cells during m.Tb.
infection (Figure 6.1D). BLK may be a target of SOX13, as overexpression of SOX13 
induces Blk expression (29). These results indicate that Sox13 specifically regulates the 
effector programming of IL-17 production in V2 cells beginning during thymic 
development. 
Summary and future directions:
Our data indicated that the transcription factor profile expressed early during the 
immature stage of γδ T cell development was already skewed toward the future effector 
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Figure 6.4 Sox13 programs V2 effector differentiation.
(A) Cells from the spleen and LN of WT and Sox13-/- mice were stained for cell surface 
markers. Middle, histogram is gated on γδ+ cells. Bottom, WT and Sox13-/- LN cells were 
stimulated for 4 hours with PMA and Ionomycin and intracellular cytokine production 
from V2 cells was assessed. (B) Cells from the thymus of WT and Sox13-/- mice stained 
cell surface markers or intranuclear RORγt and EOMES. Bottom, thymocytes were 
stimulated for 4 hours with PMA and Ionomycin and stained for cell surface markers and 
intracellular cytokine production. Top, gated on γδ+ cells. Remaining plots were gated on 
mature (CD24lo) V2 cells. 
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function of γδ T cell subsets. To determine whether alteration of those early networks 
impacted effector function of γδ T cells, we chose to analyze γδ T cell subsets from two 
models with altered V1/V6 or V2 specific transcription factors, ID3 and SOX13. Our 
data indicated that the lack of Id3 had a profound impact on cytokine production by 
V1/V6 cells, and that Sox13 was required for generation of the IL-17 V2 effector lineage, 
confirming that the subset-specific transcription factor networks established at the 
immature stage critically impact effector function. 
The aberrant expression of IL-17 in Id3-/- V6 cells indicates that ID3 is in part 
responsible for repressing networks that specify the IL-17 effector fate. Interestingly, it 
has recently been shown that CD4+ T cells preferentially develop into Th17 cells in the 
absence of Id3, which may be the result of deregulated E2A activity (111). Therefore, 
ID3, and the E2A/HEB proteins it regulates, may be involved in the repression or 
activation of factors involved in the IL-17 pathway 
Despite the inability of Id3-/- γδ T cells to sustain EOMES expression in the 
periphery, these cells were still capable of producing substantial amounts of IFNγ. This 
indicates that other transcription factors that regulate IFNγ production may be altered in 
Id3-/- V1/V6 cells. One candidate transcription factor is T-bet (Tbx21). The balance 
between T-bet and EOMES expression in CD8+ T cells has recently been shown to 
control their differentiation toward terminal effector versus memory fates (112). These 
two proteins may also co-regulate IFNγ production in γδ T cells, and a bias toward higher 
expression of T-bet may indicate a switch cells toward a high IFNγ producing fate. We 
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are currently investigating whether T-bet levels are elevated in Id3-/- V6 cells in the 
periphery. 
Sox13-/- mice have a decrease in total γδ T cells in the thymus, and a specific loss 
of V2 cells in the spleen, with minimal impact on other γδ T cell subsets. However, in 
older mice, all γδ T cell subsets are decreased in number (Nidhi Malhotra and Katelyn 
Sylvia, unpublished data). We have shown that the expression of most transcription 
factors decreases upon maturation of γδ T cells, and upon maturation, Sox13 expression 
remained highest in V2 cells. Sox13-/- γδ T cells showed a specific defect in the 
generation of IL-17 producing V2 cells. Sox13-/- V2 cells had a striking lack of 
CCR6+RORγt+BLK+ cells, which are linked to IL-17 production. Interestingly, 
overexpression of Sox13 in thymocytes resulted in the induction of BLK expression in 
DP cells, indicating that BLK may be a target of SOX13 (29). As mentioned previously, 
we are preparing to sort γδ T cell subsets from Sox13-/- mice for microarray analysis to 
determine its impact on the gene signatures of γδ T cell subsets and to further dissect its 
role in regulation of V2 effector function
Analysis of the gene signatures of mature Tcrb-/- γδ T cells revealed alterations in 
transcription factor expression. Tcrb-/- matV1/V6 and matV2 cells expressed higher levels 
of Eomes than their WT counterparts. In addition, matV2 cells did not express many of
the genes associated with IL-17 production. Stimulation of Tcrb-/- γδ T cells revealed a 
specific defect in IL-17 production in thymic and LN V2 cells. Additionally, IFNγ
production was increased from both Tcrb-/- V1/V6 and V2 cells, possibly due to the 
increase in Eomes expression we saw in these populations. In previous studies, 
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stimulation of Tcrb-/- γδ T cells was reported to generate fewer IFNγ+ cells. In these 
studies, γδ T cells were purified from the spleen and activated in vitro with αCD3 
antibodies for 18-72 hours in the absence of exogenous IL-2 (33, 34). The lack of IL-2 in 
these long cultures of purified γδ T cells could have led to differential fitness and/or 
survival of WT and Tcrb-/- γδ T cells, skewing their cytokine production. In contrast, we 
looked at the direct ex vivo ability of γδ T cell subsets to produce cytokines. Importantly, 
the results of our gene expression analysis correlate well with the phenotype of increased 
IFNγ production and decreased IL-17 production that we see in Tcrb-/- γδ T cell subsets, 
providing a molecular basis for the defects we observe.
Materials and methods:
Mice
Sox13-/- and Id3-/- mice have been described previously and were analyzed at 3-8 weeks 
of age. Tcrb-/- mice were purchased from Jackson Labs and were analyzed at 6-8 weeks 
of age. All mice used in these experiments were housed in a specific pathogen free rodent 
barrier facility. All animal experiments were approved by the University of 
Massachusetts Medical School Institutional Animal Care and Use Committee (Worcester, 
MA). 
m.Tb infection and analysis
WT m.Tb bacterial strains were used to infect 10 6-8 week old male C57BL/6 mice 
(Jackson Labs) with 2x103 CFU of m.Tb by the aerosol route. Two weeks post infection, 
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mice were sacrificed and cells were isolated from the spleen and lungs (by enzymatic 
digestion). Total spleen and lung cells were either stained immediately, or after culture 
with PMA and Ionomycin. 
Flow cytometry
The following antibodies used for flow cytometry were purchased from BD Biosciences 
or eBioscience: TCRδ, Vγ2, Vδ6.3, CD24, IL-17, IFNγ, EOMES, RORγt, CCR6, and 
CD27. Vγ1.1 antibody was purified from antibody producing cell lines by Bio-XCell and 
biotinylated using the FluoReporter Mini-Biotin-XX Protein Labeling Kit (Invitrogen). 
Vδ1 antibody was provided by Na Xiong (Pennsylvania State University, University 
Park, PA). BLK antibody was purchased from Santa Cruz. All intracellular cytokine 
staining was performed using the Cytofix/Cytoperm kit (BD Biosciences). All 
intranuclear staining was performed using the FoxP3 staining kit (eBioscience). All data 
were acquired on a BD LSRII and analysis was performed using FlowJo (Treestar). 
Ex vivo stimulation
Stimulation of thymic and LN cells from Tcrb-/-, Id3-/-, and Sox13-/- mice and stimulation 
of m.Tb infected spleen and lung cells was performed by culturing total cells (2x106/well) 
with PMA (10ng/ml) and Ionomycin (1ug/ml) for 4 hours at 37°C, with Golgi Stop and 
Golgi Plug (BD Biosciences) added after 1 hour, according to the manufacturers’ 
protocols. After stimulation, cells were stained for cell surface markers and intracellular 
cytokine production using the Cytofix/Cytoperm kit (BD Biosciences). In some cases, 
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cells were stained for cell surface markers, intracellular cytokine, and intranuclear BLK 
using the FoxP3 staining kit (eBioscience).
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CHAPTER VII:
GENERAL DISCUSSION
We have identified three stages of γδ T cell development based on the acquisition 
of distinct subset-specific molecular signatures. The first stage involves the expression of 
γδ subset specific transcription factors, which is established independent of TCR/ITK and 
trans-conditioning signals at the immature stage of development in the thymus. The 
second stage involves the divergence of the subset specific gene signatures, in which ITK 
mediated signals result the transition of V2 to a more quiescent state. The third stage is 
the terminal maturation of γδ T cell subsets, at which point V1 and V6 cells diverge and 
all subsets further elaborate and reinforce their effector programming by the distinct 
expression of chemokine and cytokine receptors. This stage is dependent upon both ITK 
and trans-conditioning signals. 
In the first stage, the transcription factors that program the development of 
immature subsets was established. Id3 was highly expressed in immV1/V6 cells, while 
immV2 cells showed activation of modulators of WNT signaling, such as Sox13. At the 
immature stage, V1 and V6 cells were nearly identical in their gene expression patterns, 
with less than 40 genes distinguishing them. However, even at this stage, the subsets 
expressed different levels of key transcription factors that drive their effector functions. 
Eomes was expressed more highly in immV1 cells, while Plzf expression was already 
increased in immV6 cells. Both immV1 and immV6 cells differed greatly from immV2 
cells, however, which expressed a unique cohort of factors that specified their effector 
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fate, including Blk and Rorc. Interestingly, lack of ITK and trans-conditioning did not 
significantly alter these initial transcriptional networks, indicating that they are 
established independently of these signals. 
In our investigation of other factors that influence the gene expression pattern of 
γδ T cell subsets, we considered the possibility that V2 and V1/V6 cells originated from 
different precursor cells during development. We saw that the metabolic signature of V2 
cells was more closely correlated with early ETP/DN1 precursors, while V1/V6 cells 
were more similar to DN3 cells. The expression of transcription factors, which were 
highly enriched in immV2 cells, were also more highly expressed in early precursors. 
Furthermore, V2 cells emerged at the earlier CD25+γδTCRlo stage of DN development, 
whereas V1/V6 cells were not detectable until the later CD25+γδTCRhi stage. We tested 
the ability of sorted ckit+DN1/DN2 and DN3 precursors to generate V2 and V1/V6 cells 
in an in vitro assay, and found that early precursors were biased toward the V2 fate. 
However, as discussed previously, more complex experiments would need to be 
performed to determine the full extent and effect of this differential development. 
In the second stage, immV2 cells transitioned to a more metabolically quiescent 
state, which required a signal through ITK. Strikingly, in the absence of Itk, immV2 cells 
resembled immV1/V6 cells, although they retained the V2-specific transcription factor 
profile. These data indicate that V2 cells require a signal through the TCR to fully initiate 
their molecular program and diverge from the V1/V6 cell program. This result appears to 
contradict previous data that indicate that V2 cells are TCR naïve, more so than V1/V6 
cells (21). It has been shown that antigen naïve V2 cells, which were CD122lo, could 
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make IL-17 in the absence of their ligand (21). However, γδ TCRs have been shown to 
signal through TCR dimerization during in vitro assays, independent of ligand, similar to 
the preTCR (21, 113). Similar to preTCR signaling, which does not induce the expression
of activation markers, γδ TCR dimerization may provide enough of a signal to drive the 
molecular differentiation of V2 cells without the upregulation of CD122 and other 
markers of activation. 
The lack of an effect upon the loss of trans-conditioning on the gene expression 
pattern of immature γδ T cell subsets was somewhat surprising, given previous data 
which established a set of γδ lineage-biased genes that were absent when lymphotoxin 
trans-conditioning was disrupted (33, 34). However, based on differences in the 
frequency of different γδ T cell subsets in Tcrb-/- mice, the analysis of total γδ T cells 
used in the lymphotoxin studies could be misleading. It had also been shown that CD27-
γδ T cells did not express the lymphotoxin-dependent γδ lineage-biased genes previously 
identified, setting a precedent for the notion that trans-conditioning did not have a global 
affect on all γδ T cells (42). Indeed, we saw that immV2 cells expressed lower amounts 
of most of these lymphotoxin-induced genes than immV1/V6 cells. We did not, however, 
see any differences in the expression of lymphotoxin-induced genes in Tcrb-/- γδ T cell 
subsets. These results suggest that trans-conditioning does not significantly affect γδ T 
cell development at the immature stage. 
The third stage of γδ T cell subset development is marked by the molecular 
divergence of the V1 and V6 subsets. At this point, matV6 cells highly upregulated PLZF 
and became more similar to αβNKT cells, with the additional upregulation of a number 
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of NK-like cell receptors. Interestingly, in the absence of Itk or trans-conditioning, matV1 
cells failed to diverge from matV6 cells. These data indicate that there may be a link 
between the ITK and trans-conditioning signals, although there is no evidence in the 
literature for the intersection of these two pathways. It is also possible that both of these 
signals must be integrated in order to fully attain the V1 molecular program, perhaps by
the induction of interacting coactivators that control the expression of key regulatory 
networks. The other intriguing implication of these studies is that the default fate of γδ T 
cells appears to lean toward to the V6 subset, as in the absence of Itk, V2 cells become 
like V1 cells, and in the absence of Itk and/or trans-conditioning, V1 cells become like 
V6 cells. Diverting cells away from the V6 state may require TCR and trans-conditioning 
signals that are essential for normal specification of the V2 and V1 fates. As we did not 
have gene expression data from Itk-/- matV2 cells, we were unable to determine the 
consequences of loss of Itk during both stage 2 and stage 3 of V2 development. However, 
we are planning to sort Itk-/- matV2 cells, and it will be interesting to see whether these 
cells are skewed toward a V6-like molecular pattern. 
As mentioned in the introduction, ThPOK has been proposed to be induced by 
strong TCR signaling and impact the development and function of V6 γδNKT cells (62).
However, we did not see any defect in the ability to upregulate ThPOK expression in Itk-/-
total V6 cells (data not shown), indicating that the decreased TCR signaling in Itk-/- γδ T 
does not affect ThPOK expression. These results suggest that factors other than TCR 
signal strength may control ThPOK induction in V6 cells. 
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We provided evidence that the transition of γδ T cell subsets from CD24hi to 
Cd24lo represents a true maturational step. A common set of genes are coordinately 
regulated by all γδ T cells upon transition to the CD24lo state, and these genes were also 
similarly regulated upon maturation of αβ lineage CD4+ and CD8+ single-positive cells. 
ITK did not greatly impact the maturation of γδ T cell subsets, but the lack of trans-
conditioning did affect this transition. In the absence of trans-conditioning, the genes that 
normally increase upon maturation did increase, and those that normally decrease upon 
maturation did decrease. However, the extent of the increase and decrease of maturation 
genes was smaller in each case, indicating a quantitative difference in the expression of 
the γδ maturation signature in the absence of trans-conditioning. This effect was most 
pronounced in Tcrb-/- matV2 cells and resulted in the closer similarity of Tcrb-/- matV2 
cells with immV2 cells, and indicated that trans-conditioning signals are important for the 
proper maturation of this subset. 
The transcriptional profile of γδ T cell subsets was also aberrant in Tcrb-/- mice. 
All Tcrb-/- mature subsets showed an increase in the expression of Eomes, which 
correlated with increased IFNγ production by V1/V6 and V2 cells in the LN and/or 
thymus. Expanded PLZF+ γδ T cells in the thymus that release low levels of IL-4 have 
been found to cause the upregulation of EOMES in CD8+ T cells, resulting in the 
development of innate CD8+ T cells that can rapidly produce large amounts of 
IFNγ (103). It is possible that this mechanism can also cause the upregulation of Eomes
in γδ T cells. Consistent with this mechanism, both Tcrb-/- and Id3-/- mice have expanded 
populations of V6 cells and the levels of EOMES are increased in γδ T cells in both 
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models.  In addition to an in increase in Eomes expression, Tcrb-/- matV2 cells failed to 
upregulate genes associated with specifying IL-17 effector function, and upon ex vivo 
stimulation of LN and thymic Tcrb-/- cells, fewer matV2 cells produced IL-17. Previous 
studies indicated that fewer Tcrb-/- γδ T cells produced IFNγ at the population level (33, 
34). As discussed in the previous chapter, these results may have been influenced by the 
long in vitro stimulation in the absence of IL-2 that was used in those studies. However, 
our data suggest that a reevaluation of the role of trans-conditioning with more careful 
attention to its effect on subsets of γδ T cells may be in order. 
We are assuming in these studies that defects in Tcrb-/- mice are the result of the 
lack of lymphotoxin trans-conditioning of γδ T cells. However, we saw no difference in 
the expression of lymphotoxin-regulated genes in immature Tcrb-/- γδ T cells. While there 
were some subtle decreases in the expression of some lymphotoxin regulated genes in 
certain subsets of mature Tcrb-/- γδ T cells (data not shown), they were gene and subset 
specific, different from the global effect of trans-conditioning that has been proposed (33, 
34). It is possible that lymphotoxin regulates the expression of a number of genes in γδ T 
cells, and that those identified previously represent only a small subset of lymphotoxin-
regulated genes. Therefore, it is possible that other unknown lymphotoxin-regulated 
genes are significantly altered in Tcrb-/- γδ T cells but were not able to be identified as 
such in our studies. A more rigorous study of the effects of lymphotoxin on the gene 
signature of γδ T cell subsets may help us identify additional interesting targets of 
lymphotoxin signaling. It is also possible, however, that lack of lymphotoxin is not 
responsible for the defects in mature Tcrb-/- γδ T cell subsets, and that other signals 
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mediated through αβ T cells are required for the development and maturation of γδ T 
cells. The nature of these signals is currently unclear, but the possibility should be 
investigated to confirm the role of αβ T cells in γδ T cell development. 
Similarly, we are assuming that, in these studies, that effects mediated by ITK are 
all due to signaling downstream of the TCR. γδTCR signaling does appear to act through 
ITK, as in its absence, γδ T cells cannot flux calcium upon activation (Catherine Yin, 
unpublished data). Therefore, the most likely role of ITK appears to be downstream of 
the γδTCR, by either ligand dependent activation or dimerization of the γδTCR. 
However, ITK is also downstream of FcεRI in mast cells, indicating it may have cell type 
specific functions (114, 115). Therefore, in γδ T cells, it is possible that in addition to its 
actions downstream of the TCR, ITK is also downstream of another as yet unidentified 
signal.
We showed that the transcriptional networks that were established during stage 1 
of immature γδ T cell subset development are crucial to the terminal maturation of these
cells. ID3 is active in immV1/V6 cells and acts as a negative regulator of E proteins such 
as HEB and E2A. Id3 deficiency led to the aberrant production of IL-17 by V6 cells and 
an increase in IFNγ production by V1 cells, indicating that ID3 is essential for 
maintaining proper lineage restricted cytokine production. Sox13 was expressed at the 
highest levels in immV2 cells and it antagonizes the WNT signaling pathway by 
inhibiting TCF1 activity (29). Sox13 deficiency led to the near complete absence of IL-17
production by V2 cells, indicating it is crucial for the regulation of IL-17 V2 effector 
functions. In both models, defects in effector function originated in the thymus, 
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indicating that the transcriptional networks established early in γδ T cell development are 
essential for subset-specific effector function.  
Overall, there are three major implications of our data. First, our data indicate that 
V2 and V1/V6 cells may represent two distinct lineages of γδ T cells. The gene 
expression profile of immV2 cells was as different from immV1 and immV6 cells as it 
was from αβ lineage semi-mature CD8+ T cells in terms of the total number of 
differentially regulated genes. Our data indicate that V2 and V1/V6 cells may originate 
from different precursors, and that they depend on different transcriptional networks for 
their effector differentiation (Sox13 for V2, and Id3 for V1/V6). These results indicate 
that V2 and V1/V6 cells may be separate lineages of γδ T cells. The second major 
implication of our data is that there are multiple steps during the development of γδ T cell 
subsets that may require TCR signaling. Whether these steps involve positive selection 
with ligand interaction or simply TCR dimerization is unclear. The third major 
implication is that the transcriptional networks that are established transiently during in 
immature γδ T cell development are critical for programming their functional 
development. The expression of most transcription factors is downregulated upon 
maturation of γδ T cell subsets, however, it is clear from our analysis of Sox13 and Id3
deficient mice that alteration of these early networks has a significant impact on the 
effector differentiation of V2 and V1/V6 cells, respectively. 
We propose the following models to summarize our data regarding the molecular 
differentiation of γδ T cells (Figure 7.1, Figure S10). Under physiological conditions, V2 
cells primarily arise from earlier ETP/DN2 precursors while V1/V6 cells arise primarily 
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Figure 7.1 Model: Molecular programming of γδ T cell subsets during thymic 
development.
V2 cells primarily arise from early ETP/DN2 precursors, while V1/V6 arise primarily 
from later DN3 precursors, and they retain traces of the gene signatures of their 
respective precursors. The transcriptional networks present at stage 1 condition the 
development of immature cells, with the modulation of the WNT-TCF1 pathway by 
SOX13 in V2 cells, and the modulation of the HEB/E2A pathway by ID3 in V1/V6 cells. 
Stage 1 immature cells express the transcription factors that control their future effector 
differentiation. ImmV2 cells express RORγt, immV1 cells express high levels of 
EOMES, and immV6 cells express PLZF. Transition to stage 2 requires ITK signaling in 
V2 cells, and in its absence, V2 cells resemble V1 cells. Transition to stage 3 marks the 
divergence of V1 and V6 cells. Transition to stage 3 requires ITK signaling and trans-
conditioning of V1 and V6 cells, and in the absence of either signal, V1 resemble V6 
cells. Trans-conditioning is also necessary for the transition of V2 cells to stage 3, and in 
its absence, V2 cells maintain a more immature phenotype. Final maturation results in the 
induction of distinct cytokine and chemokine receptors that result in the full acquisition 
of effector function and cytokine production. Orange dashed arrows represent the 
developmental path in the absence of ITK, and red dashed arrows represent the 
developmental path in the absence of trans-conditioning. 
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from later DN3 precursors, and these cells retain traces of the gene signatures of the 
precursor cells from which they arise. V2 cells can likely also arise from later precursors, 
but these cells may be phenotypically distinct. The transcriptional networks present at 
stage 1 condition the development of immature cells, with the modulation of the WNT-
TCF1 pathway by SOX13 in V2 cells, and the modulation of the HEB/E2A pathway by 
ID3 in V1/V6 cells. Stage 1 immature cells express the transcription factors that control 
their future effector differentiation. ImmV2 cells express RORγt, immV1 cells express 
high levels of EOMES, and immV6 cells express PLZF. Transition to stage 2 requires 
ITK signaling in V2 cells, and in its absence, V2 cells resemble V1 cells. Transition to 
stage 3 requires ITK signaling and trans-conditioning of V1 and V6 cells, and in the 
absence of either signal, V1 cells resemble V6 cells. Trans-conditioning is also necessary 
for the transition of V2 cells to stage 3, and in its absence, V2 cells maintain a more 
immature phenotype. Final maturation results in the induction of distinct cytokine and 
chemokine receptors that result in the full acquisition of effector function and cytokine 
production (Figure 7.1). 
As discussed previously, conventional αβ CD4+ T cells leave the thymus and 
enter the periphery as naïve cells. In the periphery, naïve CD4+ T cells interact with 
pathogens and, based on the cytokine milleu, generate distinct effector lineages. In 
contrast, our data indicate that γδ T cell effector lineages are generated directly from DN 
precursors in the thymus, prior to interaction with antigen, and these cells are exported 
into the periphery as premade effector cells (Figure S10). The thymic programming of γδ
T cell effector functions obviates the need for a lengthy peripheral effector education 
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process and  allows γδ T cells to respond rapidly to antigens to provide early protection 
from pathogens. Thymic programming of effector function may be a general mechanism 
used by the immune system to produce innate-like lymphocytes that function early in 
infections, and may apply to the generation of other innate-like subsets such as αβNKT 
cells.  
These data provide a new picture of γδ T cell development regulated by multiple 
checkpoints that shape the acquisition of subset-specific molecular signatures and 
effector functions in the thymus. We are currently sorting immature and mature subsets 
of fetal γδ T cells, and analysis of the gene signatures of these populations should help us 
identify the similarities and differences in fetal versus adult γδ T cell development. 
Analysis of the gene expression profile of γδ T cell subsets from additional mutant mice, 
such as Sox13-/- and Id3-/- mice, may help us better understand the impact of these early 
transcriptional networks. In addition, further analysis of the gene signatures identified by 
our experiments are expected to reveal interesting new regulators of γδ T cell subset 
development that can be explored to dissect the complex development and function of 
these distinct innate-like T cells.  
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SUPPLEMENTAL FIGURES
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Figure S1 Effector subset generation in αβ and γδ T cells.
(Top) Effector generation of conventional αβ T cells occurs in the periphery. αβ T cells 
develop from DN precursors and progress to the CD4+CD8+ DP stage. They then undergo 
positive and negative selection in the thymus and are exported into the periphery as naïve 
cells. Upon interaction with antigen and based on the cytokine environment, CD4+ T cells 
induce the expression of specific transcription factors and that control their effector 
differentiation into distinct T helper (Th) subsets. These subsets make specific 
combinations of cytokines, with Th1 making IFNγ, Th2 making IL-4 and IL-13, Th17 
cells making IL-17, and Tfh cells making IL-21. In addition to these effector subsets, 
innate-like αβNKT cells that make IFNγ and IL-4 simultaneously are also found in the 
periphery. (Bottom) γδ T cells have effector subsets that correspond to the αβ Th subsets, 
with Th1-like, Th17-like, and NKT-like subsets of γδ T cells. As γδ T cells are innate-
like cells, this provides the immune system with a complementary early and late effector 
cells during pathogen infection. However, the mechanism by which these cells acquire 
their effector phenotypes is unknown. 
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Figure S2 Sorting details for γδ T cells.
Three subsets of γδ T cells were sorted from the thymus of C57BL/6 mice. For each 
population, immature (CD24hi) and mature (CD24lo) cells were sorted. The phenotype 
and γ and δ chain pairings for each population is listed, as well as the major effector 
cytokines produced by the subset. The designations that will be used throughout this 
thesis are listed to the left of each population. 
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Figure S3 Summary of the three stages of γδ T cell effector differentiation.
Microarray analysis of γδ T cell subsets has identified three stages of γδ T cell effector 
development, which are summarized here. The first two stages occur in immature 
(CD24hi) cells while the third stage occurs upon maturation (CD24lo). During the first 
stage, distinct subset-specific transcription factor profiles are established in γδ T cell 
subsets independently of TCR signaling. During the second stage, the remainder of the 
V2 molecular program is specified, which depends on TCR signaling. During the third 
stage, upon maturation, the subsets diverge further into distinct effector lineages. 
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Figure S4 The transcriptional networks that specify effector function in distinct 
lineages of γδ T cells evident at the immature stage.
Immediately after TCR expression, immV1/V6 cells are very different from immV2 cells 
at the molecular level. V1 and V6 cells are very similar at this stage, indicating γδ T cells 
may consist of at least two lineages distinguished by Vγ gene usage. The transcriptional 
networks that specify subset-specific function are already evident at the immature stage. 
V2 cells express Rorγt and modulators of Wnt signaling such as Sox13, while V1/V6 
cells express Id3, which modulates E protein function. Although V1 and V6 cells are very 
similar at the immature stage, they are distinct in their expression of transcription factors 
that specify effector function, with immV1 cells expressing Eomes and immV6 cells 
expressing PLZF. 
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Figure S5 ITK functions downstream of TCR signaling.
TCR signaling results in recruitment of LCK, which phosphorylates ITK.  ITK in turn 
phosphorylates PLCγ, which leads to the cleavage of PIP2 into IP3 and DAG, which go 
on to activate calcium flux and the PKC-MAPK pathway and turn on transcription of 
NFAT and AP1, respectively. 
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Figure S6 Schematic of the Vγ genomic locus.
Schematic showing the genomic location of various Vγ genes. Vγ2 is part of the Cγ1
cluster, which also contains most of the other Vγ genes. Vγ1.1 is part of the Cγ4 cluster 
cluster, which is further downstream (~20-30kb) in the genomic locus. 
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Figure S7 Schematic of OP9-DL1 culture procedure.
OP9-DL1 cells were plated in 96 well flat bottom plates two days prior to sorting. Early 
precursors (ckit+DN1/ckit+DN2) or late precursors (DN3) were sorted onto the 
monolayers at 500 or 1000 cells/well, respectively, and cultured in the presence of IL-7
and Flt3 ligand for 6 days. On day 6, after precursors had divided and differentiated, cells 
from each well were stained for the γδ  TCR, Vγ1, and Vγ2 to determine the frequency of 
each subset that was generated. 
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Figure S8 First two stages of molecular programming of γδ T cell subsets during 
thymic development.
V2 cells primarily arise from early ETP/DN2 precursors, while V1/V6 arise primarily 
from later DN3 precursors, and they retain traces of the gene signatures of their 
respective precursors. The transcriptional networks present at stage 1 condition the 
development of immature cells, with the modulation of the WNT-TCF1 pathway by 
SOX13 in V2 cells, and the modulation of the HEB/E2A pathway by ID3 in V1/V6 cells.
Stage 1 immature cells express the transcription factors that control their future effector 
differentiation. ImmV2 cells express RORγt, immV1 cells express high levels of 
EOMES, and immV6 cells express PLZF. Transition to stage 2 requires ITK signaling in
V2 cells, and in its absence, V2 cells resemble V1 cells. 
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Figure S9 V2 and V1/V6 cells diverge upon TCR expression, whereas V1/V6 cells 
diverge upon maturation.
Immediately after TCR expression, immV1/V6 cells are very different from immV2 cells 
at the molecular level. ImmV1 and immV6 cells are very similar at this stage, indicating 
γδ T cells may consist of at least two lineages distinguished by Vγ gene usage. Upon 
maturation, V1 and V6 cells diverge, and all populations of γδ T cells are distinct in gene 
expression. 
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Figure S10 Distinct mechanisms of effector subset generation in αβ and γδ T cells.
(Top) Effector generation of conventional αβ T cells occurs in the periphery. αβ T cells 
develop from DN precursors and progress to the CD4+CD8+ DP stage. They then undergo 
positive and negative selection in the thymus and are exported into the periphery as naïve 
cells. Upon interaction with antigen and based on the cytokine environment, CD4+ T cells 
induce the expression of specific transcription factors and that control their effector 
differentiation into distinct Th subsets. These subsets make specific combinations of 
cytokines, with Th1 making IFNγ, Th2 making IL-4 and IL-13, Th17 cells making IL-17, 
and Tfh cells making IL-21. In addition to these effector subsets, innate-like αβNKT 
cells that make IFNγ and IL-4 simultaneously are also found in the periphery. (Bottom) 
γδ T cell effector lineages are generated directly from DN precursors in the thymus, prior 
to interaction with pathogens, and exported to the periphery as pre-made effector cells. 
The thymic programming of effector function allows γδ T cells to rapidly produce 
cytokines upon interaction with pathogens, and may be a general mechanism for the 
generation of innate-like lymphocytes that act early after infection.
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APPENDIX:
TRIM13 IS A NEGATIVE REGULATOR OF MDA5-MEDIATED TYPE I IFN 
PRODUCTION
Introduction:
A crucial component of the host defense against viral infections is the activation 
of the type I interferon (IFN) response, which is initiated by detection of viral RNA or 
DNA by host pattern recognition receptors. The cytosolic proteins retinoic-acid-inducible 
gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5) are essential 
intracellular sensors of viral RNA that discriminate between different classes of RNA 
viruses. RIG-I senses the nascent 5’ triphosphate moiety of viral genomes or virus 
derived transcripts of negative-sense single-stranded RNA viruses, whereas MDA5 is 
activated by long double-stranded (ds)RNA, a typical intermediate of the replication of 
plus-sense single-stranded RNA viruses. For example, RIG-I is responsible for detection 
of Newcastle disease virus, vesicular stomatitis virus (VSV), and Sendai virus (SV), 
while MDA5 is important for recognition of picornaviruses, represented by 
encephalomyocarditis virus (EMCV) and Mengovirus (116). The importance of the type I 
IFN pathway is underscored by the numerous immune evasion strategies used by viruses 
to target and interfere with components of the pathway. Tight control of type I IFN 
production is crucial to the host as evident from recent studies which link dysregulation 
of the IFN response to autoimmune diseases such as Systemic Lupus Erythematosis 
(117).
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Several members of the Tripartite Motif (TRIM) family of proteins have emerged 
as central regulators of anti-viral immunity. Many TRIM proteins, including TRIM5α
and TRIM19 (PML), inhibit the activity of numerous viruses including HIV and murine 
leukemia virus (118). In addition to direct interference with viral entry and replication, 
several TRIM family members are involved in the regulation of the type I IFN response. 
Interestingly, two TRIM proteins specifically target the RIG-I pathway: TRIM23 acts as 
a positive regulator of RIG-I and toll-like receptor 3 activity by polyubiquitinating
nuclear factor kappa B (NF-κB) essential modulator (NEMO) (119), and TRIM25 was 
shown to ubiquitinate RIG-I, a key modification that enables RIG-I to induce type I IFN 
production upon viral infection (120). Whether similar regulation of MDA5 occurs is 
unknown. It was recently shown that many TRIM proteins are upregulated in innate 
immune cells treated with type I IFNs (121, 122) indicating that other TRIM proteins are 
also likely to play important roles in the immune response to viruses. 
A unique subgroup of TRIM proteins that contain a transmembrane domain in 
their C-terminal regions consists of only two proteins: TRIM13 and TRIM59 (69).
TRIM13 is an E3 ubiquitin ligase with auto polyubiquitination properties. It localizes to 
the nuclear and endoplasmic reticulum (ER) membranes, and may play a role in ER-
associated degradation, a process that removes unfolded and misfolded proteins from the 
ER (76). As mentioned previously, Trim59 and IFT80 encode a joint transcript termed 
IFT80L, mutation of which may be associated with some cases of Jeune syndrome, a 
developmental disease in humans (78). Recent data indicate that overexpression of c-Myc
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in small lung cancer cell lines leads to the repression of Trim59 by promoter 
hypermethylation, indicating that Trim59 may play a role in oncogenesis  (79).
In the immune system TRIM13, but not TRIM59, was shown to be upregulated upon 
culture of human macrophages with LPS and IFNγ, which activates IFNβ production in 
macrophages (122, 123). As multiple TRIM proteins play roles in the antiviral response, 
we sought to determine the role of TRIM13 in innate immunity and type I IFN 
production. 
Results:
Trim13 expression is increased in innate cells upon stimulation with inducers of type 
I IFNs
Given the similarity in the sequence and structure of TRIM13 and TRIM59, it was 
necessary to determine whether these genes were coordinately regulated and possibly 
redundant in myeloid cells, or whether they had different expression patterns suggestive 
of distinct functions. We had previously investigated the expression of Trim13 and 
Trim59 in sorted immune cell subsets and precursors by quantitative real-time RT-PCR 
(qPCR) and found that while the expression of Trim13 and Trim59 do overlap, they also 
show distinct patterns, especially in the secondary lymphoid tissues (Figure 2.3 and 2.11). 
To determine the expression of Trim13 and Trim59 in the myeloid lineage, we generated 
BM derived macrophages (BMDMs) and cultured the cells in the presence of media 
alone or various inducers of type I IFN for 6 hours. Analysis by qPCR showed that 
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Trim13 and Trim59 have the opposite pattern of expression in macrophages (Figure 8.1A 
and 8.1B). Trim13 was expressed in unstimulated macrophages and its expression was 
increased upon stimulation with LPS, dA:dT, polyI:C, but only marginally increased with 
SV, and unchanged with EMCV. In contrast, Trim59 expression was highest in 
unstimulated BMDMs, and its expression decreased after stimulation with each of these 
agents. Expression of both genes was low in ex vivo dendritic cells. These results suggest 
that TRIM13 and TRIM59 may have unique roles during the development and/or 
function of macrophages. 
TRIM13 and TRIM59 inhibit MDA5-mediated type I IFN induction
Several E3 ubiquitin ligases, including TRIM25, RNF135 (REUL), Triad3A, and 
RNF125 have been shown to directly regulate type I IFN production in innate cells by 
activating (120, 124) or inhibiting (125, 126) RIG-I function. In contrast, RNF-125 is the 
only E3 ubiquitin ligase shown to modify MDA5, which it does by ubiquitin conjugation 
that targets MDA5 for degradation (125). Given that TRIM13 is an E3 ubiquitin ligase 
that is upregulated in human macrophages (122, 123) and murine BMDMs in type I IFN-
stimulating conditions (Figure 8.1), we investigated whether TRIM13 also modulates
type I IFN production through the RIG-I or MDA5 pathway. First, we performed 
luciferase reporter assays in HEK293T cells using a reporter plasmid regulated by the 
IFNβ enhancer (p125). Expression of TRIM13 alone in HEK293T cells did not activate 
the IFNβ luciferase reporter (Figure 8.2A). Transfection of expression plasmids 
containing MDA5, RIG-I, mitochondrial antiviral-signaling (MAVS), which is 
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Figure 8.1 Trim13 and Trim59 have distinct expression patterns in BMDMs.
BMDMs were stimulated with various inducers of type I IFN for 6 hours and analyzed 
for Trim13 and Trim59 mRNA expression by qPCR. DCs, CD11c+ DCs. Data shown 
were normalized to β-actin and are expressed as the mean ±SD of duplicate qPCR 
analysis and are representative of two independent experiments. 
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Figure 8.2 TRIM13 inhibits MDA5-mediated induction of type I IFN through an 
IRF3 dependent mechanism.
(A) HEK293T cells were transfected with 40ng of indicated plasmids in the presence of 
increasing amounts of TRIM13 or TRIM59 plasmid (4, 40, or 80ng) and activation of 
full-length p125 IFNβ luciferase reporters was monitored. (B) HEK293T cells were 
transfected with 40ng empty vector or RIG-I in the presence of increasing amounts of 
TRIM13 (20, 40, or 60ng, left) or TRIM59 (20, 40, or 60ng, right) plasmid and activation 
of full-length p125 IFNβ luciferase reporters was monitored.  (C) HEK293T cells were 
transfected with 40ng of indicated plasmids in the presence of increasing amounts of 
TRIM13 plasmid and activation of PRDIII-I luciferase reporter was monitored. (D) 
HEK293T cells were transfected with increasing amounts of TRIM13 or TRIM59
plasmid and induction of NF-κB luciferase reporters was monitored. (E) HEK293T cells 
were transfected with 40ng of indicated plasmids in the presence of increasing amounts 
of TRIM13 plasmid and activation of PRDIII-I luciferase reporters was monitored. 
Numbers above bars show the percent of PRDIII-I activation with the level of activation 
observed at 20ng of TRIM13 set at 100%. All data shown are expressed as the mean ±SD 
of triplicates normalized to renilla luciferase and are representative of at least three 
independent experiments. vector, empty vector. ND, not detected.
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downstream of MDA5 and RIG-I in the type I IFN pathway, and TANK-binding kinase 
1(TBK1), downstream of toll-like receptor-induced type IFN signaling, activated IFNβ
luciferase reporters in HEK293T cells as expected (Figure 8.2A, 8.2B). When co-
expressed, TRIM13 inhibited MDA5-dependent activation of the IFNβ reporter in a dose 
dependent manner (Figure 8.2A). However, TRIM13 had no or minimal effect on the 
ability of TBK1, MAVS, or RIG-I to activate the IFNβ reporter (Figure 8.2A, 8.2B). 
Interestingly, TRIM59 had a similar inhibitory effect on MDA5-mediated type I IFN 
reporter activation (Figure 8.2A, 8.2B). These data suggested that TRIM13 and TRIM59 
primarily regulate type I IFN production by inhibiting the MDA5-mediated pathway. 
The IFNβ enhancer contains four positive regulatory domains (PRD) where 
transcription factors bind. PRDIII-I contains the binding sites for IRF3 and IRF7, while 
regions II and IV contain sites for NF-κB and ATF-2/c-Jun, respectively. TRIM13 
inhibited MDA5 mediated activation of the full IFNβ promoter construct (Figure 8.2A) 
and the PRDIII-I construct (Figure 8.2C), but did not inhibit activation of PRDII or 
PRDIV (Figure 8.3A and 8.3B). These results suggest that TRIM13 specifically 
modulates the activities of IRF3/IRF7. TRIM13 was not able to inhibit PRDIII-I
activation in the presence of a constitutively active form of IRF3 (IRF3 5D) (Figure 
8.2C), implying that TRIM13 interferes with the MDA5 pathway upstream of IRF3. 
Moreover, the inability of TRIM13 to block MAVS-driven IFNβ reporter gene activity 
(Figure 8.2A) suggests that TRIM13 modulates MDA5 signaling upstream of MAVS. 
Interestingly, TRIM13, but not TRIM59, was able to activate PRDII constructs (Figure 
8.3A and unpublished data) and NF-κB luciferase reporters (Figure 8.2D) on its own in 
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Figure 8.3 TRIM13 does not inhibit MDA5 mediated activation of PRDII or PRDIV.
HEK293T cells were transfected with increasing amounts of TRIM13 plasmid in the 
presence or absence of 40ng MDA5 and activation of the PRDII (A) or PRDIV (B) 
luciferase reporters was monitored. All results are expressed as the mean ±SD of 
triplicates normalized to renilla luciferase and are representative of at least three 
independent experiments.  
250
0 20 40 60
0
1
2
3
0 20 40 60
0
5
10
15
A
B
fo
ld
 in
du
ct
io
n
PRDII (NF?b) luciferase
MDA5
vector
Trim13 (ng)
 PRDIV (ATF2/c-Jun) luciferase
MDA5
vector
fo
ld
 in
du
ct
io
n
Trim13 (ng)
Figure 8.3
251
this assay. Hence, we tested whether the mechanism by which TRIM13 was inhibiting 
MDA5-mediated IFNβ production required NF-κB activation. Transfection of a mutant 
form of inhibitor of NFκb kinase (IκBα 	, which acts as a potent inhibitor of NF-κB 
activation (called the IκBα-super repressor) had no effect on the ability of TRIM13 to 
inhibit MDA5-driven IFNβ responses (Figure 8.2E). Thus, inhibition of MDA5 mediated 
type I IFN production by TRIM13 involves inhibition of IRF3 activation and is not 
dependent on the ability of TRIM13 to drive NF-κB activation.
TRIM13 interacts with MDA5 and RIG-I
Many of the E3 ubiquitin ligases that regulate the activity of RIG-I have been 
shown to directly interact with the protein (120, 124, 125). To determine whether 
TRIM13 binds to or indirectly regulates the intracellular viral sensors to affect type I IFN 
production, we generated a V5 tagged version of TRIM13 and performed co-
immunoprecipitation experiments in 293T cells. TRIM13 co-immunoprecipitated with 
MDA5 and RIG-I, but not with AIM2, a cytosolic sensor of dsDNA that is part of the 
inflammasome response. (Figure 8.4). This result suggests that TRIM13 regulates MDA5 
through either a direct, physical association, or as part of a multi-protein complex that 
involves intermediaries. While TRIM13 can also bind to RIG-I, this interaction alone has 
minimal functional consequences in vitro (Figure 8.2B), suggesting that additional factors 
are important for controlling RIG-I activity.
Trim13-/- mice exhibit improved resistance to EMCV infection
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Figure 8.4 TRIM13 interacts with MDA5.
293T cells were transfected with 1.5ug of indicated plasmids for 24 hours and lysates 
were immunoprecipitated (IP) with anti-Flag antibodies and immunoblotted (IB) with 
anti-Flag and anti-V5 antibodies. WCL, whole cell lysate. hc, Ig heavy chain. Data shown 
are representative of three independent experiments. 
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The results from in vitro assays of TRIM13 function indicate that TRIM13 may 
be a specific negative regulator of MDA5. To determine whether TRIM13 non-
redundantly regulates MDA5 activity in vivo, we made use of the Trim13-/- mice we had 
generated previously (Figure 2.6). Trim59 expression was relatively unaltered in Trim13-
/- BMDM under various stimulation conditions (Figure 8.5), indicating that the expression 
of Trim13 and Trim59 is independently regulated. As expression of TRIM13 was able to 
inhibit the ability of MDA5 to induce type I IFN activity in vitro, we investigated 
whether lack of Trim13 would result in enhanced type I IFN production in vivo and 
whether this alteration would result in improved protection from viral infection. It has 
been shown previously that the response to the picornavirus EMCV is entirely dependent 
on MDA5 (encoded by Ifih1), but not RIG-I (127). When Ifih1-/- and WT mice were 
infected with EMCV (100 PFU), all Ifih1-/- mice died within 3 days of infection, while 
WT mice survived 2-3 days longer (127). Serum IFNα production from Ifih1-/- mice 4 
hours after a high dose EMCV infection (1 x 107 PFU) was completely absent and 
correspondingly, viral titers in the heart at 48 hours post infection were several logs 
higher in Ifih1-/- mice than in WT controls. In contrast, there was no survival difference 
between Ddx58-/- (RIG-I-deficient) and WT mice upon EMCV infection (127). If Trim13 
acts as a negative regulator of MDA5 in vivo, Trim13-/- mice infected with EMCV should 
exhibit a survival advantage. To test this, we infected WT and Trim13-/- mice with a 
lethal dose (1000 PFU) of EMCV-K i.v. and monitored their longevity and health. 
Trim13-/- mice survived significantly longer than WT mice after EMCV infection (Figure 
8.6A). This improved protection was restricted to the female mice, as there was no 
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Figure 8.5 Trim13 deficiency does not affect levels of Trim59 in BMDMs.
BMDMs were generated from WT and Trim13-/- mice and cultured in the presence of 
media alone or various stimuli for 6 hours and analyzed for Trim13 (top) and Trim59
(bottom) mRNA expression by qPCR.  Data shown are normalized to β-actin and are 
expressed as the mean ±SD of duplicate qPCR analysis and are representative of two 
independent experiments.
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Figure 8.6 Trim13-/- female mice show improved protection from lethal EMCV 
infection and increased IFN production.
(A) WT and Trim13-/- mice were infected with 1000 PFU of EMCV i.v. and monitored 
for survival. WT male n=8, KO male n=8, WT female n=9, KO female n=9. One female 
WT mouse in the infected cohort was removed from analysis as no virus was injected. 
Results shown are representative of three independent experiments. WT females vs. 
Trim13-/- females p<0.02, Gehan-Breslow-Wilcoxon Test. (B) WT and Trim13-/- mice 
were infected with 107 PFU of EMCV i.v.  Serum was collected 5 hours post-infection 
and IFN levels were measured by bioassay. WT male n=5, KO male n=5, WT female 
n=10, KO female n=10. The log2 of the reciprocal of the endpoint dilution was graphed.
Results shown are combined from two independent experiments. Asterisk, p < 0.05 
(Student’s t test).
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survival advantage in male mice. This difference likely arises from the reported 
differences in the susceptibility of male and female mice to EMCV that occur in a virus 
dose-dependent manner (128, 129).
We next determined whether the enhanced protective response to EMCV in 
Trim13-/- mice correlated with increased type I IFN production in the mice. Type I IFN 
production is central to the host immune response against EMCV, as evidenced by the 
significantly increased kinetics of mortality of EMCV infected Ifnar1-/- mice compared to 
WT mice. Ifnar1-/- mice die within 2 days of lethal EMCV infection, succumbing to 
infection even more quickly than Ifih1-/- mice (127). Therefore, we determined whether 
the enhanced protective response to EMCV in Trim13-/- mice correlated with increased 
type I IFN production in the mice. We injected mice with a high dose of EMCV-K (1 x 
107 PFU) and measured functional serum IFN levels 5 hours post-infection by bioassay.  
Female Trim13-/- mice showed significantly increased levels of type I IFN compared to 
WT female mice, while there was no difference in type I IFN production among male 
mice (Figure 8.6B). Together, these results show that female mice lacking Trim13
produce more type I IFN upon infection with EMCV, which likely contributes to the 
improved survival of female Trim13-/- mice. These results support the conclusion that 
TRIM13 negatively regulates MDA5 in vitro and in vivo.
Summary and future directions:
We show that Trim13 is expressed in multiple subsets of immune cells and that it 
is upregulated in activated BMDMs. TRIM13 specifically inhibits MDA5-mediated 
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activation of IFN reporters in an IRF3-dependent, but NF-κB independent manner. 
TRIM13 interacts with MDA5 and inhibits its function in vitro and in vivo. Consistent 
with a role for TRIM13 in the inactivation of MDA5-mediated innate immune responses, 
mice lacking Trim13 showed increased production of type I IFNs and enhanced 
resistance against a lethal challenge with EMCV. Collectively, these results demonstrate 
that TRIM13 is as a negative regulator of MDA5-mediated IFNα/β production. 
TRIM13 is an ER and nuclear membrane resident E3 ubiquitin ligase that belongs 
to a family of proteins that are gaining prominence as central regulators of innate and 
adaptive immune sensors to viruses. RIG-I and MDA5 are the major sensors that detect 
virus specific nucleic acid motifs in the cytoplasm of infected cells. While the absolutely 
essential regulation of RIG-I function by accessory factors such as TRIM25 is well 
established, less is known regarding the mode of control of MDA5 activity. Here we 
demonstrate that TRIM13 and its closest relative, TRIM59, specifically inhibit MDA5 
activity in vitro. Critically, TRIM13 performs a non-redundant function in modulating the 
MDA5-mediated response to EMCV infection in vivo. Whether TRIM59 performs a 
similar function in vivo was not tested as Trim59-/- mice have not been generated. 
However, given the rapid reduction in Trim59 expression after stimulation of BMDMs 
(Figure 8.1B), this possibility appears to be unlikely. Another TRIM protein, TRIM22, 
also controls EMCV resistance in HeLa cells, but this pathway involves the 
ubiquitination of a viral protease (130). Hence, TRIM proteins are predicted to regulate 
diverse host defensive strategies against viral infection in the cytoplasm.
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Recently, the ER resident protein stimulator of interferon genes (STING) has been 
shown to interact with RIG-I and MAVS to positively regulate type I IFN production  
(131). STING in turn is negatively regulated by TRIM56 (132). These data link the ER 
pathway with that of type I IFN induction, and combined with the ER-resident TRIM13 
regulation of MDA5, identifies the ER as a crucial regulatory site, and TRIM proteins as 
the key modulators of viral RNA sensing and activation of downstream innate effectors. 
Elucidation of the mechanism of function of TRIM13 in controlling MDA5 should reveal 
new facets of this regulatory circuit in innate immune responses.
Materials and methods:
Mice 
Trim13-/- mice were generated as described in Chapter II. Mice were backcrossed to 
C57BL/6 for 8 to 10 generations. All mice used in these experiments were housed in a 
specific pathogen free rodent barrier facility. All animal experiments were approved by 
the University of Massachusetts Medical School Institutional Animal Care and Use 
Committee (Worcester, MA).
Reagents
The luciferase plasmids p125, PRDII-I, PRDII, and PRDIV in the pLuc-MCS vector have 
been described previously (133). The IRF-3D plasmid was a gift from John Hiscott 
(McGill University, Montreal, Canada). TRIM13-V5 was generated by PCR cloning the 
coding sequence of TRIM13 into the pcDNA3-V5 vector using the pcDNA3.1/V5-his 
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TOPO TA expression kit (Invitrogen).
Culture and Stimulation of BMDMs
BM cells were isolated from C57BL/6 mice and cultured for 8-12 days in DMEM 
(Cellgro) containing 10% heat-inactivated fetal calf serum (Hyclone), Cipro (UMMS 
Pharmacy), and 20% L929 supernatant. The differentiation state of the cells was 
confirmed by flow cytometric analysis of F4/80 (Caltag) and CD11b (Pharmingen) 
expression. BMDMs were plated at a concentration of 1x106/ml in 4ml of media and 
treated with LPS 100ng/ml (LPS purified from Sigma), transfected with poly-dAdT 
(Sigma) at 2ug/well (Lipofectamine, Invitrogen), transfected with poly I:C (Amersham) 
at 2ug/well, infected with SV at 300HAU/ml (Charles River Laboratories), or infected 
with EMCV at  an MOI of 20:1 (a gift from Michael Diamond) for 6 hours. RNA from 
BMDMs was extracted with the RNeasy kit (Qiagen Inc) according to the manufacturer's 
instructions. cDNA was synthesized using the iSCRIPT cDNA Synthesis kit (Biorad).
Isolation of DCs
To induce expansion of CD11c+ DCs, B6 mice were injected with the B16-FLT3L 
melanoma cell line (from Ulrich von Adrian Harvard Medical School, Boston, MA and 
Glen Dranoff, Dana Farber Cancer Institute, Boston, MA) at ~3x106cells/mouse in 300ul 
PBS subcutaneously. Spleens were harvested 14 days after injection and CD11c+DCs 
were isolated using the CD11c selection kit (Stem Cell Technologies) according to the 
manufacturer’s directions.
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Quantitative real time PCR
RNA was prepared from cell subsets using the Trizol reagent (Invitrogen) and cDNA was 
prepared using Sensiscript RT (Quiagen). qPCR was performed using SYBR Green 
(Applied Biosystems) on a BioRad iCycler using the following primers: Trim13-51-for 
5’-AAC GAA CTG GCT CTC TCC AC-3’ Trim13-143-rev 5’-CTT CTT CAA GCA 
GCT CCA TTA C-3’; Trim59-179-for 5’-GTC CAG ATC AGG AGA TTG ACA GAC-
3’ Trim59-292-rev 5’-TGT ATG AGA GCA TGG TAG TAC ACG G-3’ β-actin-for 5’-
CTA GGC ACC AGG GTG TGA TGG-3’ and β-actin-rev 5’-TCT CTT TGA TGT CAC 
GCA CGA-3’.  
Luciferase reporter assays
HEK293T were transfected with 40ng of the indicated luciferase reporter gene together 
with 40ng of thymidine kinase Renilla luciferase reporter gene (Promega) and the 
indicated amount of expression plasmids using Genejuice (Novagen). In all experiments, 
cell lysates were prepared 24 hours after transfection using 5x Lysis Buffer (Promega) 
and reporter gene activity was measured using luciferase substrate (made at UMMS) and 
Coelenterazine (Renilla Substrate, Biotium). 
IP and Western blotting
293T cells were transfected with plasmids containing TRIM13-V5, MDA5-flag, RIG-I-
flag, or AIM2-flag (1.5ug each) using Lipofectamine Plus (Invitrogen) for 24 hours. 
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Lysates were made with radioimmune precipitation lysis buffer (RIPA, 150mM NaCl, 
50mM Tris-HCL ph 7.5, 1% Nonidet P-40, 0.25% Na-deoxycholate, 0.1% SDS, 1mM 
EDTA) with protease inhibitors (1mM Na3VO4, 2mM NEM, and 1mM PMSF, and 
Roche complete protease inhibitor). Lysates were immunoprecipitated overnight with 
anti-Flag M2 antibody (Sigma), and complexes were pulled down using Protein A 
agarose beads (Roche) and washed with RIPA buffer and RIPA buffer containing 0.5M 
NaCl. Samples were resuspended in sample lysis buffer (BioRad). Lysates were resolved 
by SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. 
Membranes were incubated with anti-V5 (Invitrogen) or anti-Flag M2 (Sigma) and the 
appropriate secondary horseradish peroxidase antibody. Proteins were detected by 
chemiluminescence (Pierce).
EMCV infection and IFN bioassay
For survival experiments, Trim13-/- and Trim13+/+ animals were injected with 1,000 PFU 
of EMCV-K i.v. (a gift from Michael Diamond) and monitored for survival. For IFN 
production measurements, Trim13-/- and Trim13+/+ mice were injected with 1 x 107 PFU 
of EMCV-K i.v. and serum was collected 5 hours after infection and used in type I IFN 
functional bioassays as described previously (134). Briefly, sera collected from mice and 
control human recombinant IFNα (PBL Interferon Source) were serially diluted (2-fold) 
in a 96-well flat-bottom plate that was seeded with 2 x 104 L-929 cells (NCTC clone 
929). The following day, cells were infected with 7.5 x 105 PFU VSV. Two days post-
infection, cell morphology and cytopathic effects were monitored, and the amount of 
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functional IFN was measured as the last dilution of serum or control recombinant IFNα
to provide any protection from VSV-mediated cytopathic effects (termed endpoint 
dilution). Due to the 2-fold serial dilutions, the log2 of the reciprocal of the endpoint 
dilution was graphed.
Statistical Analysis
Data were analyzed using the Student’s t test or Gehan-Breslow-Wilcoxon Test (for 
survival curves).  A p value of less than 0.05 was considered significant.  
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